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Function and Regulation of Bin1 in Membrane Remodeling
Abstract
The cellular membrane is a highly heterogeneous and dynamic system whose compositions and
morphologies are delicately controlled by the interplay between lipids and proteins. For instance,
membranes with distinct curvature exist in various types of organelles. Dynamic membrane remodeling is
essential in a variety of physiological functions. Membrane remodeling serves as an active regulatory
mechanism in eukaryotic cells to locally accumulate lipids or proteins as hot spots to transduce signals.
Membrane reshaping processes are found in important cellular activities, such as cell migration, division,
viral budding/fusion, and endocytosis. Bin/Amphiphysin/Rvs (BAR) domain proteins are a group of
peripheral proteins capable of sensing, generating and stabilizing curved membranes. Mutations or
deletions of BAR domains impair membrane tubulation inside cells and often lead to onset of human
diseases. In this dissertation, I aim to provide biophysical measurements to understand the molecular
mechanisms by which BAR domain proteins reshape the underlying membranes and how membrane
curvature generation is regulated. Furthermore, this study aims to shed light on how disease- associated
mutations in BAR domains contribute to the pathogenesis of human myopathies.
The protein I am interested in is called BIN1 isoform8, an N-BAR domain containing protein exclusively
expressed in striated muscle tissues. BIN1 functions in the biogenesis of T-tubules, which are
invaginations from the plasma membrane. They propagate action potentials to accomplish excitationcontraction coupling. Three mutations (K35N, D151N and R154Q) in the BAR domain of BIN1 have been
discovered in patients with centronuclear myopathy (CNM), a congenital muscular disorder in which
nuclei are centrally mislocated, and impaired organization of T-tubules has been reported. I found that
BIN1 disease mutants disrupt membrane tubulation both in vivo and in vitro. The deformation capacity of
BIN1 N-BAR mutants strongly depends on lipid composition. The R154Q mutant generates smaller
membrane curvature compared to wild-type (WT) N-BAR, while the D151N mutant is unable to tubulate
membranes under certain experimental conditions. Quantification of protein density on membranes
revealed a lower membrane-bound density for R154Q compared to WT and the other mutants, which
appears to be the primary reason for the observed deformation incapacity. Interestingly, none of the
mutants showed a significantly compromised curvature sensing ability.
At modest protein concentrations, `budding' structures were found on liposomes that are hypothesized to
be intermediates during the tubulation process except for the D151N mutant. Chemical crosslinking
assays suggested that the D151N mutant is unable to oligomerize on membranes. Although an
insignificant difference between WT and K35N N-BAR was found in in vitro assays, actin depolymerization
in live cells allowed tubulation of plasma membranes through the K35N mutant.
Another focus of this dissertation is to understand how the membrane curvature sensing & generation
(MC-S&G) ability of BIN1 is regulated in the full-length (FL) BIN1. In addition to the N-terminal BAR
domain, BIN1 contains a muscle-specific polybasic motif (exon10) as the phosphoinositide binding
module and a C-terminal Src Homology 3 (SH3) domain for the downstream signaling protein
recruitments, such as dynamin2 in muscle cells. We hypothesize that the interactions between exon10
and SH3 domain allow an autoinhibitory regulation in BIN1-FL. We established that the SH3 domain binds
to the exon10 motif stronger than the proline-rich domain (PRD) of dynamin2 due to the electrostatic
nature of exon10-SH3 interactions. In addition to blocking dynamin2 membrane recruitment by the
exon10-SH3 complex, we found that the MC-S&G ability of BIN1-FL is inhibited on membranes lacking
PI(4,5)P2. Addition of PI(4,5)P2 in the membranes activates BIN1 to sense and induce membrane
curvature. The co-presence of SH3 domain and exon10 motif leads to the strongest phosphoinositidemediated control of BIN1 function. Addition of SH3 domain ligand (such as dynamin2 derived PRD
peptide), as well as addition of water-soluble PI(4,5)P2 analog, can both enhance the MC-S&G ability of

BIN1 on PI(4,5)P2-absent membranes, indicating that the key step to activate BIN1 is to disrupt the
exon10-SH3 interaction. Nonsense mutation K436X, found in centronuclear myopathy (CNM) patients,
abolishes the SH3 domain binding with both exon10 and PRD motif, resulting in increased membrane
deformation capacity. Overall, our results suggest an autoinhibition model for BIN1 that involves a
synergistic regulation by membrane composition and protein- protein interactions.
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ABSTRACT
FUNCTION AND REGULATION OF BIN1 IN MEMBRANE REMODELING
Tingting Wu
Tobias Baumgart
The cellular membrane is a highly heterogeneous and dynamic system whose
compositions and morphologies are delicately controlled by the interplay between lipids
and proteins. For instance, membranes with distinct curvature exist in various types of
organelles. Dynamic membrane remodeling is essential in a variety of physiological
functions. Membrane remodeling serves as an active regulatory mechanism in eukaryotic
cells to locally accumulate lipids or proteins as hot spots to transduce signals. Membrane
reshaping processes are found in important cellular activities, such as cell migration,
division, viral budding/fusion, and endocytosis. Bin/Amphiphysin/Rvs (BAR) domain
proteins are a group of peripheral proteins capable of sensing, generating and stabilizing
curved membranes. Mutations or deletions of BAR domains impair membrane tubulation
inside cells and often lead to onset of human diseases. In this dissertation, I aim to
provide biophysical measurements to understand the molecular mechanisms by which
BAR domain proteins reshape the underlying membranes and how membrane curvature
generation is regulated. Furthermore, this study aims to shed light on how diseaseassociated mutations in BAR domains contribute to the pathogenesis of human
myopathies.
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The protein I am interested in is called BIN1 isoform8, an N-BAR domain
containing protein exclusively expressed in striated muscle tissues. BIN1 functions in the
biogenesis of T-tubules, which are invaginations from the plasma membrane. They
propagate action potentials to accomplish excitation-contraction coupling. Three
mutations (K35N, D151N and R154Q) in the BAR domain of BIN1 have been
discovered in patients with centronuclear myopathy (CNM), a congenital muscular
disorder in which nuclei are centrally mislocated, and impaired organization of T-tubules
has been reported. I found that BIN1 disease mutants disrupt membrane tubulation both
in vivo and in vitro. The deformation capacity of BIN1 N-BAR mutants strongly depends
on lipid composition. The R154Q mutant generates smaller membrane curvature
compared to wild-type (WT) N-BAR, while the D151N mutant is unable to tubulate
membranes under certain experimental conditions. Quantification of protein density on
membranes revealed a lower membrane-bound density for R154Q compared to WT and
the other mutants, which appears to be the primary reason for the observed deformation
incapacity. Interestingly, none of the mutants showed a significantly compromised
curvature sensing ability.
At modest protein concentrations, ‘budding’ structures were found on liposomes
that are hypothesized to be intermediates during the tubulation process except for the
D151N mutant. Chemical crosslinking assays suggested that the D151N mutant is unable
to oligomerize on membranes. Although an insignificant difference between WT and
K35N N-BAR was found in in vitro assays, actin depolymerization in live cells allowed
tubulation of plasma membranes through the K35N mutant.
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Another focus of this dissertation is to understand how the membrane curvature
sensing & generation (MC-S&G) ability of BIN1 is regulated in the full-length (FL)
BIN1. In addition to the N-terminal BAR domain, BIN1 contains a muscle-specific
polybasic motif (exon10) as the phosphoinositide binding module and a C-terminal Src
Homology 3 (SH3) domain for the downstream signaling protein recruitments, such as
dynamin2 in muscle cells. We hypothesize that the interactions between exon10 and SH3
domain allow an autoinhibitory regulation in BIN1-FL. We established that the SH3
domain binds to the exon10 motif stronger than the proline-rich domain (PRD) of
dynamin2 due to the electrostatic nature of exon10-SH3 interactions. In addition to
blocking dynamin2 membrane recruitment by the exon10-SH3 complex, we found that
the MC-S&G ability of BIN1-FL is inhibited on membranes lacking PI(4,5)P2. Addition
of PI(4,5)P2 in the membranes activates BIN1 to sense and induce membrane curvature.
The co-presence of SH3 domain and exon10 motif leads to the strongest
phosphoinositide-mediated control of BIN1 function. Addition of SH3 domain ligand
(such as dynamin2 derived PRD peptide), as well as addition of water-soluble PI(4,5)P2
analog, can both enhance the MC-S&G ability of BIN1 on PI(4,5)P2-absent membranes,
indicating that the key step to activate BIN1 is to disrupt the exon10-SH3 interaction.
Nonsense mutation K436X, found in centronuclear myopathy (CNM) patients, abolishes
the SH3 domain binding with both exon10 and PRD motif, resulting in increased
membrane deformation capacity. Overall, our results suggest an autoinhibition model for
BIN1 that involves a synergistic regulation by membrane composition and proteinprotein interactions.
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Chapter 1 Introduction and Motivation1
1.1 Structures, characteristics and biological functions of cell membranes
Cell membranes are highly heterogeneous bilayer structures which provide
physical barriers for organelle compartmentation[1]. The heterogeneity results from the
types of lipids, transmembrane proteins, peripheral proteins and lipid/protein
microdomains in membranes[1,2]. Lipids are the basic blocks of membranes. They are
amphipathic molecules that spontaneously self-assemble into bilayer structures in order
to hide the hydrophobic tails from solution[2,3] (Fig. 1A). Lipids in eukaryotes contain a
diacylglycerol backbone with a variety of headgroups[4]. Structures of fatty acyl chains
and headgroups extend the diversity of lipid compositions in different organelles. For
example, lipid compositions vary significantly between the outer and inner leaflets of
plasma membranes (PM). The outer leaflet is enriched in PC, sphingomyelin (SM), and
glycolipids, whereas the inner leaflet contains higher percentages of PE, PS, and PI[5-7].
Phosphatidylinositol, such as phosphatidylinositol 4, 5-bisphosphate (PI(4,5)P2) is a
quantitatively minor lipid in membranes[5,8]. However, it is an important messenger to
mediate protein assemblies on membranes to transduce signaling[8-10]. Demixing of
lipids leads to co-existences of nanometer-sized lipid phases (termed as lipid rafts),
causing local composition fluctuations in membranes[11].
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In addition to the heterogeneity resulting from variations in lipid compositions,
proteins associated with the membrane (Fig. 1A) contribute to the complexity of cell
membranes as well[1]. Proteins interacting with cell membranes can be divided into three
groups: integral (transmembrane) proteins (such as ion channels, proton pumps and Gprotein-coupled receptors), lipid-anchored proteins and peripheral proteins.[1] Formation
of protein microdomains on membranes demonstrates a variety of biological
functions[12,13] (Fig. 1A). In this study, I will focus on the interactions between
peripheral proteins and plasma membranes.
1.2 Shape transitions in cell membranes
Cell membranes are dynamic. Membranes with different shapes co-exist in cells,
ranging

from

flat

membrane

sheets

in

Golgi,

vesicular

liposomes

like

endosomes/phagosomes, to the tubular structures in filopodia[2,14-16] (Fig. 1B).
Dynamic membrane shape transitions are tightly coupled to biological processes, such as
secretion, viral entry, cell mobility and material recycling[14,17-19]. Clathrin-mediated
endocytosis (CME) is one of the well-studied processes during which continuous changes
in membrane curvature are induced and stabilized by the sequential recruitment of
proteins to the endocytic site[20-22]. CME is characterized as a precisely regulated
spatial & temporal assembly of the endocytic machinery at the plasma membrane to
achieve uptake of nutrients and signaling molecules (Fig. 2A). During CME, the F-BAR
protein Fer/Cip4 homology domain-only protein (FCHo) is believed to first arrive at the
clathrin-coated pit to stabilize the shallow curvature of budded membranes, which is
followed by subsequent recruitments of endophilin, amphiphysin and dynamin to further
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constrict the neck region of the endocytic vesicle, which is finally pinched off from
plasma membranes[23-25] (Fig. 2A). Another example of a membrane reshaping process
is filopodia formations involved in neurite outgrowth and cell migrations[26]. Filopodia
formation requires proteins capable of producing membrane protrusions (Fig. 2B). The
Rho family GTPase effector, IRSp53, is activated through the association with the GTPbound Cdc42 protein and induces negative membrane curvatures with the help from
action polymerization. IRSp53 anchors actin cytoskeleton at plasma membranes to
facilitate membrane shape transitions[27,28] (Fig. 2B). SLIT-ROBO Rho GTPaseactivating protein 2 (srGAP2) is another protein involving in the filopodia formation in
neurons[29-31]. Defects in membrane remodeling often lead to disordered cellular
functions and human diseases, which I will discuss in more detail in Chapter 1.7.
1.3 Peripheral proteins involved in modulating membrane shapes
Membrane curvatures can be generated via different mechanisms including
changes in lipid compositions, influences from transmembrane proteins, cytoskeleton
remodeling and interplay with peripheral proteins[14]. Here I will focus on membrane
remodeling processes mediated by peripheral proteins. Peripheral proteins that can induce
curved

membranes

are

known

as

membrane-sculpting

proteins[14].

Bin/Amphiphysin/Rvs (BAR) domain-containing proteins (Figs. 3A-D) are one group of
membrane-sculpting proteins that exist as homodimers which bind to membranes with a
banana-shaped interface[32,33]. Upon membrane association, the underlying membrane
is constrained to fit into the concave surface of BAR domain proteins[17,34]. Endophilin,
amphiphysin and sorting nexin are members in the BAR domain family. They are
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sequentially recruited to the necks of budded endocytic vesicles to achieve scission
during CME[35-37]. Membrane-sculpting proteins lacking intrinsically curved
membrane-binding interfaces induce curvatures via amphipathic helix insertion[38-40].
Epsin (Fig. 3E) in CME[14] and ADP ribosylation factor (ARF) proteins in the COPI
vesicle trafficking[41] contain a disordered polypeptide which folds into an amphipathic
α-helix on membranes. The helix penetrates into the bilayer as a wedge and causes
asymmetry between two leaflets[14,38,39]. Sometimes, BAR domain proteins can utilize
multiple mechanisms simultaneously to regulate membrane shapes, which I will discuss
in detail in Chapter 1.4.
1.4 Structural characteristics of BAR domain proteins and their physiological
functions
Thus far, we have discussed the importance of coupling between membrane
morphologies and cell signaling events. However, how different membrane curvatures
are precisely regulated is yet not completely understood. In this work, the focus is to shed
light on the molecular mechanisms of membrane curvature generation & regulation by
Bin/Amphiphysin/Rvs (BAR) domains, which participate in endocytosis, exocytosis and
organelle generation[42]. The BAR domain family is characterized as a structurally
conserved helical bundle dimerizing into a curved interface for membrane
interactions[15,20,43,44]. Depending on the arc length and structural uniqueness, BAR
family is divided into three subfamilies: 1) N-BAR domain, containing an N-terminal
amphipathic helix allowing for membrane insertion; 2) Fes/CIP4 homology BAR (F	
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BAR) and 3) Inverse BAR (I-BAR) containing a convex interface to induce negative
membrane curvature (Figs. 3A-D)[45,46].
1.4.1 Structural characteristics of BAR domain proteins

The BAR domain was first identified as a 260 amino acid, α-helix enriched
module in early 1990s[47-49]. In 2004, Peter et al. first solved the Drosophila
amphiphysin BAR structure[50], which allows further exploration of the structurefunction relationship in BAR domains[51-55]. Based on the sequence homology, N-BAR
domains are characterized into the arfaptin group, amphiphysin group, endophilin group,
BAR-pleckstrin homology domain (BAR-PH) group, and phox-BAR domain (PX-BAR)
group in sorting nexins (SNX)[33]. A BAR monomer consists of 3 long helices
connected by two turning loops (Figs. 3A-D)[51,52]. The monomer possesses a half-cone
shape with a three-helix bundle in center and a two-helix bundle at the distal end[51,52].
BAR domain is believed to exist in solution as a homodimer (Figs. 3A-D)[33].
Hydrophobic residues are accumulated at one side of the central three-helix bundle
driving dimerization to hide the hydrophobic residues[51,52]. Dimerization contact areas
vary from 2100 Å2 in amphiphysin2 to 6400 Å2 in APPL1 BAR-PH domain[33].
Remarkably large free energy gains resulting from dimerization suggest that BAR dimers
are stable. Moreover, recent Förster Resonance Energy Transfer (FRET) measurements
revealed dynamic monomer exchanges in endophilin N-BAR and led to the discovery of
a dimerization affinity of a nano-molar scale, further supporting the conclusion that BAR
domains function as a dimer[56].
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A BAR dimer is symmetrical and banana-shaped. Besides enhancing protein
stability, the dimeric structures of BAR domains are related to their membrane sculpting
functions. Membrane-binding interfaces are concave in N-BAR and F-BAR domains and
convex in I-BAR domains (Figs. 3A-D)[51-55]. Positively charged residues are enriched
at the concave/convex surfaces for electrostatic binding with membranes. Mutational
studies discovered key residues at the concave/convex interfaces which would
compromise membrane binding and tubulation ability of BAR domains[50,53,57,58].
Convex surfaces in I-BAR proteins such as MIM and IRSp53, are consistent with the
biological functions of I-BAR proteins to induce membrane protrusions instead of
invaginations[28,59].
Structural characteristics relating to the membrane deformation capacities of three
BAR domain subfamilies are shown in Figs. 3A-D. The intrinsic curvatures of the
concave/convex surfaces, controlled by the angle of the dimerization, the length of the
arm and the directions of the kinks in the helices[33,45], are different in three subfamilies.
Overall, BAR domains demonstrate a correlation between protein structures and
membrane curvature generating/sensing functions.
1.4.2 Cellular functions of BAR domains

Physiological functions of BAR domains are to change membrane morphologies
during cell signaling processes[45]. Neuronal isoforms of endophilin and amphiphysin
are recruited to clathrin-coated pits at neurological synapses to facilitate the growth of
endocytic vesicles and recruit dynamin to achieve membrane scissions[43,60-64]. F-BAR
proteins, such as CIP4 and FBP17, participate in cell membrane protrusions to form
	
  

6	
  

	
  

filopodia essential for cell mobility and polarity[65-68]. A recently reported chemically
inducible dimerization assay (CID) allows real-time investigations of BAR domains
distributions in vivo and characterizations of membrane shapes induced by BAR
domains[69]. This study demonstrated that BAR domain proteins in each subfamily show
different preferences in subcellular locations and different capacities in membrane
curvature generation. N-BAR domains are accumulated at plasma membranes and induce
membrane tubulation. N-BAR domains are also recruited to ER and Golgi, generating
membrane tubulation[69]. In contrary, F-BAR is mainly recruited to ER forming puncta
ranging from 1 to 3 µm in length[70]. I-BAR proteins are enriched on plasma membranes
and mitochondria, triggering the formations of membrane protrusions[69,71]. Clearly, the
BAR domain proteins control membrane shapes in an organelle-specific manner[16,69].
1.5 Mechanisms of membrane curvature sensing & generation (MC-S&G)
Several mechanisms have been proposed to explain how N-BAR domains induce
membrane curvatures (Fig. 3F).
1.5.1 Protein scaffolding

Crystal structures of BAR domain superfamily reveal a dimerized helical bundle
with a concave or convex surface (Figs. 3A-D)[51-55]. Positively charged residues are
located on the concave/convex surfaces for membrane association. BAR domain dimers
are intrinsically curved, forcing the membranes underlying BAR domains to adopt the
geometry compatible with the curvature of BAR domains[14]. This explained why BAR
domains from different subfamilies generate membrane tubules with various diameters
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(20-40 nm by N-BAR, 30-100 nm by F-BAR and 40-100 nm by I-BAR)[50,58,59,68,7274]. In order to fulfill the scaffolding mechanism, protein-membrane interactions must
satisfy the following requirements that the protein-membrane binding interface is curved,
rigid and large enough to induce a defined topology on membranes[14]. Proteins from
BAR domain family show different intrinsic curvatures of membrane-binding interface,
thus leading to a wide variety of membrane shapes in cells[69].
1.5.2 Hydrophobic insertion into the lipid bilayer

Some BAR domains contain amphipathic helices that are able to penetrate into the
lipid bilayer[40,75]. For instance, endophilin contains an N-terminal amphipathic helix
H0 and a central insert helix Hi. H0 is unstructured in solution and folds into an α-helix on
membranes. The folded helix is amphipathic and exposes all the hydrophobic residues to
the alkyl-chains inside membranes. Helix insertion is driven by hydrophobic interactions.
Membrane insertion acts as a ‘wedge’ to induce asymmetry between the inner- and outerleaflet.

Helix

insertion

allows

BAR

domains

to

sense

membrane

curvature[15,34,37,39,45]. Protein-liposome co-sedimentation studies showed that the
deletion of insertion helix H0 or Hi in endophilin reduces the amount of proteins bound to
membranes[76]. Additionally, removing H0 leads to loss of membrane curvature sensing
ability of endophilin in the “single liposomes of different diameters and therefore
curvature” (SLiC) assay[38,40,77]. Lipid packing defects are the binding sites where
amphipathic helices are able to penetrate into membranes. The density of lipid packing
defects on curved membranes is much higher than on the flat ones, thus an increase in
BAR domain density on curved membranes was observed[38,77]. Extent of helix
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insertion determines the membrane morphologies induced by BAR domains[78]. Proteins
containing multiple inserting helixes even promote membrane fission to produce vesicles
around 20-30 nm in diameter (a process termed as vesiculation)[79]. Consistently,
deletion of the inserting helix significantly compromises the tubulation and vesiculation
capacity of N-BAR domain proteins. Besides BAR domains, helix insertion is a general
mechanism employed by proteins to deform membranes. Epsin is such a protein involved
in the early stage of clathrin-mediated endocytosis (CME) to facilitate membrane
budding. It contains an insertion domain (epsin ENTH domain, Fig. 3E) to sense and
generate membrane curvature[80].
1.5.3 Oligomerization

Oligomerization on the curved membrane is essential for BAR domain
functions[14,17,34]. Cryo-electron microscopy and single particle reconstruction have
demonstrated that BAR domains assemble into lattice-like structures on tubular
membranes[68,74,81,82]. However, the arrangements of proteins on membrane tubules
differ among BAR domain subgroups. F-BAR domain in CIP4 was shown to form a
helical coat via lateral tip-to-tip interactions among adjacent F-BAR dimers[81,83].
Lattice of endophilin N-BAR domains on cylindrical membrane tubules is mediated by
the N-terminal inserting helix H0[74]. Additional modes of oligomerization arrangements
via the distal arms in endophilin were reported by Mizuno et al.[82]. It is hypothesized
that the patterns of BAR domain assembly controls the ultimate membrane morphologies
induced by proteins[44,82].
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1.5.4 Protein Crowding

A relatively recent membrane curvature generation mechanism has been reported
that proteins can induce membrane deformation independent of their molecular
structures[84]. Hayden et.al discovered that the lateral pressures generated by collisions
among the membrane-bound proteins drive membranes to bend. It has been demonstrated
that green fluorescent protein (GFP) alone can induce tubulation from large unilamellar
vesicles (GUVs) at the protein density exceeding certain threshold[84,85]. Molecular
crowding can be a general mechanism by which steric congestion on cellular membranes
could assist curvature generation.
1.6 BIN1-structures, biological functions and involvements in human diseases
In this chapter, we will discuss about the biological significances of studying the
membrane curvature sensing & generation ability of the N-BAR domain protein called
BIN1 and its implications in the pathogenesis of human diseases.
1.6.1 BIN1 gene and its tissue-specific domain organizations & functions

BIN1 is an amphiphysin-like gene conserved in the evolution from yeast to
human. It is also known as Myc box-dependent interacting protein-1, bridging integrator1 or SH3P9[49,86]. The gene encoding BIN1 is subjective to alternative splicing,
yielding in tissue-specific isoforms[87,88]. Human BIN1 gene is located on chromosome
2q14 and contains 20 exons encoding several structural and functional important modules
in BIN1[87,89]. Exons 7, 13, 14, 15, and 16 are brain specific, present in the neuronal
isoforms 1-7[86,90,91]. Isoform 8 contains a phosphoinostol-interacting motif and is only
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expressed in the skeletal muscle tissues[90,92-94], whereas isoform 9 and 10 are
ubiquitously expressed[87,90].
Exons 1-10 encode the N-BAR domain in BIN1. The crystal structure of BIN1 NBAR domain shows a concaved homodimer congruent to the structure of other BAR
domains such as Drosophila amphiphysin and murine endophilin BAR domains[52],
although little sequence similarities were found in these three proteins. The BIN1 dimer
consists of two segments. Two α-helices are at the distal ends packing as a conventional
antiparallel, left-handed coiled-coil[52]. The center of the BIN1 BAR dimer comprises a
six-helix bundle associated in an antiparallel fashion. Dimerization of BIN1 N-BAR is
driven by the ‘knob-into-holes’ interactions in which nonpolar residues are buried in a
hydrophobic core[52]. The first 50 residues are not resolved in the crystal structure due to
the high degree of disorder in solution. However, projection of the first 33 residues to a
helix wheel predicts an amphipathic nature[93]. Such N-terminal amphipathic helix,
usually termed H0, is commonly found in the N-BAR domain family and allows for
membrane penetration to sense and induce membrane curvatures[77]. Computational
simulation, Cryo-EM and FRET measurements suggest that H0 has multiple roles in
regulating N-BAR domain functions. In addition to inserting into lipid packing defects
for curvature sensing, H0 is believed to involve in directing protein assembly on the
tubular membranes[74,95]. Moreover, H0 is proposed to autoinhibit the rate of subunit
exchange among BAR dimers via the intra-dimer/inter-monomer association with the Cterminal Src Homology 3 Domain (SH3 domain)[56,96]. The concave surface of BIN1
N-BAR fits a sphere of 220 Å in diameter[52], resulting from the angle at which two
	
  

11	
  

	
  

monomers intersect, and the kinks produced by proline 144 and 207[52]. The intrinsic
curvature of BIN1 is comparable to endophilin and Drosophila amphiphysin. A close-up
analysis of the electrostatic potential of the BIN1 dimer suggests that the basic residues
are enriched at the concave surface and the distal arms while the convex surface is
negatively charged. Such bipartite charge distribution aids the electrostatic interactions
between BIN1 and membranes as well as facilitating alignments of neighboring dimers
into oligomeric lattice on membranes.
Following the N-BAR domain is a phosphoinositol-interacting module encoded by
exon11[94,97,98]. This PI-interacting module is a polypeptide sequence enriched in
lysine and arginine residues (in this dissertation, it is termed exon10 motif)[98]. In-vitro
protein-liposome co-sedimentation showed that the extended BIN1 N-BAR domain
containing exon10 (BIN1 N-BAR* domain) can recognize PI(4,5)P2 in membranes and
increase the amount of BIN1 binding to membranes containing PI(4,5)P2[94]. Exon 10 in
isoform8 is muscle-specific. It has been reported that the exon10 motif in BIN1 is crucial
for the biogenesis of tubular membranes in skeletal muscle tissues called transverse
tubules (T-tubules)[94,98]. Only the N-BAR* domains are able to induce plasma
membrane invaginations[94]. This is consistent with the notion that T-tubules are
enriched in PI(4,5)P2. During myocyte differentiation, both the expressions of BIN1 and
PI(4,5)P2 are up-regulated. Recently, it was discovered that membrane-bound BAR
domains can induce PI(4,5)P2 clustering and inhibit the lateral diffusion of both bound
lipids and proteins[99]. BAR domain induced phase boundaries are hypothesized to serve
as the hot spots for protein assembly and membrane scission[99]. Additionally, exon10
motif was found capable of associating with the C-terminal SH3 domain to regulate the
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downstream ligand recruitments and protein conformations[100], which will be discussed
in detail in Chapter 4.
The N-BAR domain and the exon10 motif are the main modules to interact with
membranes. Additionally, BIN1 can contain a clathrin and AP2 (CLAP) binding domain
encoded by exons 13-16[86,90]. The CLAP domain only exists in isoforms 1-7, which
are exclusively expressed in the brain[101]. Clathrin and AP2 are the proteins functioning
in clathrin-mediated endocytosis (CME) at the neuronal synapses[61]. CME is
characterized as a well-controlled assembly of endocytic proteins at plasma membranes
to form nascent vesicles for the intracellular trafficking of receptors and cargo[102].
Clathrin and AP2 initiate membrane budding[61]. The presence of the CLAP domain in
the brain-specific isoforms of BIN1 highlights the involvement of BIN1 in clathrinmediated endocytosis.
The Myc-binding domain (MBD) is encoded by exon17[49]. The MBD domain in
BIN1 is responsible for the interactions with transcription factor c-Myc. Misregulation of
BIN1 isoforms containing MBD is related to disorders in cell apoptosis, leading to
cancers[49,87].
The C-terminus of BIN1 contains a Src Homology 3 (SH3) domain encoded by
exon 19 and 20[86,89]. The SH3 domain serves as an adaptor for downstream ligand
recruitment[103]. SH3 domains are found in a great variety of BAR domain proteins
despite their sequential/structural variations[100]. The SH3 domain recruits downstream
proteins primarily by the interactions with its canonical PxxP ligands[100,103,104]. For
instance, endophilin recruits dynamin to the neck of a clathrin-coated pit to accomplish
membrane scission[105,106]. Recruitment of dynamin is achieved through the
	
  

13	
  

	
  

hydrophobic interaction between the aromatic residues in SH3 domains and the PxxP
sequence in dynamin[107-109]. The crystal structure of the BIN1 SH3 domain shows
several notable features different from other SH3 domains found in BAR domaincontaining proteins. The SH3 domain in BIN1 contains a negative electrostatic patch
covering a large portion of its dynamin binding interface. This patch explains the
requirement of amphiphysin2 for two conserved arginines in the PxRPxR consensus
sequence[104].
1.7 Biological functions of BIN1 and its implications in human diseases
1.7.1 Interactions with cytoskeleton

Previous experimental results have demonstrated that BIN1 can regulate the
cytoskeleton network[87]. It has been discovered in cardiac cells that BIN1 temporarily
associates with microtubules[110,111]. Leprince et al. reported that BIN1 interacts with
microtubule-binding cytoplasmic linker protein 170 (CLIP-170). The binding partnership
is mediated by the N-BAR domain in BIN1 and the coiled-coil region of CLIP-170[110].
The in vivo tubulation capacity of BIN1 depends on the microtubule polymerization and
the association with CLIP-170[110]. The recruitment of CLIP-170, ultimately the
microtubules, to BIN1 can serve as a potential membrane anchoring mechanism for
cytoskeleton to modulate plasma membrane dynamics.
1.7.2 Altered BIN1 expression in cells leads to cancer

BIN1 is first known as a Myc box-dependent interacting protein[49]. Exons 17 &
18 encode the Myc-binding domain (MBD)[49]. BIN1 isoform 9, which contains the
	
  

14	
  

	
  

MBD, mainly localizes in the nuclei[49]. BIN1 interacts with the MB1 domain in the
transcription factor c-Myc[49]. c-Myc activates the gene expressions of proteins involved
in cell proliferations. BIN1 suppresses cell transformation and tumor growth by inhibiting
the Myc-dependent cell proliferations[112-114]. Expression of BIN1 is often reduced in
cancer cells such as breast, colon, prostate and lung cancers[115-117]. BIN1 knockout
mice show increased cancer prognosis and metastasis[116,118]. BIN1 is also a regulator
in DNA repair by inhibiting the poly (ADP-ribose) polymerase (PARP1) to block the
base excision pathway[119]. Downregulation of BIN1 reduces the sensitivity of cancer
cells to the DNA-damaging chemotherapy such as cisplatin treatment[120,121]. BIN1
may be a new biomarker for cancer diagnosis and a potential therapeutic target to
increasing chemotherapy sensitivity.
1.7.3 Mutations in BIN1 cause myopathies

Centronuclear nuclear myopathy (CNM) is a congenital muscle disease with onset
at

birth

or

infancy[122].

Clinical

symptoms

of

patients

with

CNM

are

heterogeneous[122-124]. Characteristics of CNM patients are weakness in the muscle
tissues, centralized nuclei and sometimes mental retardation or severe hypotonia (Figs.
4A-C)[122-126]. Multiple genetic mutations in proteins related to membrane remodeling
have been identified (Fig. 4E), including 1) the X-linked recessive form caused by the
mutations in Myotubularin1 (MTM1)[127-129]; 2) the autosomal dominant and sporadic
form caused by the mutations in dynamin2[130,131] and 3) the autosomal recessive form
by mutations in BIN1[132,133].
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Thus far, only a few BIN1-related CNM cases have been discovered. Phenotypes
of these patients demonstrated muscle weakness and mental retardation[93,122,126,133136]. The pathological mechanisms how the mutations in BIN1 gene contribute to the
onset of CNM are still poorly understood. One scope of this dissertation is to investigate
the molecular basis of how mutations in BIN1 impair muscular functions in Chapter 3.
In skeletal myocytes, BIN1 locates on tubular membranes invaginated from the
plasma membranes called transverse tubules (T-tubules) (Fig. 4D)[94]. T-tubules
incorporate Ca2+ releasing channels and ryanodine receptors, and are the membranous
platforms essential for synchronous Ca2+ release (Fig. 4D)[94,137,138]. Knockdown of
BIN1 in skeletal muscle have revealed disorganized T-tubule formations and impaired
intracellular Ca2+ signaling[138]. Additionally, BIN1 is required for C2C12 myoblast
fusion and differentiation[94,98]. Moreover, Drosophila with deletion of BIN1 shows
flightless, sluggish and defects in T-tubule organization and EC coupling[115,139].
Knockdown of BIN1 in adult mouse caused alteration in T-tubule network and Ca2+
signaling defects[140]. The PI-interacting motif (exon10) is crucial for the biogenesis of
T-tubules. Skipping exon10 in mouse induced T-tubule network alteration, abnormal
DHPR distribution and a high number of centrally located nuclei[97].
Interestingly, several mutations have been identified in the BIN1 gene in patients
with autosomal recessive centronuclear myopathy (CNM). To date, five mutations in the
BIN1 gene have been discovered in CNM. Among those, three mutations are in the NBAR domain region: K35N, D151N, and R154Q. The other two are nonsense mutations
in the C-terminal SH3 domain: Q434X and K436X (the amino acid number is based on
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the sequence in human isoform8)[93,126,135,136]. Nicot et al. demonstrated that
expressions of BIN1 mutants in vivo resulted in loss of membrane tubulation[93].
Localization of BIN1 on T-tubules and the triad architecture were changed in the mouse
knockout model[138,140]. Disease mutations in N-BAR domains of BIN1 result in
defective T-tubule biogenesis and triad formation in skeletal myocytes[132,133]. The
nonsense mutations in SH3 domains do not compromise the membrane tubulation ability
of BIN1, but abolish recruitment of dynamin2 on membrane tubules[93,132,133].
Disrupted membrane remodeling by BIN1 mutations is thus clearly connected with
centronuclear myopathy, however, not on the molecular mechanism level.
In addition to CNM, BIN1 is related to myotonic dystrophies (DM). The
myotonic dystrophies are inherited muscular disorders with progressive muscle wasting
and weakness[123,124]. For example, patients experience prolonged muscle contractions
(myotonia) and are not able to relax certain muscles after use[124]. Studies proposed that
the myotonic dystrophies are caused by the expression of mutant mRNA containing
expanded CUG or CCUG repeats which lead to abnormal alternative splicing of proteins
such as BIN1[88]. BIN1 in patients with DM contains exon 7 but lacks exon 11. Muscle
biopsies of DM patients showed misplacement of nuclei and altered T-tubule
morphologies[88].
1.7.4 Potential role of BIN1 in Alzheimer’s disease

Advances in large genome-wide association studies (GWAS) have discovered the
correlation between BIN1 gene and the late-onset Alzheimer’s disease (LOAD)[141,142].
Alzheimer’s disease is a complicated neurodegenerative disease that affects the elderly
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resulting in dementia[143]. The late-onset Alzheimer’s disease (LOAD) shows a large
number of senile plaques and neurofibrillary tangles[143,144]. BIN1 is now considered
as an important genetic susceptibility related to LOAD[145-150]. The expression of
BIN1 is altered in aging mice and transgenic AD models[144,145]. BIN1’s participation
in tauopathy, membrane trafficking/endocytosis, inflammation and calcium homeostasis
are suggested to contribute to the pathogenesis of LOAD[144,145,149,150].
1.8 Regulatory mechanisms of BAR domain protein functions
Previous sections focus on the functions of BIN1 in muscle development.
However, the membrane curvature generation capacity of BAR domains is under tight
regulation.

The

regulatory

mechanisms

of

BAR

domain

functions

include

phosphorylation, protein-protein interactions and autoinhibition[45]. Langen et al.
reported that endophilin induces different membrane shapes via the phosphorylation at
residue S75. The Electron paramagnetic resonance (EPR) data suggests that endophilin
adopts a conformation in which N-BAR domain is closer to membranes allowing for
deeper penetration of insertion helices into the lipid bilayer[151]. Multiple
phosphorylation sites were discovered in the F-BAR domain protein Cdc15, which is
involved in the formation of the contractile ring during cytokinesis[152-154].
Phosphorylation leads to an inactive conformation of Cdc15 in which protein assembly at
the division site is compromised. Dephosphorylation activates Cdc15[155]. Hof1 is
another crucial protein regulating cytokinesis in budding yeast. When binding with
septins, its function is inhibited. Upon phosphorylation, Hof1 is activated to relocate from
septins to the actomyosin ring[156].
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Autoinhibition is another general conformation-switching mechanism to control
protein functions. Autoinhibition is usually achieved by intra- or inter-molecular
interactions involving SH3 domains[157,158]. Recent studies have pointed out that SH3
domains can act not only as recruiters of PRD ligands, but also regulate protein
conformations and functions through an autoinhibition mechanism in which SH3
domains intramolecularly bind to the rest of the protein leading to a closed, inactive
conformation[159]. The Haucke group has identified structural evidence suggesting an
SH3 domain-mediated autoinhibition mechanism in syndapin1[157]. Syndapin1 is locked
in a resting state with compromised membrane deformation capacities by the direct
interactions between SH3 and F-BAR domains[157]. Addition of the dynamin1-derived
PRD peptide dissociates SH3 domains from the F-BAR domains and rescues membrane
tubulations[56,157]. Such regulatory role of SH3 domain exists in N-BAR proteins as
well. SH3 domains in endophilin complex with the N-terminal inserting helices (H0) to
influence the BAR domain dimerization kinetics[56]. Both experiment and molecular
dynamics simulation have demonstrated that H0 is bound with SH3 domain in solution
and slows the subunit exchange between N-BAR dimers[56,95]. Moreover, McMahon et
al. reported that both endophilin and amphiphysin are autoinhibited through their cognate
SH3 domains with impaired membrane binding capacities[106]. In BIN1 isoform8, the
SH3-exon10 interactions suggest a potential autoinhibition mechanism. Both pull-down
and NMR assays have shown that the exon10 motif can directly bind with the SH3
domain and the binding interface between exon10 and SH3 domains overlaps with
PRD[100]. Such intramolecular association inhibits the membrane recruitment of
dynamin. However, little is known about the impact of autoinhibition on the membrane
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remodeling properties of BIN1, particularly in the context of MC-S&G. This will be the
topic of Chapter 4.

	
  

20	
  

	
  

Fig. 1 Heterogeneity of cell membranes in compositions and curvatures.
A) Schematic presentation of the fluid mosaic model of the plasma membrane showing
the bilayer structure of membranes decorated with proteins and substances 2 ； B)
Subcellular membraneous structures with various curvatures and functions[15].
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  http://www.bio.tu-‐darmstadt.de/ag/fachgebiete/membrane_dynamics/meckel_1.en.jsp.	
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Fig. 2 Continuous membrane morphological changes are accomplished through
recruitment of proteins in a spatially & temporally precise manner.
A) Schematic presentations of proteins involving in clathrin-mediated endocytosis (CME)
at different stages of membrane curvature[160]. B) Proteins and actin skeleton induce
filopodia formations[161].
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Fig. 3 Structures and molecular mechanisms of proteins capable of sensing and
generating membrane curvatures.
Cartoon representation of crystal structures of A) mouse endophilin A1 N-BAR domain,
PDB ID: 1ZWW; B) human amphiphysin 2 N-BAR domain, PDB ID: 2FIC; C) human
FCHo 2 F-BAR domain, PDB ID: 2V0O and D) I-BAR domain of insulin receptor
substrate p53 (IRSp53), PDB ID: 1WDZ. Underlying solid lines indicate the intrinsic
curved membrane-binding interfaces. E) Cartoon representation of the crystal structure of
rat epsin N-terminal homology domain, PDB ID: 1EYH. The arrow indicates the
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insertion amphipathic helix. F) Diagrams of proposed mechanisms of membrane
curvature generation by peripheral proteins. The scaffolding mechanism, in which the
intrinsic shape of the membrane-binding interface of proteins (indicated in blue) is
imprinted on membranes. The hydrophobic insertion mechanism, in which hydrophobic
residues penetrate into lipid bilayer, leading to area expansions of outer leaflet and
compensatory curving of membranes. The oligomerization mechanism, in which
scaffolding is achieved by assemblies of multiple protein subunits. The protein crowding
mechanism, in which bulky peripheral segments avoid steric overlap by increasing
membrane curvature[160].
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Fig. 4 Multiple proteins involving in membrane remodeling are related to
centronuclear myopathies (CNMs).
Biopsy images showing the centralized nuclei in the muscle fibers of CNM patients: A)
cross-section or B) longitudinal section of the muscle fibers[122]. C) The longitudinal
section of a patient’s muscle fiber under electron microscope[122]. D) Hypothetical
model of T-tubule biogenesis and the localizations of proteins involved in this
process[137]. E) Summary of the types and corresponding mutations in the genes
associated with CNM.
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Chapter 2 Experimental materials and methods3

2.1 Materials
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3phospho-L-serine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), Lα-phosphatidylinositol-4,5-bisphosphate(Brain), distearoylphosphatidylethanolamine-N(biotinyl(polyethylene glycol)2000) (DSPE-Bio-PEG2000), and cholesterol were
purchased from Avanti Polar Lipids (Alabaster, AL). Alexa Fluor 488 C5-maleimide and
TexasRed-1, 2-dihexadecanoyl-sn-glycero-3-phos-phoethanolamine triethylammonium
salt (TR-DHPE) were from Invitrogen (Carlsbad, CA). Streptavidin-conjugated
microspheres with a diameter of 6µm were from Polysciences (Warrington, PA).
2.2 Molecular cloning of DNA plasmids
2.2.1 Site-directed mutagenesis

In this work, BIN1 N-BAR* (1-282) in pEGFP-C2 vector and GST-fused BIN1
N-BAR (1-254) in pGEX-4T-2 were kindly provided by Dr. De Camilli lab (Yale
University). CNM-associated mutations were introduced by standard primer-directed
PCR mutagenesis procedures described as below. All the primers used for the sitedirected mutagenesis are designed via the QuikChange Primer Design Tool (Agilent
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  Parts of this chapter are reproduced by previously published work: Wu T, Shi Z, Baumgart T (2014) Mutations in
BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and
Oligomerization. PLoS ONE 9(4): e93060. doi:10.1371/journal.pone.0093060 and Tingting W., Baumgart T. (2014).
BIN1 membrane curvature sensing and generation show autoinhibition regulated by downstream ligands and PI(4,5)P2.
Biochemistry, accepted, doi: http://dx.doi.org/10.1021/bi501082r.
.	
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Technologies. Inc): http://www.genomics.agilent.com/primerDesignProgram.jsp and
listed in Table 1. Complimentary oligonucleotides were synthesized and desalted on a 25
nM scale by Sigma.
Table 1 Primers used for constructing plasmids coding BIN1 variants
Mutagenesis

Forward primer

Reverse primer

5’CTTGGTCTCATCTGCATTCCCCA

5’CTCCAGAAGCTGGGGAATGCAG

GCTTCTGGAG3’

ATGAGACCAAG3’

5’TGCCGGGCACTGTTGTAGTCCA

5’GCTGGTGGACTACAACAGTGCC

CCAGC3’

CGGCA3’

5’ACTCGTAGTGGTGCTGGGCACT

5’CTACGACAGTGCCCAGCACCAC

GTCGTAG3’

TACGAGT3’

5’CTGGAACCAGCACTAGGAGCTG

5’CTTCTCCAGCTCCTAGTGCTGGT

GAGAAG3’

TCCAG3’

5’GAGCGACTGGAACTAGCACAA

5’GCTCCTTGTGCTAGTTCCAGTC

GGAGC3’

GCTC3’

5’CAAGGCCCAGCCCAGTGACAAC

5’GCAGGCGCGTTGTCACTGGGCT

GCGCCTGC3’

GGGCCTTG3’

5’CCGCGTCTCGAGCCGGAATTCA

5’CGATGCGGATCCTCGAGGGGCT

TGGCAGAGAT3’ (XhoI)

GGGCCTTGAC3’(BamHI)

N-BAR* (1-254) PCR

5’CCGGACTCGGATCCCCGGAATT

5’CGATGATACACTCGAGTTAAGG

to PGEX-4T-2 vector

CATGGCAGAGATGGGC3’(BamHI)

GCTCTTGTTCCC3’(XhoI)

N-BAR* (1-254) PCR

5’ATCCCTCGAGTTCATGGCAGAG

5’GATACAGGATCCTTAGGGCTCT

ATGGGCAGT3’(XhoI)

TGTTCCC3’(BamHI)

5’CAAGTCCGGACTCGAGTCCATG

5’TGCCGGATCCCCGCCGTCTGGG

GCAGAGATGGGCAG3’(XhoI)

ACCCTCTCAGTGAAG3’(BamHI)

5’GGCGGCAGTGGATCCGGGCGCT

5’GGCTGCCTGGGCCCTCGAGTCA

TGGACCTGCCCCC3’(BamHI)

TGGGACCCTCTCAGTG3’(XhoI)

K35N

D151N

R154Q

K436X

Q434X

Exon10-deletion
N-BAR (1-254) PCR
to mKateN1 vector

to mKateN1 vector
BIN1-FL PCR
to mKateN1 vector
BIN1-SH3 PCR
to PGEX-4T-2 vector
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Standard site-directed mutagenesis protocol:
1) Prepare the reaction mix and control samples as described in Table 2:
Table 2 Reaction mix of site-direct mutagenesis
Control reaction (µl)

Sample reaction (µl)

10 x reaction buffer

5

5

10 mM dNTP mix

0

1.5

10 µM forward primer

2.5

2.5

10 µM reverse primer

2.5

2.5

Double-distilled water (ddH2O)

38

35.5

dsDNA template (50 ng/µl)

2

2

PfuTurbo DNA polymerase (2.5 U/µl)

0

1

2) Cycle each reaction using a thermal cycler. The thermal cycling parameters are
outlined in Table 3.
Table 3 Thermal cycler parameters for site-direct mutagenesis reaction
Segments

Cycles

Temperature

Time

1

1

95 °C

30 s

2

16

95 °C

30 s

55 °C

60 s

68 °C

16 min

4 °C

∞

3

1

3) Add 1 µl of DpnI restriction enzyme (10 U/µl) directly to each amplification reaction
and incubate at 37 °C to digest the parental dsDNA.
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4) Transformed 1 µl of the DpnI-treated DNA to supercompetent cells for future use
following section 2.2.3.
2.2.2 Polymerase chain reaction and ligation protocol for BIN1 constructs cloning

Standard PCR and ligation reaction were performed as follows:
1) Preparing the reaction mixtures in PRC tubes:
Table 4 PCR reaction mix
Sample reaction (µl)
10 x Taq buffer

5

10 mM dNTP mix

1.5

10 µM forward primer

2.5

10 µM reverse primer

2.5

Double-distilled water (ddH2O)

35.5

dsDNA template (50 ng/µl)

2

PfuTurbo DNA polymerase (2.5 U/µl)

1

2) Using a thermal cycler to amplify the reaction following the conditions:
Table 5 Thermal cycler parameters for PCR reactions
Segments

Cycles

Temperature

Time

1

1

95 °C

30 s

2

16

95 °C

30 s

55 °C

60 s

68 °C

6 min

4 °C

∞

3
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3) Purifying the amplified nucleotides by the QIAquick PCR Purification Kit (Qiagen).
Double digestion and ligation protocol:
1) Set up the double digestion of vector and insert as shown in Table 6:
Table 6 Reaction mix of digesting vector & insert by restriction enzymes
Sample reaction (µl)
10 x Digestion buffer

5

DNA

1.5

1st Enzyme

2.5

2nd Enzyme

2.5

Double-distilled water (ddH2O)

35.5

2) Incubate the reaction mixtures at 37 °C overnight;
3) Add loading buffer an run the reaction solution on the agarose gel and cut the desired
bands with expected molecular weight;
4) Purify the isolated gel fragments following the recommended protocol of QIAquick
Gel Extraction Kit (Qiagen). Determine the final concentration of extracted insert and
vector by measuring the absorbance@260 nm via a UV-Vis Spectrometer (Agilent).
The concentration of DNA is calculated by the equation: [DNA] = Abs (260 nm) x
dilution factor x 50 ng/µl.
5) Combine 200 ng of vector with a 5-fold molar excess of insert. Use NEBioCalculator
to calculate molar ratios. Adjust the volume to 10 µl with ddH2O if the volume of the
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insert and vector combined is less than 10µl; Add 10 µl of 2X Quick Ligation Buffer
and mix; Add 1 µl of Quick T4 DNA ligase and mix thoroughly. Centrifuge briefly
and incubate at 37 °C for 30 min. Chill on ice for another 30 min, then transform or
store at -20 °C.
The plasmids encoding BIN1-FL-mKate, N-BAR*-mKate, N-BAR-mKate, GSTBIN1-FL, GST-BIN1-N-BAR* and GST-BIN1-SH3 were cloned via the methods above.
The mKateN1 vector is a mammalian expression plasmid containing the red fluorescence
protein tag, mKate. The fluorescent protein tag will be at the C-terminus of the backbone.
The PGEX-4T-2 plasmid is a bacteria expression vector that contains an N-terminal GST
(Glutathione S-transferase) tag. The GST tag can be removed by the protease thrombin.
All constructs were confirmed by sequencing.
2.2.3 Bacteria transformation

100 µl of the bacteria (XL1-Blue supercompetent cells from Agilent Technologies
or BL21-Codon Plus (DE3)-RIL bacteria from Stratagene) were pipetted into a prechilled Falcon 2059 tube (BD). 400 ng of plasmids were added into the tube. The tube
containing DNA was incubated on ice for 30 min. The bacteria-plasmid mixture was heat
shocked in a 42 °C water bath for 45 s and placed on ice immediately. After 2 min on ice
incubation, 450 µl of the SOC medium (Life Technologies) were added and the cells
were recovered. Shaking at 225 rpm, 37 °C for one hour before spreading 100 µl each
transformation onto LB plates with appropriate antibiotic. The plate was incubated at
37 °C overnight. Each step was conducted in a sterilized manner.

	
  

31	
  

	
  

2.3 Purification of recombinant proteins
GST-fusion proteins of BIN1 and its variants were transformed in BL21-Codon
Plus (DE3)-RIL bacteria (Stratagene). Starter culture was conducted by picking up a
single colony and cultured in 100 mL LB medium (containing appropriate antibiotic)
overnight. On the second day, the starter culture was transferred to a 1.5 L LB medium.
Cells were grown at 37 °C to OD600 of 0.8 and protein expression was induced by 1 mM
IPTG for 3 hours at 37 °C or overnight at 18 °C. Then cells were harvested by
centrifugation, resuspended in the lysis buffer (20 mM Tris-HCl, 300 mM NaCl, 1 mM
DTT, 1 mM PMSF, pH 7.4) and lysed on ice by tip sonication. After centrifugation, the
supernatant was applied to a GST-affinity column on a fast protein liquid
chromatography (FPLC) system (ÄKTA, GE) equilibrated with the lysis buffer and
eluted with the elution buffer (50 mM Tris-HCl, 20 mM reduced glutathione, 150 mM
NaCl, pH 8.0). The GST-tag was cleaved via thrombin digestion at room temperature for
4 hours and the untagged BIN1 proteins were further purified by cation exchange
chromatography (Fig. 5A) and size exclusion chromatography (SEC) (Fig. 5B) (GE
Healthcare). Fractions from chromatography were analyzed by the SDS-PAEG gel (Fig.
6) and proteins were concentrated by centrifugation using an Amicon Ultra spin column.
The endogenous cysteine residues were labeled by Alexa 488 C5-maleimide (Invitrogen)
at 4 °C overnight. Free fluorophores were removed via passing the samples through three
desalting column connected consecutively (Fig. 5C). The purity of the final product was
confirmed by analytical SEC column (Superdex 200 10/30, GE, Fig. 5D).
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2.4 Determination of protein concentration and fluorophore labeling efficiency
Protein concentrations were measured by following standard Bradford assay
protocol (Thermo Scientific). The average of three independent measurements were
determined and used to represent the concentration of the proteins. The standard
deviation of the multiple measurements was used to determine the uncertainty in the
concentration determination (0.5%-1% uncertainty in protein concentration determination)
(Fig. 7) and concentrations of fluorophores were determined by absorbance at 494 nm
(with molar extinction coefficient 71,000 cm-1M-1). Labeling efficiency was calculated by:
Labeling efficiency [%] = Alexa 488 concentration / Protein concentration * 100. All the
protein samples used in our studies were freshly thawed and ultra-centrifuged to remove
potential aggregates. Protein concentration was determined by Bradford assay before
each experiment. No sample stored at 4 °C for longer than one week was used in this
study.
2.5 Cell culture, transfection and confocal fluorescence imaging
C2C12 myoblasts or HeLa cells were cultured in Dulbecco's Modified Eagle
Medium (DMEM medium, Life Technologies) containing 10% fetal bovine serum (FBS)
(Invitrogen). Cells were cultured in MatTek glass bottom culture dishes until 95%
confluency before transfection. 1.5 µg EGFP-tagged or mKate-tagged plasmids were
transfected with Lipofectamin2000 (Life Technologies, Invitrogen) and incubated at
37 °C, 5% CO2 for 5 hours before changing to the culture medium. Cells were imaged
after 24 hours with a fluorescence confocal microscopy (FV300) scanning system
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integrated with a motorized inverted microscope IX81 (Olympus, Center Valley, PA)
using a 60 x, 1.2 NA water immersion lens (Olympus). In order to investigate the spatial
distribution of N-BAR* domains in BIN1 on plasma membranes, total internal reflection
fluorescence microscope (TIRF) imaging was performed on an inverted IX71 microscope
system equipped with a 60 x, 1.45 NA TIRF objective (Olympus) using 50 mW 488 nm
laser (Coherent, Santa Clara, CA) and appropriate neutral density filters (Thorlabs,
Newton). Images were imported into and processed with ImageJ.
To quantify the in vivo membrane tubulation capacity of BIN1 N-BAR* and its
variants (Chapter 3, figs. 9 & 11), cell phenotypes are categorized into three groups: 1)
Long tubules: more than 30 tubules with a length five times greater than tubule diameter
in a single cell; 2) Clusters: more than 30 fluorescence speckles with the length less than
five times of the tubule diameter; 3) Featureless: homogeneous fluorescence distribution
or containing less than 30 fluorescence clusters. Confocal images were imported to
ImageJ. Tubules lengths and diameters were determined by the ImageJ measurement tool.
The number of cells (overexpressing a certain BIN1 N-BAR* variant) in each category
was counted and the percentage of each phenotype was calculated by: (No. of cells
showing each phenotype) / (Total No. of cells) x 100%. The percentage of each
phenotype was plotted in a BAR chart.
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2.6 Liposome preparation
2.6.1 Large unilamellar vesicles (LUVs) preparation

Liposomes were prepared using the desired lipid compositions. In this study, the
following lipid compositions were used: 100% DOPS, 60% DOPC/20% DOPS/10%
PI(4,5)P2/10% DOPE, 68% DOPC/20% DOPS/2% PI(4,5)P2/10% DOPE and 64%
DOPC/26% DOPS/10% DOPE. Lipids were mixed and air-dried to form thin films in a
round-bottom glass flask. Lipid films were left under vacuum for at least an hour before
rehydration in 20 mM Hepes, 150 mM NaCl, 1 mM DTT, pH 7.4 buffer. The final total
lipid concentration was 1 mg/mL. Liposome solutions were then sonicated for 15 minutes
and extruded through 400 nm or 800 nm nuclepore membranes (Whatman) 11 times. All
liposome solutions were stored at 4 °C.
2.6.2 Giant unilamellar vesicles (GUVs) preparation

GUVs of certain lipid compositions were prepared by the standard electroswelling
method in 0.3 M sucrose solution. Osmolarity of the GUV dispersion was measured by a
micro-osmometer (Advanced Instruments Inc., Norwood, MA).
2.7 Liposome tubulation assay
5 µM proteins of interest were incubated with LUVs (final lipid concentration 0.1
mg/mL) in 20 mM Hepes, 150 mM NaCl, 1 mM DTT, pH 7.4 buffer at room temperature
for 30 min. Samples were absorbed on the carbon/formvar supported copper grids
(Electron microscopy science, Hatfield, PA) for 1 min and excess samples were washed
by blotting on a filter paper (Whatman). The grids were then stained with 2% (w/v)
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uranyl acetate for 1 min, washed, and dried under room temperature. Grids were observed
with a JEM 1011 transmission electron microscope (JEOL, USA) with the accelerating
voltage set to 100 kV.
To quantify in vitro tubulation capacities, TEM images were imported into
ImageJ for analysis. We consider three measurable to quantify the tubulation capacity of
BIN1 variants: tubule diameter, tubule length and tubulation event. To measure the tubule
diameter and tubule length, a line was drawn across or along a membrane tubule and the
length of the line was measured by the ImageJ measurement tool. To quantify the
tubulation event percentages, we defined three morphological types in the tubulation
assay: 1) Tubulation: elongated membrane structures with a length 5 times greater than
the diameter; 2) Vesiculation: liposomes with a diameter less than 30 nm. The formation
of vesiculated liposomes is a general feature of proteins containing amphipathic helices
when interacting with membranes; 3) Intact vesicles: liposomes with diameters greater
than 30 nm. The percentage of each morphological type was calculated by: (No. of events
showing each morphology type) / (Total No. of events) x 100%.
2.8 Protein densities quantifications on GUV membrane and Langmuir isotherm
DOPC mixed with 0.05% ~ 0.7% (molar percentage) BODIPY-DHPE (Invitrogen)
were made via electroformation method and imaged by a confocal microscope. The mean
grey level on a GUV equator was measured by ImageJ and plotted against BODIPY
densities. BODIPY densities were estimated considering the averaged lipid headgroup
size as 0.72 nm2. To figure out the ratio of fluorescence intensities between BIN1 N	
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BAR-Alexa488 and BODIPY-DHPE, we measured the bulk fluorescence of SUVs (50
nm in diameter) containing 0.05%~0.7% BODIPY-DHPE and BIN1 N-BAR-Alexa488
as a function of fluorophore concentration. Ratio between the slopes from the linear
fitting corresponds to a relative efficiency of Alexa 488 to BODIPY-DHPE[162-164]. 22
µM GUVs of desired lipid compositions were incubated in 20 mM Hepes, 50 mM NaCl,
pH 7.4 buffer containing increasing concentrations of BIN1 N-BAR*, disease mutants
and BIN1-FL. Samples were incubated at room temperature for 30 min before imaging
by confocal microscopy. Images were imported into ImageJ and the density of
membrane-bound proteins was measured as the mean grey level on the GUV equator and
converted to molecular densities based on an adapted fluorescence calibration method
described above. The Langmuir isotherm equation was fitted to data:

𝐵=

𝐵!"#
𝐾
(1 + 𝑐! )

2.9 Tether pulling force and membrane lateral tension measurements
Micropipettes were fashioned from glass capillaries (World Precision Instruments
Inc., Sarasota, FL) that were stretched by a pipette puller. Pipette tips were cut using a
microforge at desired inner diameters of 5~8 µm. Irreversible adhesion of membrane to
the pipette was prevented by filling the pipette tips with 5 mg/ml casein dissolved in 1x
PBS buffer. Pipettes were then rinsed and filled with 0.3 M sucrose solution using a
MicroFil needle (WPI, Sarasota, FL). A sample chamber was formed from two coverslips
overhanging both sides of a microscope glass slide, creating a 1 mm thick cell that was
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open on three sides to allow the insertion of micropipettes. The bottom of the chamber
was pre-coated with 2 µL of 5 mg/ml casein (dissolved in 1x PBS) to prevent the
adhesion of microspheres and proteins to the coverslip. A mixture of sucrose and buffer
solution with the same osmolarity as the GUV dispersion was prepared while keeping the
NaCl concentration at 50 mM. The chamber was filled with 90 ~100 µL of sucrose and
buffer mixture, 1 µL of microsphere dispersion and 3 µL of GUV dispersion. BIN1 was
added to reach the desired concentration. The chamber was mounted on an inverted
microscope (1X71; Olympus, Center Valley, PA) equipped with a home built optical trap,
which uses a second, independently positioned objective (60 x, 1.1 NA, water immersion,
1.5 mm working distance; Olympus) oriented opposite to the imaging objective to
introduce a 1064 nm wavelength laser into the chamber. Micropipettes were moved via a
three-dimensional motorized micromanipulator system (Luigs & Neumann, Ratingen,
Germany). Aspiration pressure was controlled through adjustments of the height of a
water reservoir, and pressures were measured with a differential pressure transducer
(Validyne Engineering, Los Angeles, CA). The chamber was equilibrated for 10 ~ 20 min
before an individual GUV (typically between 8 and 15 µm in radius) was aspirated at a
constant pressure. The optically-trapped bead was brought into contact with the vesicle,
and then either the vesicle or the bead was retracted at a speed about 5 µm/s, generating a
membrane tether around 10 ~ 20 µm in length. Forces exerted on the bead were measured
in real-time. Aspiration pressure was changed subsequently to generate the relation
between tether pulling force and membrane lateral tension. Each lateral tension was
maintained until the pulling forces reached equilibrium (typically 1 ~ 2 min).
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2.10 Optical trap Design and Calibration
Our home-built optical trap has been previously described[165]. The pulling force
f exerted by the tether is determined as for a Hookean spring: f = kΔx, where k is the trap
stiffness and Δx is the displacement of the bead relative to its equilibrium position. The
stiffness of the trap was calibrated by the drag-force method for at least 3 beads before
the tether pulling experiment and was typically 0.05 pN/nm. After each experiment, the
trap stiffness was recalibrated to confirm the previously measured value and monitor the
possible influence of chamber solution evaporation on the measured stiffness of the
optical trap.
2.11 Curvature sorting assay
To investigate curvature-sensing abilities of BIN1 variants, I examined their
fluorescence intensities on the tubular membrane under varying membrane tensions. The
experiments were carried out in a chamber constructed from glass slides, containing
GUV dispersions and protein solution. Two micropipettes (World Precision Instruments,
Sarasota, FL), which were fabricated by using a microforge, were inserted into the
sample chamber by a three-dimensional motorized manipulator system (Luigs and
Neumann, Ratingen, Germany). Vesicles in the chamber were aspirated via micropipette.
Membrane tensions of the aspirated vesicle were controlled by adjusting the height of a
connected water reservoir, and measured by a pressure transducer with a DP-28
diaphragm (Validyne Engineering, Los Angeles, CA). The other pipette then aspirated a
bead, contacted the vesicle, and was moved away to form a membrane tether. Kalman	
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averaged images of the tether cross section (xz plane, which was orthogonal to the axis of
the tether) were recorded for measuring tether fluorescence intensities, with a stepwidth
of 0.07 µm and a total imaging depth of 6 µm. The recorded tether fluorescence intensity
profiles were then background-corrected, and estimated in an elliptical region of interest
to obtain the protein and lipid intensity signals under varying membrane tensions. For
each protein variant, at least five independent experiments were executed, analyzed and
binned to obtain the final results.
2.12 Chemical cross-linking assay
6.6 µg (5 µM as final concentration) BIN1 N-BAR domains and CNM-related
mutants were mixed with 100% DOPS liposomes (0.1 mg/mL) in a total volume of 40 µl
of 20 mM Hepes, 150 mM NaCl, pH 7.4 buffer. Samples were incubated for 30 min at
room temperature before adding the cross-linking reagent bissulfosuccinimidyl suberate
(BS3) (Thermo Scientific) from a 100 mM stock in distilled water to reach final
concentrations of 0, 0.5, and 5 mM. Samples were further incubated for 2 min at 37 °C.
6x Laemmli sample buffer was added to terminate the reactions. Samples were boiled at
95 °C for 5 min, subjected to SDS-PAGE electrophoresis and visualized by coomassie
staining. Control samples were prepared by replacing liposomes with incubation buffer.
2.13 Actin depolymerization in BIN1 N-BAR* variants transfected cells
C2C12 myoblasts were transfected with BIN1 N-BAR* variants tagged with
EGFP in Bioptechs delta T culture dishes (Bioptechs Inc.). Cells were maintained at
37 °C by Bioptechs objective and culture dish heaters (Bioptechs Inc.). Images were
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collected by a 60 x, 1.45 NA TIRF lens (Olympus, Center Valley, PA) on an inverted
microscope system (IX71, Olympus, Center Valley, PA) using a 488 nm laser (50 mW,
Coherent, Santa Clara, CA). 1 µM latrunculinA (Biomol International, Plymouth Meeting,
PA) dissolved in culture medium was added into the culture dishes. Data were recorded
every 100 ms using a cooled EMCCD camera (HAMAMATSU, Bridgewater, NJ).
2.14 Monolayer insertion of BIN1 N-BAR variants
Insertion of WT and K35N N-BAR domains into a lipid monolayer was
investigated by measuring the change of surface pressure (π) at constant surface area
using a 1 mL circular Teflon trough and wire probe connected to a Kibron MicroTrough
X (Kibron, Inc., Helsinki). A lipid monolayer containing 60% DOPC, 20% DOPS, 10%
PI(4,5)P2 and 10% DOPE was spread onto the sub-phase composed of 20 mM Hepes,
150 mM NaCl at pH 7.4 until the desired initial surface pressure (π0) was reached. Then
excess N-BAR protein was injected into the sub-phase through a hole in the wall of the
trough. The change in surface pressure (Δπ) was monitored after equilibration. The
resulting Δπ was plotted versus π0, and critical surface pressure (πc) was determined as
the x-intercept.
2.15 Isothermal Titration Calorimetry (ITC) measurements
ITC binding reactions were performed with a MicroCal iTC200 system (GE
healthcare, life sciences) at 25 °C. Protein and peptide samples were dialyzed side by side
in 20 mM Hepes, pH 7.4 buffer containing 0 mM, 50 mM or 150 mM NaCl. 40 µl of the
ligands in an injection syringe was titrated into a 200 µl reaction cell in 16 or 20 cycles.
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The duration of each injection was 5 s or 4 s with an interval of 120 s between injections.
Concentrations used in the ITC measurement: exon10-SH3 domain binding: 500 µM
exon10 peptide in the injection syringe and 50 µM GST-SH3 domain in the reaction cell;
PRD-SH3 domain binding: 1 mM PRD peptide in the injection syringe and 50 µM GSTSH3 domain in the reaction cell; exon10-SH3/K436X mutant binding: 500 µM exon10
peptide in the injection syringe and 50 µM GST-SH3/K436X mutant in the reaction cell;
exon10-IP3 binding: 500 µM exon10 peptide in the injection syringe and 25 µM IP3 in
the reaction cell.
ITC data from at least 4 independent experiments was analyzed with MicroCal’s
custom scripts in Origin 7.0 (OriginLab). Best fits were selected on the basis of residual
analysis. Integrated heats from all the binding reactions fit well to a single-site binding
model. The fitting equation is:

𝑛𝑀! ∆𝐻𝑉!
𝑋!
1
𝑄 =   
[1 +
+
−
2
𝑛𝑀! 𝑛𝐾𝑀!

𝑋!
1
1+
+
𝑛𝑀! 𝑛𝐾𝑀!

!

−

4𝑋!
𝑛𝑀!

in which, n is no. of binding site; K is binding constant; ΔH is the molar heat of ligand
binding; V0 is the active cell volume; Mt is bulk concentration of macromolecules in V0,
Xt is bulk concentration of ligand. Heat Qi at the end of the ith injection is corrected for
the displaced volume by the equation:

∆𝑄! = 𝑄! +

𝑑𝑉! 𝑄! + 𝑄!!!
− 𝑄!!!
𝑉!
2

From the fitting, n, K and ΔH can be obtained.
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2.16 Single Liposomes of different diameters and therefore Curvature assay (SLiC
assay)
2.16.1 Fabrication of imaging chambers

PDMS precursors mixed with the curing agent (10:1 in weight ratio) was poured
onto one plastic petri dish (100 mm diameter x 13 mm deep) and left at 65 °C overnight.
PDMS was then peeled off from the petri dish and cut into rectangular shapes. Four
consecutive holes were drilled by a hole puncher (7 mm in diameter). The PDMS and
cover glasses were then oxidized by oxygen plasma for 45 s. Imaging chambers were
assembled by placing PDMS replica in contact with cover glass and incubated at 65 °C
for 30 min before use.
2.16.2 Immobilization of LUVs in imaging chambers

To immobilize single liposomes in the imaging chamber, 0.1 mg/mL bovine
serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO), 1 mg/ml biotinylated-BSA
(Fisher, Pittsburgh, PA), and 0.00125 mg/ml streptavidin (Fisher) in 1x PBS buffer were
added into a chamber consecutively and incubated for 30 min at room temperature.
Before each protein addition, the imaging chamber was rinsed thoroughly with 1x PBS
buffer. Polydisperse liposomes doped with TexasRed DHPE (concentration around 0.001
mg/mL) were then added into the treated chamber. Once the surface was covered with
enough liposomes (around hundreds of liposomes per field of view), the chamber was
rinsed with 1x PBS buffer to remove excessive liposomes.
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2.16.3 Curvature-dependent membrane binding affinity measured by SLiC assay

BIN1 variants labeled with Alexa488 C5-maleimide (Invitrogen, Carlsbad, CA) of
various concentrations (ranging from 50 nM to 4 µM) was added into the imaging
chamber and incubated at room temperature for 30 min before imaging. Protein and lipid
fluorophore intensities were recorded by a 60 x 1.45 NA TIRF lens (Olympus, Center
Valley, PA) on an inverted microscope system (IX71, Olympus, Center Valley, PA)
equipped with an EM-CCD camera (Hamamatsu, Bridgewater, NJ).
2.16.4 Algorithm for liposome localization and size conversion

Localization of a single liposome was accomplished by a MATLAB algorithm.
Any pixel above the intensity threshold T1 was selected as a single object. T1 was
defined as the average pixel intensity of one single frame plus four standard deviations of
pixel intensity. In the mean time, the pixels of the selected objects must exceed the
second threshold T2. T2 was set for removing occasional bright pixels resulting from
camera shot noises. To avoid identification of densely distributed liposomes as a single
subject, a third threshold T3 was set as a maximum pixel number. Objects passing all
three thresholds were identified as a single liposome and then processed for the
determination of spatial coordinates.
To determine the actual vesicle sizes through the fluorescence intensities of
vesicles, a conversion factor (k) between vesicle size and fluorescence intensity was
determined. Based on the assumption that fluorescent lipids distributed homogeneously
on spherical vesicles, the fluorescence signal of vesicles (𝐼! ) is proportional to the surface
area of the liposome:
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𝐼! ∝ 4𝜋𝑟 !

𝑟   ∝   

𝐼!
4𝜋

The mean radius (𝑟!"#$ ) was determined by a second approach such as dynamic
light scattering or electron microscopy. Dynamic light scattering was chosen in this case.
The conversion factor, k, was then introduced as the ratio between 𝑟!"#! and ( 𝐼! )!"#$ :
𝑘=

  𝑟!"#$
( 𝐼! )!"#$

With k determined, fluorescence intensity distributions can then be transformed
into actual vesicle size distributions.
2.17 Circular dichroism spectroscopy
CD data were collected on an Aviv Model 410 spectrometer with a Xe lamp
(Aviv Biomedical, Lakewood, NJ) using a 1 mm quartz cuvette at 25 °C. LUVs were
prepared using lipid compositions of 100% DOPS and 68% DOPC/20% DOPS/10%
DOPE/2% PI(4,5)P2. Solutions of the exon10 peptide were prepared at 10 µM or 100 µM
in 20 mM Hepes, 150 mM NaCl, pH 7.4 buffer with/without 63 µM lipid vesicles. Pure
Hepes buffer or LUVs diluted to the final concentration was used as the blank. Readings
were then converted to molar residue ellipticity (θ). Scans from 200 to 260 nm with data
points taken every 1.0 nm were obtained and averaged for each sample.
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2.18 Peptide synthesis and labeling
The exon10 peptide (sequence: RKKSKLFSRLRRKKN) and the dynamin2derived proline-rich domain peptide (sequence: PPQIPSRPVRIPPGI) were synthesized
via solid phase peptide synthesis, using 9-fluorenylmethoxycarbonyl (FMOC) chemistry
and upon resin cleavage purified by reverse-phase high-performance liquid
chromatography (HPLC). The purity of the synthesize peptides are > 95%. The molecular
weight of the peptide is confirmed by mass spectroscopy. The rhodamine-conjugated
PRD peptide was labeled at the N-terminus.
2.19 Fluorescence recovery after photobleaching (FRAP) measurement
FRAP measurements on GUVs were performed on a confocal microscope
(Olympus Fluoview300). A 60 x, 1.2 NA water immersion lens (Olympus) was used for
all experiments. Alexa488-conjugated proteins were imaged using a 488 nm laser line,
and TexasRed labeled GUVs were imaged using a 543 nm laser line. A GUV was
aspirated by a micropipette. The projection area in the micropipette was bleached by
bleaching scans (20 s) with 100% intensity of 488 nm laser lines and 100% intensity of
410 nm laser lines. Recovery of fluorescence was monitored 60 times every 4 s followed
by 20 times every 15 s. The recovery fraction at given time t is defined by the equation:

𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦  𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛  %   =   
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(𝐼! − 𝐼!! )
∗ 100%
(𝐼! − 𝐼!! )

	
  

in which, the 𝐼! is the fluorescence intensity of the bleached area at time t, 𝐼!! is the
intensity of the bleached area immediately after photobleaching and 𝐼! is the fluorescence
intensity before bleaching.
The recovery fraction is plotted against time. Data were fitted in GraphPad Prism
(GraphPad Software, Inc.) to a single exponential equation: Y = Y0 + (Plateau - Y0) * (1exp (-K * x)). Mobile fraction and recovery half-time (t1/2) were obtained for each
recovery curve, and the means and standard error of the mean were calculated.
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Fig. 5 FPLC chromatography in BIN1 N-BAR domain purification.
A) Cation exchange chromatography using SP-HP medium (GE). The thrombin digestion
product following the GSH elution of GST-N-BAR from a GSTrap column was loaded to
the SP column. The black trace shows absorption at 280 nm over the course of a linear
gradient of NaCl (grey trace) in 20 mM Hepes, pH 7.4 buffer. The main peak marked by
the red stroke represents the isolated BIN1 N-BAR domain. B) Based on characterization
by SDS-PAGE electrophoresis, the fractions corresponding to the N-BAR domain were
selected and applied to a Superdex 200 HiLoad 16/600 column (GE). The main peak
pointed at by the red stroke is the purified N-BAR domains. C) The main peak fractions
from B) were concentrated and labeled with Alexa488-C5-malamide overnight. The
excess dyes were deactivated by 2 mM DTT and the solution was applied to three 5 ml
HiTrap desalting columns (GE) connected in series on an FPLC. The main peak belongs
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to the labeled N-BAR domains. The shoulder peak represents the excess dyes. The purity
of the final product was examined by the Superdex 200 10/30 analytical column (GE) in
D).
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Fig.

6

SDS-PAGE

characterizations

of

BIN1

N-BAR

fractions

during

chromatography purifications.
A) SDS-PAGE gel analysis of the supernatant of the cell lysate after tip sonication.
Concentrated band with molecular weight around 56 kDa indicates the expression of
GST-fused BIN1 N-BAR proteins. After elution by GSH from GSTrap column (GE), the
thrombin-digested products were characterized. The fusion protein band disappeared and
two additional bands with molecular weight around 30 kDa and 26 kDa showed on the
gel, which corresponds to BIN1 N-BAR domain and GST tag, respectively. Elution
fractions from B) cation exchange and C) size exclusion chromatography (SEC) were
analyzed by SDS-PAGE electrophoresis. Proteins purity was improved during
purification and is shown as a single band on the gel after SEC. Gels are stained by
coomassie blue.
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Fig. 7 BSA standard curve of the coomassie protein assay measured by UV-Vis
spectrometer.
A) UV-Vis spectrum of 5 µl diluted BSA standards mixed with 1.0 mL coomassie
reagent. The concentrations of the BSA standards range from 0.125 mg/mL to 2 mg/mL.
B) Absorbance at 595 nm was corrected by the background at 850 nm and plotted against
BSA concentrations. Data was fitted to a linear relationship. The slope from the fitting
was used to determine the concentration of unknown samples.
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Chapter. 3 CNM-associated mutations in BIN1 N-BAR domain impair
membrane-sculpting capacity via different mechanisms4
BIN1 is a N-BAR domain containing protein involving in the biogenesis of Ttubules at the excitation-contraction coupling in skeletal muscle tissues. Centronuclear
myopathy patients show genetic mutations in BIN1 gene. In this chapter, I will
investigate how BIN1 mutants cause disorders in muscles.
3.1 Point mutations associated with CNM in BIN1 impair membrane remodeling
BIN1, a BAR domain-containing protein, is implicated in membrane remodeling
during T-tubule generation. Previous research has demonstrated that overexpression of
BIN1 in cells leads to membrane tubulation[94]. The first two N-BAR domain mutations
(K35N and D151N) found in CNM patients were reported to abolish the membrane
deforming function of BIN1 in COS-1 cells[93]. However, for the most recently
discovered mutant (R154Q), only tissue biopsy data are available thus far. These indicate
that R154Q also disrupts T-tubule organization and thus triad function at sarcoplasmic
reticulum (SR) / T-tubule junctions [126,135].
In order to test the hypothesis that all disease mutations found in BIN1 N-BAR
domain impair membrane tubule formation, we transiently transfected C2C12 myoblasts
with BIN1 N-BAR* wild type (WT) and CNM-related mutants conjugated with mKate at
the C-terminus. The N-BAR* domain is distinguished from the N-BAR domain by a
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  Parts of this chapter are reproduced by previously published work: Wu T, Shi Z, Baumgart T (2014) Mutations in
BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and
Oligomerization. PLoS ONE 9(4): e93060. doi:10.1371/journal.pone.0093060.
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longer sequence that includes exon10 (Fig. 8). We used the BIN1 N-BAR* domain
because it has been reported that the polybasic sequence encoded by exon10 is required
for targeting to the plasma membrane mediated by PI(4,5)P2 and that in vivo membrane
tubulation is not observed by BIN1 N-BAR domains[94].
Confocal micrographs in Fig. 9A demonstrated that BIN1 N-BAR* WT
expression resulted in the generation of invaginated membrane tubules, while cells
expressing the CNM-associated mutants showed essentially homogeneous cytosolic
fluorescence. To exclude potential membrane morphological influences by the
fluorescence tags, mKate (Fig. 10A) or EGFP (Fig. 10B) alone were expressed in C2C12
myoblasts. No significant long tubules (tubules length is 10 times larger than the tubule
diameter) were induced by the expressions of EGFP or mKate fluorescent proteins. To
quantitatively compare membrane deforming differences, we categorized tubules in live
cells into three groups based on tubule lengths and calculated the percentages of cells in
each group[93]. As shown in Fig. 9B, on average, over 90% of cells with over-expressed
WT N-BAR* had long tubules generated, while this phenotype was absent in all disease
mutants. In cells transfected with disease mutants, we found fluorescent clusters in 30%
of the cells. These clusters may be protein aggregates or short tubules that we were not
able to distinguish due to the optical resolution limit.
To understand the origins of membrane tubule generation, we used Total Internal
Reflection Fluorescence microscopy (TIRF) to examine the spatial organization on the
plasma membrane of BIN1 N-BAR* domains conjugated with green fluorescent protein
(GFP). The introduction of fluorescent tags at the N-terminus might affect N-terminal
helix membrane insertion. However, we did not observe changes in in-vivo tubulation
	
  

53	
  

	
  

phenotypes among BIN1 N-BAR* variants when proteins were either N-terminally (Fig.
11) or C-terminally (Fig. 9) labeled. Consistently, distinct fluorescent speckles were only
present on plasma membranes of cells transfected with N-BAR* WT, whereas disease
mutants were distributed more evenly on the membrane (Fig. 12).
From the TIRF imaging results we conclude that: 1) most of the membrane
tubules induced by BIN1 N-BAR* are oriented perpendicularly to the TIRF plane. Thus,
fluorescence projections on the plasma membrane show up as speckles; 2) only the WT
protein, which possesses the capacity for cellular membrane tubulation, shows significant
clusters at the plasma membrane.
The findings from this section emphasize that BIN1 N-BAR* acts as a membrane
curvature generator, causing membrane tubulation in cells, and that this function is
perturbed by disease mutations.
3.2 In vitro tubulation abilities of recombinant N-BAR domain variants vary with
lipid composition
To further characterize the BIN1 N-BAR domain and its mutants, we purified the
recombinant WT BIN1 N-BAR domains as well as disease mutants. Due to the fact that
we neither observed retention volume shifts in the size exclusion chromatography, nor
any change in CD spectra, we believe that none of the disease mutations significantly
affected the folding of the proteins (data not shown).
To characterize curvature generation capacity of BIN1 N-BAR domains and its
mutants, we adopted an in vitro liposome deformation assay involving negative staining
transmission electron microscopy (TEM). Negative staining is a widely accepted method
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to study biological macromolecules. It involves embedding liposome-protein complexes
adsorbed to sample grids in a dried heavy metal solution for contrast enhancement[166].
We first used large unilamellar liposomes (LUVs) composed of 100% DOPS to
maximize electrostatic interactions between protein and membrane without the potential
complications of lipid demixing. In this lipid composition, 100% of the lipid headgroups
are negatively charged. Contrary to the observations from cellular studies described
above, tubules were found in all the samples when BIN1 variants were incubated with
liposomes composed of 100% DOPS (Fig. 13A). We used tubule diameter and tubule
length as two parameters to quantify the strength of the membrane shaping ability of
BIN1 N-BAR domains. Shown in Fig. 13B, the averaged tubular diameter induced by
BIN1 N-BAR WT was 34 ± 1 nm (note that here and below uncertainties are expressed
as standard errors of the mean if not indicated otherwise), which is comparable to the
reported tubule dimensions generated by N-BAR domain proteins (ranging from 20-50
nm)[72,76]. The length of tubules varied from 300 nm to 4 µm with an averaged tubule
length around 549 ± 43 nm. No significant differences between WT and K35N were
found with respect to either tubule diameter or length (K35N: 35 ± 1 nm in diameter and
436 ± 22 nm in length). For D151N, although there was a slight increase in the tubule
diameter (40 ± 1 nm), the averaged tubule length was similar as WT (D151N: 385 ± 26
nm). For the R154Q mutant, tubules were shorter (190 ± 11 nm, 3 fold decreased)
suggesting reduced tubulation ability of R154Q. We acknowledge that dehydration
during sample preparation may cause variations in geometric measurements that can be
avoided using the alternative method of Cryo-EM imaging[166,167]. The diameters of
the tubules generated by endophilin N-BAR domain ranged from 24 nm to 28 nm in
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Cyro-EM studies. The tubule dimensions we measured here were slightly higher than the
published data, which could result either from tubule collapse during the drying process,
variations in the lipid composition, or protein concentration used in different
studies[74,82].
Two types of membrane deforming events occur as consequences of BIN1 NBAR binding: tubulation and vesiculation. N-BAR domains are known to be able to
deform large liposomes into vesicles with diameters smaller than 30-40 nm[79].
Therefore, we quantified both tubulation and vesiculation events as a measure of
membrane deformation ability of peripheral proteins.
We compared the average number of tubulation and vesiculation events in 30
individual images. WT and K35N had similar deformation capacities with 5-6 tubules
and 48 vesiculated liposomes (diameter was less than 30 nm) on average per frame (Fig.
13C). Tubule numbers for D151N and R154Q were reduced to 71 ± 12% and 40 ± 6% of
that for WT. Vesiculation numbers for D151N and R154Q, however, decreased more
significantly to 22 ± 5% and 27 ± 4% of the vesiculation events observed for WT protein.
To conclude, on 100% DOPS membranes, BIN1 N-BAR domains are able to
deform spherical membranes into tubules or small vesicles. Mild decrease in the
membrane deformation capacity is found in the D151N and R154Q mutants.
Because with model membranes consisting of 100% DOPS we found only mild
impairment of deformation capacity of disease mutants (Fig. 12) compared to the
significant differences observed in cells (Fig. 9), we next tested the hypothesis that lipid
composition plays a role in regulating deformation capacity of BIN1 variants. We chose a
lipid composition meant to better mimic the headgroup composition of the inner plasma
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membrane leaflet: 60% DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2. Here, DOPS and
PI(4,5)P2, which are enriched in the inner leaflet of the plasma membrane[168], provide
negative charge promoting electrostatic interactions with BAR domains while the
presence of the smaller headgroup in DOPE lipids results in more lipid packing defects
that facilitate insertion of amphipathic helices leading to enhanced tubulation and
vesiculation[169-171]. In this composition, only 50% of the total lipid headgroups are
negatively charged as a result of -1 charge per DOPS molecule and –3 charge per
PI(4,5)P2 molecule at physiological conditions[172,173]. We note that PI(4,5)P2, as a
multivalent lipid, could introduce specific effects on protein-membrane interactions[174].
Despite this potential complication, we aim, with this more physiological lipid
composition, to provide biologically relevant insights into how BIN1 N-BAR membrane
interactions differ among our mutants.
For this lipid composition, electron micrographs of liposomes incubated with
BIN1 N-BAR variants are shown in Fig. 14A. WT BIN1 N-BAR protein acted as a
strong curvature generator. The averaged tubule diameter was 29 ± 1 nm with a tubule
length distribution ranging from 200 nm to 2 µm. With this lipid composition, more
vesiculated liposomes (with diameters less than 30 nm) were found on grids (Fig. 14B)
than for the 100% DOPS composition. Compared to WT BIN1, membrane tubules
induced by K35N had similar width, but tubule lengths reduced to 61 ± 5% of those
generated by WT. Tubules generated by the R154Q mutant are wider (37 ± 1 nm) and
shorter (135 ± 9 nm). Strikingly, we found severely impaired membrane deformation for
D151N (Fig. 14C): Among over 30 analyzed EM micrographs, no tubulation or
vesiculation was observed (Figs. 14A&D). Differences among N-BAR variants are
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clearly demonstrated in the tubulation and vesiculation analyses in Fig. 14D. While
K35N showed a number of tubulation events per frame that was comparable to the WT
protein, the other mutants exhibited decreased probabilities of tubulation and vesiculation
from liposomes.
3.3 R154Q causes compromised membrane association density
Our observations from the tubulation assays suggest that different disease
mutations have varying effects on membrane deformation capacity. Membrane
association is the first step required for membrane curvature sensing & generation to
occur. It has been shown that curvature-coupling is protein density dependent[163]. Here
we used a GUV binding assay to quantify BIN1 variants density on membranes to test if
point mutations in the BIN1 BAR domain impair membrane binding.
In Figs. 15A&B, we quantified BIN1 N-BAR membrane binding density on giant
unilamellar vesicles using the two lipid compositions described above as a function of
increasing bulk protein concentration in buffer containing 50 mM NaCl. In these binding
studies, care was taken to maintain protein solution concentration at values low enough to
prevent microscopically visible tubulations. Recombinant BIN1 N-BAR variants were
labeled with Alexa-488 on endogenous cysteines and we then measured mean
fluorescence intensities per pixel along the GUV equator. Fluorescence signals were
converted to protein membrane binding densities based on an adapted calibration method
[162-164]. By plotting the protein membrane binding densities against protein
concentration, a membrane-binding isotherm can be obtained. The following equation
was fitted to data:
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𝐾
(1 + 𝑐! )

Here, B is the membrane-bound protein density quantified from the protein fluorescence
intensities on GUVs. c is the protein bulk concentrations. Two binding parameters, the
binding dissociation constant, Kd, and protein saturation density, Bmax can be obtained as
fitting parameters. Bmax describes the maximum protein density on membranes when bulk
concentration approaches infinity.
On the 100% DOPS vesicles, the density of membrane-bound protein increased
with increasing protein solution concentration, as expected. The membrane binding
affinities (Kd) that we obtained were similar among BIN1 N-BAR variants. The
membrane binding dissociation constants Kd are: 320 nM ± 51 nM (WT), 400 nM ± 29
nM (K35N), 540nM ± 172 nM (D151N) and 640 nM ± 94 nM (R154Q). From these
affinities, one finds that the maximal binding free energy difference comparing WT and
mutants is only about 0.7 kBT, i.e. on the order of thermal fluctuations. The saturation
densities for the disease mutants were only slightly lower compared to the WT N-BAR
domain (Fig. 15A). The overall high protein packing densities (> 100,000 per µm2), even
for disease mutants on 100% DOPS membranes, are consistent with the notion that the
mutants are still able to generate tubules from liposomes but with shorter lengths and
lower probabilities, as shown in Fig. 13, because of the slightly decreased protein
densities compared to WT.
For the composition 60% DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2 (Fig. 6B),
where disease mutants show significant variations in membrane deformation capacities,
the membrane dissociation constants increased due to the reduced membrane charges.
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The observed membrane dissociation constants Kd are: 720 nM ± 173 nM (WT), 1300
nM ± 346 nM (K35N), 1000 nM ± 415 nM (D151N) and 1800 nM ± 57 nM (R154Q).
The differences among Kd values are on the order of thermal fluctuations. However, we
obtained the saturation protein densities Bmax from the curve fitting and found that Bmax of
the disease mutants were reduced compared to WT N-BAR, especially for the R154Q
mutant. Bmax of the R154Q mutant was 54 ± 7% of the saturation density for WT N-BAR
domain on the membrane. The decreases in Bmax for the K35N (95 ± 15%) and D151N
(80 ± 7%) mutants were less noticeable. These data suggest that R154Q impairs
membrane association more severely compared to the other N-BAR variants considered
here.
Recent studies have assigned an important role of protein density on membranes
in influencing curvature coupling. Even protein crowding alone can lead to membrane
tubulation[84,163]. Our results from protein density quantifications on GUVs suggest
that the R154Q mutation reduces protein packing density on membranes due to the loss
of a positively charged residue at position 154, thus reducing electrostatic interactions
between N-BAR domains and negatively-charged membranes. Arginine is also often
found inserted into the lipid bilayer[175]. Mutational studies of peptide-membrane
interactions have revealed that arginine density governs the strength of peptide-lipid
headgroup interactions and depth of insertion into the lipid membrane[176]. We
hypothesize that the R154Q mutant compromises the membrane association by reducing
electrostatic interactions with membranes and compromising Arg-mediated membrane
penetration at the membrane-binding interface.
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N-BAR domains are known to function as curvature sensors[177]. The SLiC
(Single Liposomes of different diameters and therefore Curvature) assay has revealed
that N-BAR domains of endophilin preferentially bind to smaller liposomes with higher
affinity and density[38], mainly through sensing membrane defects via the amphipathic
H0 helix[75]. It has also been shown that the N-BAR domain from endophilin is able to
partition onto highly curved membrane tethers[178]. We next asked the question if
compromised curvature sensing ability caused the impaired membrane deformation
capacity of the D151N mutant.
To investigate the ability of the disease mutants to sense membrane curvature, we
used a tether-pulling system to quantify the protein partitioning ratio between flat and
curved membranes. In this assay, a tubular membrane was pulled from a GUV
(composed of 59% DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2/0.5% DSPE-BioPEG2000/0.5% Texas Red-DHPE) by a polystyrene bead aspirated by a micro-pipette
(for fluorescence imaging) or trapped by optical tweezers (for mechanical force
measurement on tubule)[80,165,178]. A typical fluorescence image of a tether-pulled
vesicle is shown in Fig. 15C (top panel). At a membrane tension of 0.12 mN/m, increased
fluorescence signal on the tubular membrane relative to the quasiflat GUV was observed
in WT N-BAR at 100 nM in bulk. In contrast, significantly reduced fluorescence was
found on vesicles incubated with R154Q under the same conditions, confirming our
conclusion that R154Q binds to membranes more weakly than the WT protein.
With increasing membrane tension (regulated through increasing pipette
aspiration pressure), protein fluorescence signals on tethers were observed to increase.
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The curvature partitioning 𝐼! /𝐼!! is defined as a ratio of fluorescence signals on the tether
(superscript t) from protein (green) and lipid (red) normalized to a corresponding ratio on
!
!
!
!
the GUV (superscript v), 𝐼! /𝐼!! = (𝐼!"##$
/𝐼!"#
)/(𝐼!"!!"
/𝐼!"#
). 𝐼! /𝐼!! is observed to vary

linearly with the square root of membrane tension; Σ1/2 (Fig. 15C), in accordance with
simple first-order thermodynamic theories[80,165,177-180], and similar to what has been
reported for ENTH and other types of N-BAR domains[80,163]. We note that curvature
sorting behavior is known to be protein density dependent[163]. Therefore, in the
experiments just described, only vesicles showing comparable fluorescence intensities on
GUVs were analyzed, as shown in the inset in Fig. 15C. An F-test of the linear
regressions revealed that the slopes of the curvature sorting/square root of tension
relationship comparing WT and K35N are indistinguishable. Although 𝐼! /𝐼!! values for
the D151N and R154Q mutants are slightly lower compared to WT N-BAR, these two
mutants both show that the curvature sorting ratios 𝐼! /𝐼!! increase proportionally to the
square root of membrane tension. The slopes of the fluorescence intensity ratio for all the
BIN1 variants investigated here deviate significantly from the null hypothesis of absent
curvature sorting (slope = 0). Results from the curvature sorting assay imply that CNM
mutations do not eliminate the curvature sensing ability of N-BAR domains. The
defective membrane deformation capacity, especially for the D151N mutant, cannot be
attributed to the loss of membrane curvature sensing ability.
We next aimed to characterize curvature generation capacities of BIN1 N-BAR
domains in more details. The measurement of membrane tether pulling forces is a
powerful assay to probe the mechanical influence of protein binding to membranes. With
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the help of optical tweezers, forces needed to mechanically stabilize tethers can be
monitored in real time[165]. As expected, the presence (100 nM bulk concentration) of
BIN1 N-BAR domains was shown to reduce tether pulling forces relative to a pure lipid
control at a membrane tension of 0.21 ± 0.003 mN/m (Fig. 15D). This observation
implies that binding of BIN1 N-BAR domains on the tether stabilizes membrane
curvature.
At the same bulk protein concentrations as the WT protein, equilibrium pulling
forces on the tethers covered by BIN1 N-BAR mutants were lower and significantly
different from the ones on a bare lipid tube, based on a Student t test. Although the
R154Q mutant showed a higher pulling force on average compared to the other mutants,
the differences among the mutants are not statistically significant. This is consistent with
the observation that we found similar curvature-coupled protein sorting behaviors among
the BIN1 variants. Particularly, the D151N mutant is able to sense and stabilize the pulled
membrane tethers, but it is not able to induce spontaneous tubule formation from
liposomes (Fig. 14). A decrease of the curvature generation capacity of the R154Q
mutant relative to the other mutants and the WT protein is likely to be caused by the
decreased membrane association density (Fig. 15B).
To summarize, membrane curvature sorting is displayed by all CNM-associated
mutants, and they are able to stabilize cylindrical membrane curvatures. The significantly
higher pulling force measured on GUVs incubated with the R154Q mutant is a result of
reduced membrane-bound protein density.
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3.4 D151N is unable to initiate curvature required for tubule growth, possibly due to
impaired protein assembly/oligomerization on membranes
As shown above, the D151N mutant binds membranes and senses membrane
curvature equivalently to the WT protein. However, the tubulation assay clearly
demonstrated that the D151N mutation impair tubulation under certain conditions.
During clathrin-mediated endocytosis (CME), proteins including clathrin, AP2
and FCHo1/2, arrive at the plasma membrane at an early stage and nucleate to form
initial buds that recruit other proteins, including BAR domain proteins, to further promote
membrane invagination and scission[102,181-184]. In our tubulation assay, the initiation
of membrane tubulation occurs via BAR domain protein binding only.
In order to test the possibility that D151N is deficient in membrane budding
initiation, we varied protein concentration in the EM tubulation assay to monitor
membrane morphology changes as a function of protein concentrations. We first
examined BIN1 WT N-BAR in this manner. Fig. 16A shows micrographs of liposomes
incubated with BIN1 WT N-BAR at various protein concentrations. At a low protein
concentration of 200 nM, the morphologies of liposomes were similar to the lipid control
(Fig. 14A). When increasing protein concentration to 500 nM, membrane ‘wobbles’
appeared, as indicated by the arrows in Fig. 16A. We speculate that those buds serve as
sites for tubule growth through recruitment of additional proteins. Consistent with that
idea, when we further raised protein concentration to 1 µM and 5 µM, tubule generation
set in and tubule diameters decreased with increasing protein concentration (Fig. 16A).
However, we failed to observe membrane morphology changes for the D151N mutant
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(Fig. 16B) for a wide range of protein concentrations (200 nM-15 µM). Because we have
shown above that the ability to reduce the pulling force of a cylindrical membrane tether
(Fig. 15D), as well as curvature sensing, are not eliminated by D151N, we hypothesize
that D151N impairs membrane budding at the onset of the tubulation process.
Thus far, our results suggest that the D151N mutation interferes with membrane
curvature initiation only, but retained the capacity to stabilize cylindrical membrane
curvature (Figs. 15C&D). We next asked, if the addition of a small amount of WT protein
(large enough to cause budding (Figs. 16A) but small enough to prevent significant
tubulation) might rescue the curvature initiation defect observed in the presence of
D151N alone. When only 500 nM WT N-BAR was incubated with liposomes, vesicle
boundary wobbling (Figs. 16A&17B) was observed, in addition to the generation of some
short tubes (Fig. 17B). On the other hand, 5 µM D151N failed to deform membranes
(Figs. 16B&17B). However, mixing 500 nM WT N-BAR with 4.5 µM D151N mutants
(achieving identical total protein concentration as in Figs. 13&14) successfully rescued
the N-BAR tubulation ability (Figs. 17A&B). Both budding and long tubule formation (>
1 µM) were found in such samples (Fig. 17B). This observation supports our hypothesis
that the defect for D151N tubule generation lies in impaired spontaneous curvature
initiation (budding), instead of lack in cylindrical curvature stabilization.
Cryo-EM reconstructions and simulations of endophilin N-BAR revealed that
oligomeric assembly on flat and tubular membranes is essential for inducing and
stabilizing tubulation[74,82]. Additionally, recent computer simulations have proposed
that transient protein lattice formation / aggregation on flat membranes is a prerequisite
for tubulation induced by N-BAR domains[95,185]. Here, we used a chemical cross	
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linking assay to ask the question if failures in membrane budding by the D151N mutant
was due to defective protein oligomerization on membranes[186]. In the absence of
crosslinkers, BIN1 N-BAR and variants were monomeric in solution under denaturing
conditions. SDS-PAGE gels showed a single band corresponding to a molecular weight
around 30 kDa. At 0.5 mM or 5 mM crosslinker concentration, BIN N-BAR domains
were crosslinked into dimers in solution (Fig. 18). However, when liposomes were
present, multiple oligomeric bands with molecular weight larger than a single dimer
appeared on SDS-PAGE gels for the cases of WT and K35N, demonstrating that higherordered protein complexes were formed when associated with membranes (Figs. 18A&B).
For these two proteins, after adding 5 mM BS3, a fraction of the crosslinked species
became too large to be able to enter the resolving gel. Addition of BS3 crosslinker to the
mixture of R154Q and liposomes resulted in diminishing dimer bands and an
unresolvable pattern of oligomeric species on the gel. The unresolvable oligomer pattern
of R154Q could be a result of the lowest membrane association affinity among all
mutants. In contrast, we observed only dimer bands for D151N mutants in the presence
(or absence) of liposomes confirming that the capacity to form protein assemblies on the
membrane is impaired for the D151N mutant. Even at high crosslinker concentration (5
mM), absence of protein retention in the stacking gel indicated absence of D151N
oligomers (Fig. 18D).
BAR domain assemblies are proposed to be stabilized by amphipathic helices as
in endophilin N-BAR domains[74,82], or through edge-edge interactions such as in
various F-BAR domains[81-83]. The intermolecular contacts among F-BAR domains are
mediated through charged residues at the contact interfaces[81,83]. Since residue D151 is
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located in the distal arm region with the side chain pointing outward in the crystal
structure, this orientation might allow for interactions with a charged residue from a
neighboring BAR domain in an anti-parallel manner. The crystal structure reveals several
charged or polar residues at the distal tip region. We screened these residues by mutations
to alanines and transfected the mutants in C2C12 myoblasts to determine if they were
important for the maintenance of tubulation capacity as well.
After a series of mutational analyses (confer Table 7), residue H155 emerged as a
possible candidate interacting with D151. H155A resulted in loss of membrane tubulation
when expressing the GFP-conjugated form in C2C12 myoblasts similarly to the D151N
mutant (Fig. 19). Our results imply that the conservation of charge either at the 151(-) or
155(+) position is important for maintaining tubulation ability of BIN1 N-BAR domain
(confer Table 7). Additionally, we observed that a double mutation D151N/H155R
rescued membrane tubulation in cells. Membrane invaginations marked by green
fluorescence in C2C12 cells appeared with tubule morphology similar to the WT (Fig.
19).
3.5 Tubulation induced by BIN1 N-BAR domain is antagonized by actin
polymerization
Thus far, we have not been able to identify any conditions under which K35N can
be distinguished from WT BIN1 N-BAR domains except in cellular studies. We first
recall that the K35 residue is predicted to be projected onto the charged surface of the Nterminal amphipathic helix[93], thus the K35N mutation may influence helix insertion
into membranes thus influence membrane tubulation. To test this, we compared the
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interactions of WT and K35N BAR domain with lipid monolayers[174,187]. The lipid
monolayer was spread at a constant area at a given initial surface pressure (π0), and the
change in surface pressure (Δπ) was monitored on a Langmuir trough after injecting
proteins into the subphase. A linear relationship between Δπ and π0 was observed that
allows determination of the critical penetration pressure πc, which can be interpreted as
the upper limit of π0 that allows protein penetration into the lipid membranes. We
determined close πc values for the WT and K35N BAR domains: 26.2 and 25.6 dyne/cm,
respectively. According to an F-test on the linear regressions in Fig. 20A, the slopes are
not significantly different but the intercepts (πc) differ slightly (p=0.024). However, the πc
values we determined here are below 31 dyne/cm, which is an estimated surface pressure
for the cell membrane[174]. Thus the N-terminal helix insertion may not be the key
reason for the reduced membrane deformation capacity by K35N mutant in the in vivo
study.
Furthermore, it has been reported that an extended N-BAR peptide that carries the
N35 mutation cannot be distinguished from the 1–34 peptide in biophysical
measurements including a tubulation assay[188]. Thus, we next asked if there are other
cellular processes regulating membrane tubulation and if perturbation of such processes
might reveal a role of the K35N mutation. Specifically, we tested the role of actin in the
membrane tubulation process and asked how perturbation of actin polymerization affects
tubulation by disease mutants.
To that end, C2C12 myoblasts were transfected with GFP-labeled BIN1 WT and
K35N N-BAR* domains, and examined using TIRF microscopy. At t = 0 s, cells were
treated with 1 µM LatrunculinA, an actin polymerization inhibitor. GFP-positive
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membrane tubules started to grow from the plasma membrane shortly after inhibitor
addition in cells expressing BIN1 N-BAR domains, or alternatively, the K35N mutants
(Fig. 20B), similarly as reported before both for F-BAR domains and other N-BAR
proteins[189,190]. Importantly, we did not observe tubule formation from cells
expressing D151N and R154Q mutants after depolymerizing the actin cytoskeleton (data
not shown). This is consistent with our findings that D151N and R154Q are mutations
that cause inability to deform membranes, while K35N behaves similarly to WT. This
suggests that the tubulation ability of the K35N mutant could be inhibited in cells,
possibly through the actin polymerization underneath plasma membranes. However, it
remains unknown if there are other proteins involved in coupling BIN1 to cytoskeletal
components, and how the mutated N-terminal helix is involved in this inhibitory
interaction.
3.6 Summary and Significance
In conclusion, our studies have shown that both protein density and
oligomerization on membranes determine membrane curvature generation capacity.
Based on the membrane structures revealed in the tubulation assay, we suggest that in
order to initiate spontaneous liposome deformation and tubule growth, transient ordered
protein oligomers are required to form on a flat membrane and to allow for the initiation
of tubule formation. A schematic illustration of this process is shown in Fig. 21. We have
divided the tubulation process into the following four steps:
1) A membrane association step enables proteins to reach a certain density on the
membrane. In the class of N-BAR domains, this interaction is primarily mediated by
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electrostatic interactions between charged residues located at the binding interface with
negatively charged lipid headgroups. The membrane insertion via the amphipathic helix
in BAR domains also contributes to increasing the protein density on membranes. GUV
isotherm measurements demonstrated that the R154Q mutant led to decreased protein
density on GUVs. We hypothesize that the reduced binding may result from the
unfavorable charge change at residue 154, where a highly membrane binding and
inserting residue has been mutated to a neutral one. Although, based on the crystal
structure, R154 is located in the tip region of the BAR domain and the orientation of this
residue does not point directly to the membrane binding interface. Given the length and
the flexibility of the arginine side chain, we hypothesize that the R154 residue may adopt
a conformation allowing interactions with anionic lipids, thus the mutant R154Q may
influence membrane binding by interrupting electrostatic interactions.
2) With increasing protein density on membranes, local curvature is induced as
budding sites for tubule formation grow, a process where protein oligomerization is
involved[95]. At an intermediate protein concentration (500 nM), liposome boundaries
developed wobbles and semi-spherical structures appeared on the membrane. We
consider those buds as the initiation sites for tubulation to occur. In our experiments, we
observed bud formation for both WT and K35N mutants, and for R154Q mutants at
higher protein concentration. However, budding formation was absent in D151N mutants
even at 15 µM concentration. Our chemical crosslinking assay further confirmed that
covalently crosslinked protein oligomers occurred under conditions where membrane
deformations were induced by N-BAR domains. The D151N mutant specifically
abolished protein assembly on membranes. Our observations suggest a correlation
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between protein nucleation and membrane bud formation. This hypothesis is further
supported by recent computational simulations, which reported that N-BAR domains
form linear aggregates on the membrane, with emerging membrane buds at low surface
protein densities[74,95,185].
3) After the initial curved membrane is formed, BAR domains can sense the high
curvature membrane and migrate onto tubules to facilitate tubule growth. Currently, the
most popular interpretation of the membrane curvature sensing mechanism is that it is
mediated by N-terminal amphipathic helix insertion in which curved membranes display
increased membrane defect density promoting hydrophobic insertion[38,75,77,171]. In
our curvature sensing assay, we did not observe significant differences in curvature
sensing ability among BIN1 N-BAR mutants. For the D151N and R154Q mutants, the
intact N-terminal helix likely provides a driving force for curvature sensing. Strikingly,
we observed that the K35N behaved similarly to WT BIN1 N-BAR domain. Previous
studies on an extended N-terminal peptide of human Amphiphysin II (residue 1-44) have
shown that K35N mutants cannot be distinguished from WT peptide in CD/NMR spectra
and tubulation assays[188]. Together with our in vitro biophysical measurements, it can
therefore be inferred that the K35 residue is not critical for amphipathic helix function.
Our preliminary findings implicate that the cytoskeleton plays a role, because upon actin
depolymerization, K35N mutant in cells are able to tubulate membranes just as WT NBAR. However, future work is needed to understand the role of the K35 residue in
regulating protein tubulation ability.
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4) More proteins are sorted onto the tubular membranes and a membrane tubule
becomes decorated by a protein coat to stabilize the generated curvature indicated in
previous EM studies.
In summary, we have focused on the differences in the membrane deformation
ability among disease-related mutations in the N-BAR domain of BIN1. We hasten to
remark that T-tubule biogenesis in skeletal muscle tissues is likely to be a more
complicated process than discussed here. This is in part due to the fact that in the fulllength BIN1 protein, exon10-encoded peptide and SH3 domain contribute to the
regulation of membrane deformation ability of the BIN1 protein. Particularly, the SH3
domain acts as an adaptor to allow BIN1 complexation with other proteins to modulate
membrane morphology. In addition to dynamin2, it has been recently discovered that
myotubularin (MTM1) binds the BIN1 SH3 domain and enhances BIN1-mediated
membrane tubulation. Binding between SH3 domain and downstream proteins such as
dynamin2 and MTM1 induces a conformational change in full-length BIN1 that favors
membrane deformation[191]. This finding supports a more complex pathological
mechanism in centronuclear myopathy. The mutations we examined in this study do not
have an impact on MTM1 recruitment to BIN1 because they were located outside of the
SH3 domain. This finding also supported our argument that mutations in the N-BAR
domain did not alter the protein conformation as confirmed by CD spectroscopy and size
exclusion chromatography. Thus, the biophysical measurements we performed here
provide a basis for elucidating molecular mechanisms contributing to membrane
deformation defects in the CNM-related mutations, specifically in the N-BAR domains.
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Fig. 8 Location of CNM-associated mutations in BIN1.
A) Schematic demonstration of K35N, D151N, R154Q, and two nonsense mutation in
SH3 domain found in CNM patients in human BIN1 protein. B) Cartoon structure of
human BIN1 N-BAR domain (PDB ID code: 2FIC). Residues D151 and R154 are shown
as sticks at the distal arm of a BAR domain dimer.
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Fig. 9 Expressing CNM-related mutants in C2C12 cells leads to loss of membrane
tubulation.
A) BIN N-BAR* WT and mutants are fused to fluorescent proteins, mKate and
transiently transfected in C2C12 myoblasts. The mKate tag was conjugated at the Cterminus of BIN1 N-BAR* domain. Cells are imaged by confocal fluorescence
microscopy. Scale bar: 20 µm. B) Quantification of three types of membrane
deformations by BIN1 N-BAR* variants. Quantification details can be found in Chapter
2.5. Over 50 cells were analyzed in each separated experiments. Error bars: standard error
of the mean in black and standard deviation in light grey. Student t-test for statistical
significance: n.s: p>0.05, *: p<0.05, **: p< 0.01, ***: p< 0.001.
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Fig. 10 Expression of EGFP or mKate alone in C2C12 cells does not induce plasma
membrane tubulation.
Confocal images of C2C12 cells transfected with A) pEGFP-N1 vector; B) mKate-N1
vector. Scale bar: 20 µm.
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Fig. 11 Fluorescence tag labeled at the N-terminus does not change tubulation
abilities of BIN1 N-BAR* variants.
A) BIN N-BAR* WT and mutants are fused to EGFP transiently transfected in C2C12
myoblasts. The EGFP tag was conjugated at the N-terminus of the BIN1 N-BAR*
domain. Cells are imaged via confocal fluorescence microscopy. Scale bar: 20 µm. B)
Quantification of three types of membrane deformations by BIN1 N-BAR* variants.
Quantification details can be found in Chapter 2.5. Over 50 cells were analyzed in each
separated experiments. Similar tubulation phenotypes are observed as in the case of the
C-terminal labeled proteins (Fig. 9). This observation suggests that fluorescence tag
labeled at the N-terminus of BIN1 N-BAR* does not interfere with the functions of
insertion helix H0. Error bars: standard error of the mean in black and standard deviation
in light grey. Student t-test for statistical significance: n.s: p>0.05, *: p<0.05, **: p<0.01,
***: P< 0.001.
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Fig. 12 TIRF micrographs show homogeneous fluorescence of CNM-related mutants
on plasma membrane.
BIN N-BAR* WT and mutants are fused to EGFP at N-terminus and transiently
transfected in C2C12 myoblasts. Cells are imaged by TIRF fluorescence microscopy.
Scale bar: 20 µm. All variants of BIN1 N-BAR* proteins show binding ability on plasma
membrane. However, only WT BIN1 N-BAR* generates fluorescent puncta on
membranes. The total number of fluorescent clusters on plasma membranes expressing
disease mutants is largely reduced.
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Fig. 13 On membranes with high negative charge, D151N and R154Q show slight
reduction in tubulation capacity.
A) Electron micrographs of liposomes (100% DOPS) tubulated by BIN1 N-BAR and
mutants. Membrane tubules are observed for all BIN1 N-BAR variants. Scale bar: 200
nm. B) Quantifications of tubule diameter and length by BIN1 variants. The R154Q
mutation leads to increased tubule diameters and decreased tubule length comparing to
WT BIN1. C) Averaged occurrence of membrane tubules and vesiculated liposomes in
each micrograph. K35N and D151N mutant are similar to WT N-BAR in membrane
tubulation. All the disease mutants cause decrease in vesiculation to varied extent. The
quantification method is described in detail in Chapter 2.7. Over 30 images were
analyzed for quantifications. Error bars: standard error of the mean in black and standard
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deviation in light grey. Student t-test for statistical significance: n.s: p>0.05, *: p<0.05,
**: p< 0.01, ***: p< 0.001.
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Fig. 14 Lowering membrane negative charge further reduces tubulation ability for
the D151N and R154Q mutants.
A) Electron micrographs of liposomes (60% DOPC/20% DOPS/10% DOPE/10%
PI(4,5)P2) incubated with BIN1 N-BAR and the mutants. WT and K35N still strongly
deform vesicles. Short tubules are observed in R154Q samples. Almost complete loss of
curvature generation is observed in D151N. Scale bar: 200 nm. Electron micrograph in B)
is the zoom-in image boxed in A). Uniform small vesicles with 28 ± 7 nm diameters are
found after incubation with N-BAR proteins. Scale bar: 50 nm. C) Quantifications of
tubule diameter and length by BIN1 variants. R154Q mutation shows compromised
curvature generation. D) Quantification of the averaged occurrence of membrane tubules
and vesiculated liposomes in each micrograph. K35N shows similar number of tubules
per frame and mild decrease in vesiculation. Both D151N and R154Q lead to significant
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decrease in tubulation and vesiculation. The quantification method is described in detail
in Chapter 2.7. Over 30 images were analyzed for quantifications. Error bars: standard
error of the mean in black and standard deviation in light grey. Student t-test for
statistical significance: n.s: p>0.05, *: p<0.05, **: p<0.01, ***: p< 0.001.
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Fig. 15 R154Q mutation lowers membrane association density.
Protein adsorption isotherm on GUVs composed of A) 100% DOPS and B) 60% DOPC/
20% DOPS/ 10% DOPE/ 10% PI(4,5)P2. Proteins and vesicles are incubated in 20 mM
Hepes, 50 mM NaCl, 1 mM DTT, pH 7.4 buffer at room temperature for 30 minutes
before imaging on confocal fluorescence microscopy. Green fluorescence intensities on
vesicle equators are measured and normalized to the total membrane area. Absolute
molecule density is calculated according to the calibration curve. Data are fitted by the
Langmuir isotherm model to obtain Kd and Bmax. Membrane bound density of R154Q
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dramatically decreases on biomimetic membranes. The error bars are the standard error
of the mean of 10 measured GUVs. C) Quantitative analysis of the curvature sorting
abilities of BIN1 N-BAR domain and its mutants. A membrane tether is pulled from a
micropipette-aspirated GUV (60% DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2,
labeled by Texas-Red lipid dye) by a polystyrene bead and imaged by confocal
fluorescence microscopy. At 100 nM, WT N-BAR fluorescence on GUV and tether is
brighter than R154Q N-BAR as shown in the upper panel. WT (100 nM), K35N (100
nM), D151N (100 nM) and R154Q (600 nM) are pre-incubated with GUVs in 20 mM
Hepes, 50 mM NaCl, 1 mM DTT, pH 7.4 buffer at room temperature for 30 minutes
before transfer to aspiration chamber. By increasing membrane tension controlled by
aspiration pressure, protein partitioning on tubular membrane tether and decrease in lipid
fluorescence on tether is observed. Curvature coupling parameter 𝐼! /𝐼!! from images
recorded by Kalman-averaged confocal xz line-scan images is plotted with square root of
membrane tension, revealing a linear relationship. Data from six vesicles was binned
(vertical error bars represent standard error of the mean of 𝐼! /𝐼!! and horizontal error bars
show standard error of the mean of square root of tension). Inset graph demonstrates
similar fluorescence intensity on GUVs analyzed for four BIN1 variants. Error bars are
standard errors of the mean. D) Equilibrium forces of tethers pulled from GUVs (60%
DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2) were measured by optical trap at
membrane tension of 0.21 ± 0.003 mN/m. Error bars: standard error of the mean in black
and standard deviation in light grey. Student t-test for statistical significance: n.s: p>0.05,
*: p<0.05, **: p<0.01, ***: p< 0.001.
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Fig. 16 Spontaneous tubulation by BIN1 N-BAR includes ‘membrane budding’ step
which is compromised in the D151N mutant.
A) Electron micrographs of liposome tubulation by BIN1 N-BAR WT at protein
concentrations ranging from 200 nM to 5 µM. Scale bar: 200 nm. At low protein
concentration, no morphology deformation is observed. At 500 nM, membrane showed
waviness at liposome edges. Increasing protein concentration to 1 µM or 5 µM results in
the formation and elongation of membrane tubules. B) Titrating D151N N-BAR in
tubulation assay (200 nM – 15 µM) does not change liposome morphologies.

	
  

84	
  

	
  

Fig. 17 Mixing D151N mutants with 500 nM WT N-BAR restores tubulation.
A) Electron micrographs of liposomes incubated with 500 nM WT + 4.5 µM D151N.
Scale bar: 200 nm. B) Quantification of tubulation enhancement after mixing WT NBAR with D151N mutants. 500 nM WT primarily generates membrane buds on vesicles
with occasional tubules found on the grid (Fig. 16A). D151N consistently had a
negligible effect on membrane morphology (Fig. 16B). When mixing D151N N-BAR
with 500 nM WT N-BAR domain, tubulation was observed suggesting D151N was able
to induce membrane tubule elongation as long as the initiation intermediates were present.
Over 30 images were analyzed. Error bars: standard error of the mean in black and
standard deviation in light grey. Student t-test for statistical significance: n.s: p>0.05, *:
p<0.05, **: p<0.01, ***: P< 0.001.
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Fig. 18 Chemical crosslinking reveals that D151N mutation impairs protein
oligomerization upon membrane binding.
A) WT, B) K35N, C) R154Q and D) D151N are incubated in the absence or presence of
100% DOPS LUVs (0.1 mg/mL, final concentration) at room temperature for 30 min.
Indicated amount of BS3 (Bis(sulfosuccinimidyl) suberate) is added in each sample
followed by incubation at 37 °C for 2 min. Samples are analyzed by SDS-PAGE gel and
stained by coomassie staining. In absence of liposomes, N-BAR domains are crosslinked
into dimers with MW around 66 kDa. In presence of liposomes, WT and K35N show
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oligomers at 0.5 mM BS3 concentration. Further increasing crosslinker concentration
yields species that cannot enter the resolving gel. R154Q in C) shows weaker crosslinked
bands while D151N in D) shows major dimer bands in presence of membranes. The
higher molecular weight band is absent even at 5 mM BS3 concentration in the D151N
sample. Buffer: 20 mM Hepes, 150 mM NaCl, pH 7.4.
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Fig. 19 D151N/H155R double mutant rescues tubulation ability in C2C12 cells.
BIN N-BAR* WT and its mutants are fused to GFP and transiently transfected in C2C12
myoblasts. Cells are imaged by confocal fluorescence microscopy. Scale bar: 20 µm.
Expression of BIN1 N-BAR* WT causes great membrane tubulation in C2C12 cells.
H155 is identified as a key residue in regulating N-BAR* domain tubulation ability.
Mutating H155 to alanine abolishes tubulation in C2C12 cells while double mutantD151N/H155R deforms membrane into tubular structures.
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Fig. 20 K35N does not change membrane insertion and depolymerizing actin in cells
allows membrane deformation by the K35N mutant.
A) WT and K35N BAR domain insertion was studied by monolayer composed of 60%
DOPC/20% DOPS/10% PI(4,5)P2/10% DOPE. πc was determined by extrapolating the
Δπ versus π0 plot to the abscissa. πc is 26.2 and 25.6 dyne/cm for WT and K35N,
respectively. Error bars represent standard error of the mean of three independent
experiments. An F-test of the fittings indicates two linear regressions are not significantly
different. B) TIRF images of C2C12 myoblasts transfected BIN1 N-BAR* WT or K35N
maintained at 37°C. At t = 0 s, cell culture medium containing 1 µM LatrunculinA are
added into the culture dish and time-lapse images are recorded. New membrane tubules
are generated after actin is depolymerized as indicated by the arrows. No increased
tubulation was observed in cells transfected with D151N and R154Q N-BAR* (data not
shown).
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Fig. 21 Proposed schematic illustration of BIN1 N-BAR domain tubulating
membranes.
1) N-BAR domains bind on membrane; 2) Proteins oligomerize locally to create
membrane buds; 3) N-BAR domains sense local curvature and diffuse onto the tubule to
further elongate membrane tubule and stabilize the highly curved membrane; 4) Finally,
the tubules are fully decorated by N-BAR domains. Electron micrographs are WT NBAR domains (200 nM - 5 µM) incubated with 60% DOPC/20% DOPS/10% PI
(4,5)P2/10% DOPE at room temperature. Scale bar: 200 nM.
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Chapter 4 Phosphoinositides and downstream effectors synergistically
activates auto-inhibited BIN1 to be a membrane curvature sensor and
generator5
Besides the N-terminal BAR domain to interact with membranes, full-length
BIN1 also contains a muscle-specific polybasic peptide (exon10) as the phosphoinositide
binding motif and a C-terminal Src homology3 (SH3) domain for the recruitment of
downstream proteins such as dynamin2. Previous chapter focused on elucidating
mechanisms of membrane curvature sensing & generation (MC-S&G) capacity of BIN1
N-BAR domains. However, less is known about how the MC-S&G is regulated in BIN1.
It has been proposed that exon10 motif is able to bind with SH3 domain to inhibit
dynamin2 recruitment. Studies have also shown that SH3 domains involve in the
regulation of BAR protein membrane deformation functions through a mechanism called
autoinhibition[157,158]. In this chapter, we aim to investigate whether autoinhibition
exist in BIN1, whether autoinhibition in BIN1 is mediated through exon10-SH3
interactions and how membrane remodeling by BIN1 is affected.
4.1 Exon10 peptide is in the random coil conformation both in solution and on
membranes
It is currently unclear, how the exon10 motif interacts with membranes. It is well
known that N-BAR domain proteins contain short peptide modules (such as an N	
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BIN1 membrane curvature sensing and generation show autoinhibition regulated by downstream ligands and PI(4,5)P2.
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terminal H0 helix that forms through membrane interaction) that enhance membrane
binding [57,72,77,79]. It has been demonstrated that the insertion helix in N-BAR
domain proteins is in a disordered conformation in solution and folds into a α-helical
structure upon membrane binding. The α-helical conformation exposes the hydrophobic
surface on the helix to the lipid acyl-chains to allow insertion[78]. We asked the question
which conformation the exon10 motif adopts and whether conformational changes can be
induced upon membrane binding. We set out to measure via Circular dichroism (CD)
spectroscopy[192] the secondary structure of the exon10 peptide in solution and on large
unilamellar vesicles (LUVs). The CD spectrum revealed a negative peak at 204 nm (Fig.
22, dashed line), which is the characteristic of a random coil in solution[193]. Upon the
addition of 4 mM of LUVs (lipid compositions: 68% DOPC/20% DOPS/10% DOPE/2%
PI(4,5)P2), no significant changes in the CD spectra were observed (Figs. 22, solid lines).
This result implies that exon10 motif is unstructured on membranes. This finding is
compatible with the highly charged nature of the exon10 sequence and corresponding
behavior is found for the effector domain of myristoylated alanine-rich C-kinase substrate
(MARCKS-ED) peptide, which is another peptide enriched in basic residues[194,195].
4.2 Exon10 motif binds to the SH3 domain stronger than the PRD peptide
We compared exon10-SH3 domain to PRD-SH3 domain binding affinity through
isothermal titration calorimetry (ITC). We first titrated the synthetic exon10 peptide
(RKKSKLFSRLRRKKN) into the recombinant GST-SH3 domains (derived from BIN1)
(Figs. 23A&B). Due to the basic nature of exon10 peptide, we investigated the effects of
salt concentrations on the exon10-SH3 domain binding. Consistent with our expectation,
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lowering ionic strength increases the affinity of the exon10 peptide for the SH3 domain,
indicating that the exon10-SH3 binding is driven by electrostatic interactions (Fig. 23C).
Fitting the curve to a single site binding model, yielded a dissociation constant Kd of 3.9
± 0.18 µM in 50 mM NaCl buffer (Fig. 23A) and 11.3 ± 0.55 µM in 150 mM NaCl buffer
(Fig. 23B). When titrating the exon10 peptide into BIN1-FL proteins, the reaction did not
reach the saturation rendering the determination of Kd and stoichiometry inaccurate due
to the low affinity for the full-length proteins (data not shown). The reduced affinity of
exon10 binding to full-length proteins compared to SH3 domains is consistent with a
competition of free exon10 with the endogenous exon10-SH3 complexes and thus
suggests a model of autoinhibition involving exon10-SH3 binding.
SH3 domains are known as proline-rich domain (PRD) recruiters[103]. To
compare the binding strength of the SH3 domain-involved intra- and inter-molecular
complexation, we titrated the PRD peptide (PPQIPSRPVRIPPGI, derived from dynamin2)
into a GST-SH3 domain solution. As for exon10-SH3 domain binding, ionic strengthregulated PRD-SH3 domain binding was observed, albeit with lower binding affinity
(Figs. 23A&B). The Kd obtained for the SH3-PRD interaction by ITC was 13.7 ± 1.2 µM
and 68.3 ± 4.9 µM in 50 mM or 150 mM NaCl buffer, respectively (Figs. 23A&B). The
salt effect on the dissociation constant agrees with the extensive patch of negative
electrostatic potential covering a large portion of the dynamin binding site of the SH3
domain[104] and two conserved Arg residues in the PxRPxR consensus sequence[103] of
the dynamin2 PRD domain. The weaker binding affinity of the PRD peptide to the SH3
domain compared to the exon10 motif (Fig. 23C) further supports the notion that the SH3
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domain can be masked from its PRD ligand due to the stronger exon10-SH3 interactions.
Ligand recruitment may require sufficiently a high concentration of the downstream
effectors to compete with the endogenous exon10 motif. Alternatively, other regulatory
mechanisms may release the SH3 domain, for example through phosphoinositide binding
during submembrane localization[100].
4.3 Curvature sensing ability of BIN1-FL is inhibited on the PI(4,5)P2-absent
membrane
It

has

been

shown

that

N-BAR

domains

function

as

curvature

sensors[163,178,196]. The curvature sensing process is defined as the enrichment of
proteins on curved membranes, and in turn, stabilization of the tubular membranes. This
is crucial to a great number of cellular processes. Particularly, BIN1 is responsible for the
membrane tubulation process in myocytes. We have previously demonstrated that the NBAR domain from BIN1 preferentially partitions onto cylindrical tethers compared to flat
membranes[196]. We next asked how the exon10-SH3 domain interaction affects MCS&G, and whether phosphoinositides regulate the BIN1-membrane interaction through a
mechanism similar to their regulation of dynamin recruitments[100]. To compare
membrane curvature sensing of BIN1-FL on membranes with and without PI(4,5)P2, we
used a micropipette-assisted tether-pulling assay.
For this purpose, the following two lipid compositions were chosen in this study
which are meant to mimic the inner leaflet headgroup compositions, but to prevent lipid
demixing: 68% DOPC/20% DOPS/10% DOPE/2% PI(4,5)P2 (abbreviated as (+)
	
  

94	
  

	
  

PI(4,5)P2) and 64% DOPC/26% DOPS/10% DOPE (abbreviated as (-) PI(4,5)P2). The
charge densities in these two compositions are similar assuming that the charge of
PI(4,5)P2 is -3 at physiological buffer conditions[172,173,197,198]. A tubular membrane
was pulled from an aspirated giant unilamellar vesicle (GUV) by a polystyrene bead and
membrane tension was controlled by the aspiration pressure in the micropipette. The
radius of the cylindrical tubule is inversely related to membrane tension[178]. The
membrane curvature of the tether can therefore be well controlled by changing the
aspiration pressure. Figs. 24A&B show fluorescence intensities of the tether cross-section
in both protein and lipid channel plotted against the membrane tension. On (+) PI(4,5)P2
membranes, by increasing membrane tension, the protein fluorescence signals on the
tether cross-sections were observed to increase while the fluorescence intensities for the
lipid channel were decreasing (Fig. 24A). In sharp contrast, for (-) PI(4,5)P2 membranes,
both protein and lipid fluorophore fluorescence intensities decreased when the tether
radius decreased (Fig. 24B). To obtain a quantitative characterization of the curvature
sensing ability of BIN1-FL, we calculate the ratio 𝐼! of protein (green label) and lipid
!
!
(red label) fluorescence intensities on the tether (𝐼! = 𝐼!"##$
/𝐼!"#
), and divide it by the
!
!
corresponding ratio on the vesicle (𝐼!! = 𝐼!"##$
/𝐼!"#
). This partitioning ratio 𝐼! /𝐼!! , can be

shown to be proportional to the protein density on the tether normalized by the protein
density on the GUV [199,200]. 𝐼! /𝐼!! has been observed for several (albeit not all)
proteins to vary linearly with the square root of membrane Σ1/2, in accordance with a firstorder thermodynamic theory[80,177,199]. The slope of the 𝐼! /𝐼!! -Σ1/2 relationship is
related to the curvature sorting ability of a given protein. Significant curvature sorting of
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BIN1-FL on the membrane containing PI(4,5)P2 was observed. On (-) PI(4,5)P2
membranes, the partitioning ratio barely increases with the square root of the membrane
tension yielding a linear fit slope substantially smaller compared to the case of (+)
PI(4,5)P2 membranes (Fig. 24C).
We note that in the curvature sensing assay, we chose for analysis GUVs
displaying comparable protein fluorescence intensities, in order to exclude the influence
of protein density on curvature coupling[163]. We found that BIN1-FL binds to the
GUVs (±) PI(4,5)P2 with comparable affinities. Fig. 24D shows a titration of BIN1-FL
into GUVs (±) PI(4,5)P2. The dissociation constant Kd was obtained by fitting a
Langmuir isotherm model to the titration curve. BIN1-FL binds to (+) PI(4,5)P2
membranes with a Kd of 350 nM and to (-) PI(4,5)P2 membranes with a Kd of 860 nM,
respectively. We only fitted data for which membrane tubulation was not visible on
GUVs. The membrane binding affinity was slightly increased on the PI(4,5)P2-present
membranes possibly due to the multivalency of the PI(4,5)P2 headgroup[198] and/or
increased membrane penetration driven by PI(4,5)P2[174]. The effect of PI(4,5)P2 on the
curvature sensing ability of BIN1-FL is more dramatic than the effect on membrane
binding. Overall, our data suggest that BIN1 senses membrane curvature in a PI(4,5)P2dependent manner.

	
  

96	
  

	
  

4.4 The PI(4,5)P2-dependent curvature sorting ability requires co-presence of SH3
domain and exon10 motif
We next aimed to evaluate possible mechanisms responsible for the differing
curvature sorting abilities of BIN1-FL on (±) PI(4,5)P2 membranes. Specifically, we
asked whether exon10-SH3 association contributes to the dependency of BIN1 function
on lipid composition. Therefore, BIN1 curvature sorting was determined on (±) PI(4,5)P2
membranes for truncated versions (Fig. 25) meant to disrupt SH3-exon10 interactions:
BIN1 N-BAR (aa: 1-254, Fig. 26A), BIN1 N-BAR* (aa: 1-282, Fig. 26B) and BIN1-FLΔexon10 (BIN1-FL-Δaa: 255-269, Fig. 26C). The PI(4,5)P2-dependent curvature sorting
was abolished by mutants lacking SH3 domain or/and exon10 (Figs. 26A-C). These
observations demonstrate that the co-presence of exon10 and SH3 domain is responsible
for hindering curvature coupling of BIN1 on membranes without PI(4,5)P2. We
acknowledge that the curvature sensing ability of BIN1 truncates is higher on the (+)
PI(4,5)P2 compared to (-) PI(4,5)P2 membranes, which may indicate specific effects of
PI(4,5)P2 on membrane interactions with BAR domains. However, all the variants do
show significant curvature sorting behavior on (-) PI(4,5)P2 membranes (Figs. 26A-C),
different from the full length protein (Fig. 24C). Thus, only for BIN1-FL, membranes
lacking PI(4,5)P2 result in an inactive state incapable of sensing membrane curvature.
Addition of PI(4,5)P2 in the membrane allows exon10 to interact with the membrane and
releases the SH3 domain. Deletion of either SH3 domain or exon10 motif disrupts this
regulatory mechanism. Taken together, BIN1 is autoinhibited via an exon10-SH3
complex and can be activated through phosphoinositides in membranes.
	
  

97	
  

	
  

4.5 Membrane curvature generation ability of BIN1-FL is compromised on (-)
PI(4,5)P2 membranes
BIN1 is not only a membrane curvature sensor but also a curvature
generator[72,79]. N-BAR domains from BIN1 can induce membrane tubulation[196]. To
investigate if the curvature generation capacity of BIN1 is autoinhibited and regulated by
phosphoinositides, we studied the membrane morphologies modulated by BIN1 and its
variants via negative staining transmission electron microscopy (TEM). In the absence of
BIN1, liposomes did not show membrane tubules for either (+) PI(4,5)P2 or (-) PI(4,5)P2
membranes (Fig. 27A). Upon the incubation with 5 µM BIN1-FL, tubules with diameter
of 28.4 ± 0.73 nm were generated from (+) PI(4,5)P2 membranes. Vesiculation
(individual vesicles boxed in Fig. 27A) was observed as well, which is a general feature
for N-BAR domains containing amphipathic membrane-inserting helices[79,201].
However, significantly less membrane shape changes were observed on (-) PI(4,5)P2
liposomes. The morphology of those vesicles was similar to the ones in the lipid control
(Fig. 27A). This finding confirms that the curvature generation ability of full length
protein is inhibited on (-) PI(4,5)P2 membranes, in correspondence with the curvature
sensing ability of BIN1-FL.
Next we aimed to investigate the hypothesis that the inhibited curvature
generation results from the co-presence of exon10 and SH3 domain. We therefore studied
the tubulation ability of BIN1 N-BAR* and BIN1-FL-Δexon10 on the two lipid
compositions (±) PI(4,5)P2 (Fig. 27A). As expected, BIN1 N-BAR* domains are able to
induce spontaneous tubulation from both lipid compositions. For the BIN1-FL-Δexon10
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mutant, reduced tubulation was observed. The number of membrane tubules decreased
compared to BIN1-FL and N-BAR*. This can be explained by the compromised
electrostatic interactions of BIN1-FL-Δexon10 with membranes. The membrane
deformation capacity of BIN1-FL-Δexon10 is similar in the presence or absence of
PI(4,5)P2 in membranes. We conclude that as for curvature sensing, the PI(4,5)P2dependent tubulation ability of BIN1-FL is caused by the co-presence of SH3 domain and
exon10.
We next asked if BIN1 is autoinhibited at the plasma membrane. When
transfecting plasmids encoding a red fluorescence protein conjugated to BIN1 N-BAR*
or BIN1-FL in C2C12 myoblasts, membrane tubulation was caused by both constructs.
As shown in Fig. 27B, invaginations from the cell membrane were induced by both NBAR* and BIN1-FL, suggesting that autoinhibition of BIN1’s membrane sculpting
ability is released at the plasma membrane. Contrarily, a tubulation-defective version of
N-BAR* (mutation D151N within the N-BAR* domain) leads to essentially
homogenously distributed fluorescence in cells (rightmost panel in Fig. 27B). This
observation is in accordance with the compromising effects of disease-related mutations
in BAR domains on membrane deformation, and further supports the role of full length
BIN1 in T-tubule biogenesis in vivo[94,137]. The spontaneous activation of BIN1-FL at
plasma membranes likely is due to their specific lipid compositions. It is known that
PI(4,5)P2 is enriched in the inner leaflet of the plasma membrane[168]. Given our
observations that the binding of exon10 to the PI(4,5)P2 in membranes switches BIN1
into an active conformation allowing sensing and induction of membrane curvature (Figs.
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25&27), BIN1-FL likely is activated upon plasma membrane binding, and remains
inactive in the cytosol or other intracellular compartments.
We hypothesize that another way to activate BIN1 is through dissociation of the
exon10-SH3 complex by SH3 domain association with a ligand, such as dynamin2 or
other PRD domain containing proteins. Such an activation mechanism has been proposed
in the autoinhibition model of syndapin[157], in which the addition of the PRD peptide
rescued the tubulation ability of syndapin[157,201]. Consistent with this finding, ligand
binding to the SH3 domain of the cytoskeletal protein IRSp53 leads to activation of this
protein[158]. Therefore, we next tested if downstream ligand recruitment influences
BIN1 autoinhibition.
4.6 PRD peptide releases autoinhibition of BIN1-FL curvature sensing & generation
So far, we have demonstrated that PI(4,5)P2 in membranes modulates the MCS&G ability of BIN1. In order to test our hypothesis that SH3 domain ligands are able to
release autoinhibition, we pre-incubated BIN1-FL with 200 µM PRD (well above Kd at
the ionic strength chosen, see Fig. 23) peptide prior to performing curvature sensing
measurements on (-) PI(4,5)P2 membranes. Co-incubation with PRD peptide enhanced
the protein partitioning onto the membrane tether. The fluorescence intensities increased
while the membrane tether got narrower as indicated by the drop in lipid fluorophore
intensities (Fig. 28A). Note that the trend of protein signal changing with membrane
tension (green data points in Fig. 28A) shows the opposite trend compared to the one in
Fig. 24B, although no PI(4,5)P2 was present in the membrane. The slope of the 𝐼! /𝐼!! -Σ1/2
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relationship deviates significantly from the case where the PRD was absent (Fig. 28B).
The activation of BIN1-FL through the PRD peptide on (-) PI(4,5)P2 membranes further
supports our assumptions that the exon10-SH3 complexation compromises the membrane
remodeling function of BIN1. Either the binding to PI(4,5)P2 (by exon10) or PRD motif
(by SH3 domain) can release the autoinhibitory interaction and induce BIN1 to adopt a
conformation suitable for membrane remodeling.
We next investigated if co-incubation with PRD peptide is able to rescue the
membrane deformation ability as well. PRD peptide (200 µM) was first incubated with
BIN1-FL (5 µM) before addition to (-) PI(4,5)P2 LUVs. As a control, BIN1-FL was
added (at the same concentration) to (±) PI(4,5)P2 LUVs without the PRD peptide. The
tubulation assay was performed in 50 mM NaCl instead of 150 mM (Fig. 27) due to the
dependence of PRD-SH3 binding on salt concentration and to achieve consistency with
the experimental conditions used for the tether-pulling assay. TEM images of each
condition are shown in Fig. 28C. In order to quantitatively evaluate the membrane
curvature generation capacity, we divided the observed morphologies into three groups:
(1) vesiculation: liposomes with diameters less than 30 nm; (2) tubulation: elongated
membranes and (3) unchanged vesicles with diameters larger than 30 nm. We consider
both small vesicles and tubules as products of membrane curvature generation[79].
Consistent with Fig. 27, BIN1-FL produces membrane curvature only on (+) PI(4,5)P2
membranes. Curvature induction by BIN1-FL at low ionic strength predominantly leads
to vesiculation. As shown in the boxed area in Fig. 28C, uniformly sized vesicles were
formed after incubating BIN1-FL with (+) PI(4,5)P2 liposomes. However, vesiculation
	
  

101	
  

	
  

and tubulation are rarely seen in the (-) PI(4,5)P2 sample. Pre-incubation of the PRD
peptide with BIN1-FL effectively increased both the number of membrane tubules and
vesiculated liposomes in the (-) PI(4,5)P2 sample. To obtain a quantitative evaluation of
the BIN1 activation achieved by association with the PRD peptide, the percentages of
three morphological groups are plotted in Fig. 28C. Over 90% of the membrane
morphologies induced by BIN1-FL from the (+) PI(4,5)P2 membranes belong to
vesiculation while more than 80% of the events are intact vesicles in the case of (-)
PI(4,5)P2 membranes. Co-incubation with the PRD peptide resulted in an enhancement of
tubulation and vesiculation abilities of BIN1-FL and a decrease in the occurrence of
intact vesicles for the membranes lacking PI(4,5)P2.
To summarize, we demonstrated that adding the PRD peptide activates both
curvature sensing and curvature generation capacity of BIN1, in agreement with our
autoinhibition model. The key to activate BIN1 membrane remodeling ability is to
dissociate exon10-SH3 mediated inhibitory complex. Our model indicates a
combinatorial regulation/activation mechanism in BIN1 through plasma membrane
localization and protein-protein interactions.
4.7 Analog of PI(4,5)P2 headgroup releases the inhibited membrane curvature
sensing ability of BIN1 on (-) PI(4,5)P2 membranes
So far, we have shown that PI(4,5)P2 in the membrane, or the association with an
SH3 domain ligand, activates BIN1 MC-S&G. To further support this finding, we asked
if addition of water-soluble PI(4,5)P2 leads to release of BIN1 autoinhibition on (-)
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PI(4,5)P2 membranes. We chose D-myo-Inositol-1,4,5-triphosphate (IP3) as a water
soluble analog of the PI(4,5)P2 headgroup. We first used ITC to find out whether IP3 is
able to bind with exon10 motif and to determine the corresponding affinity. The binding
between the exon10 peptide and IP3 is dependent on ionic strength. The averaged Kd of
exon10 binding with IP3 in 0 mM NaCl buffer is 1.02 ± 0.14 µM while the Kd in 50 mM
NaCl buffer is 5.6 ± 0.76 µM (Fig. 29A). At physiological ionic strength, the Kd was too
high to be obtainable by ITC, implying that interactions between the exon10 peptide and
IP3 molecules are dominated by electrostatic interactions. Since the salt concentration
used for the curvature sensing assay was 50 mM, we chose to carry out curvature sensing
measurements by using 20 µM of IP3 (around 4 times higher than Kd) mixed with 40 nM
BIN1-FL on (-) PI(4,5)P2 membranes. If IP3 molecules were able to dissociate exon10
from the SH3 domain, then a release in autoinhibition would be expected. Indeed, we
observed an enhancement of protein localization on the membrane tether. The
partitioning ratio 𝐼! /𝐼!! is observed to always be higher than BIN1-FL alone on (-)
PI(4,5)P2 membranes (Fig. 29B). However, the released curvature sensing ability (as
indicated by the slope in Fig. 29B) is weaker in the presence of IP3 than in the case of the
BIN1-FL on (+) PI(4,5)P2 membranes (Fig. 24C). There are two possible explanations for
the partially released curvature sensing function. First, membrane binding of exon10 may
be required to fully release the MC-S&G capacity of BIN1. Secondly, it is reasonable to
assume that the binding affinity of exon10 motif with membranous PI(4,5)P2 is stronger
than with IP3. This is a common effect for protein-membrane interactions that are
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enhanced by proximity, local ionic strength and favorable orientation achieved on the
surface of membranes[151,202,203].
4.8 CNM-related SH3 domain truncation abolishes BIN1 autoinhibition
Centronuclear myopathy (CNM) is a congenital myopathy with abnormal cell
nuclei displacement in skeletal muscles[122,123,134]. Mutations in the human BIN1
gene have been shown to cause CNM[93,126,132]. Three single point mutations in the
BAR domain region have been shown to interfere with the membrane tubulation capacity
of BIN1 and to cause disorganized T-tubules[93,126,132,135]. Two additional nonsense
mutations were found to be located in the C-terminal SH3 domain[93,126]. Previous
studies have suggested that CNM-related mutations in the SH3 domain disrupt the
binding interface with proline-rich sequences, and interfere with the ability to recruit
dynamin2. In fact, cellular experiments showed that the co-localization of BIN1 C
terminal mutants and dynamin2 were decreased relative to BIN1-FL[93]. Due to the fact
that the SH3 domain binding interface for exon10 overlaps with that for the proline-rich
domain[100], we asked how the disease mutation in the SH3 domain affects the
autoinhibitory interactions with exon10.
First, to test if the SH3 domain bearing the CNM-associated mutation K436X can
bind with exon10, we performed ITC measurements in which the exon10 peptide (50 µM)
were added to GST-SH3-K436X mutant (500 µM). Limited and constant amounts of heat
were generated during the titration (Fig. 30A). The ITC titration profile is similar to the
control trial where the exon10 peptide was titrated to pure buffer (Fig. 31). Compared to
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Figs. 23A&B, we conclude that the truncation mutant K436X compromised the binding
between SH3 domain and exon10 motif. We hypothesize that the deletion of the Cterminus disrupts the interface responsible for recruiting both exon10 motif and PRD
peptide.
If the mutated SH3 domain is unable to associate with the exon10 motif, one
would expect the autoinhibitory effect on the membrane curvature sensing & generation
ability to vanish for this truncation mutant. To test this hypothesis, tubulation assays were
performed by incubating the CNM mutant K436X with liposomes with or without
PI(4,5)P2. In contrast to WT BIN1-FL, where tubulation was inhibited on (-) PI(4,5)P2
membranes, tubulation was observed in both cases, independent of PI(4,5)P2 (Fig. 30B).
This observation further supports the autoinhibition model in BIN1, which requires not
only the co-presence, but also the integrity of each binding partner.
Dynamin2 is a large GTPase with diverse roles in cellular functions. Mutations in
dynamin2 contribute to deficits at the sarcotubular network indicating that misregulation
of dynamin2 leads to the pathogenesis of neuromuscular diseases[130,204]. Membrane
recruitment of dynamin2 via BIN1 is critical for healthy muscle development. The SH3
domain is the module responsible for recruiting dynamin2 by the interaction with PRD
domains. We asked how autoinhibition of BIN1 can modulate the recruitment of
downstream signaling molecules and whether activation of membrane remodeling and
downstream effector recruitment act in synergy.
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To answer this question, we synthesized a Rhodamine-labeled PRD peptide and
incubated it with GUVs in presence or absence of BIN1 variants. The PRD peptide itself
does not bind to (+) PI(4,5)P2 membranes in 50 mM NaCl (Fig. 8C). Contrarily, on
GUVs pre-incubated with 2 µM BIN1-FL (labeled with Alexa488 dye), significant
enhancement of Rhodamine fluorescence was observed (Fig. 8C). Of note, images of the
vesicles were taken under the excitation at 543 nm. To exclude bleed-through from
Alexa488 into the Rhodamine channel, imaging parameters (illumination intensity and
detector settings) were carefully selected (Fig. 32). In contrast to BIN1-FL, the disease
mutant K436X is incapable of recruiting the PRD peptide to the membranes (Fig. 30C),
consistent with the decreased dynamin2 localization on BIN1-positive tubules in cells[93].
This supports the hypothesis that the PRD binding interface is disrupted in the truncation
mutant. As a negative control, the co-incubation with BIN1 N-BAR* domains failed to
bind the PRD peptide as well (Fig. 30C), confirming that the recruitment of PRD
domains requires the presence and integrity of the SH3 domain.
To further understand the influence of phosphoinositides on dynamin2 membrane
recruitment, we repeated the PRD recruitment assay on (-) PI(4,5)P2 membranes. We
argue that the presence of PI(4,5)P2 in the membrane will compete with the SH3 domain
to bind to exon10 motif and increase the availability of the SH3 domain for PRD
recruitment. Similarly, the PRD peptide does not bind with the (-) PI(4,5)P2 on its own.
Indeed, signals of the PRD peptide recruited by BIN1-FL on (-) PI(4,5)P2 membranes is
weaker than the ones on (+) PI(4,5)P2 membranes (Fig. 30C). However, no PRD peptide
is recruited to (-) PI(4,5)P2 membranes via the BIN1-FL-K436X mutant or the N-BAR*
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domain as expected. We quantified the PRD fluorescence on membranes for each
experimental condition. The decrease in the PRD membrane recruitment on (-) PI(4,5)P2
membranes via BIN1 is statistically significant (Fig. 30D). Little PRD peptide is recruited
by the K436X mutant to membranes regardless of the lipid compositions, further
confirming that the functional SH3 domain is a key factor for recruiting downstream
ligands. The weaker PRD membrane recruitment on (-) PI(4,5)P2 membranes not only
supports the autoinhibition model, but also implies a synergistic regulation of BIN1
function through exon10-PI(4,5)P2 and SH3 domain-ligand binding.
4.9 Summary & Significance
One of the major findings of the present contribution is that the exon10 motif and
C-terminal SH3 domain serve a dual role in regulating the function of BIN1. The exon10
motif causes autoinhibition via association with the SH3 domain and allows for
membrane modulation by targeting PI(4,5)P2. Similarly, the SH3 domain has two
functions: autoinhibition and ligand recruitment. Autoinhibition is a regulatory
mechanism found in other BAR domain proteins as well. It has been reported that various
inputs work synergistically for membrane localization and functional activation[158].
One example is the F-BAR domain protein syndapin1, which can form a molecular clamp
between SH3 and BAR domain that leads to a compact, autoinhibited conformation
unable to generate membrane curvature[81,157]. The activation of syndapin requires the
binding of dynamin to the SH3 domain to induce an open conformation[157,201]. Such
coupling between membrane curvature generation and dynamin recruitment was also
found for endophilin and amphiphysin[106]. In fact, a great number of peripheral proteins
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contain domains, such as the SH3 domain, specialized for the recruitment of downstream
effectors. Autoinhibition mediated by SH3 domains is also found in cytoskeletal protein
N-WASP and IRSp53[158,205,206]. The intramolecular autoinhibition and simultaneous
activation by specific membrane localization and effector recruitment may be a general
mechanism for proteins to control their function.
Overall, the autoinhibition model in BIN1 is shown schematically in Fig. 33.
BIN1 is in an inhibited state via the interactions between PI(4,5)P2 sensing motif-exon10
and SH3 domain, consistent with an earlier study showing that the exon10 peptide binds
to the SH3 domain in a region overlapping with the binding interface of the proline-rich
domain[100]. The autoinhibitory interaction between exon10 and the SH3 domain
showed a Kd of 11 µM, which is likely enhanced by the proximity and orientation within
the full-length protein. In the autoinhibited state, exon10 is masked from interacting with
the membranes, and the ligand recruitment through the SH3 domain is impaired. We
showed that in the autoinhibited state, BIN1 still binds to but cannot reshape the
membranes. Upon membrane association, the local membrane composition becomes
critical in determining if BIN1 is active or not. Particularly, PI(4,5)P2 in the membrane
plays an important role in releasing autoinhibition. On membranes where PI(4,5)P2 is
absent, BIN1 remains in a resting state, unable to sense and induce curvature (Figs.
24&27). However, the presence of PI(4,5)P2 in the membrane attracts exon10 away from
the autoinhibitory interaction. This may explain the observation that T-tubules are
enriched in PI(4,5)P2 and the production of BIN1 and PI(4,5)P2 during the differentiation
of C2C12 cells is upregulated[94].
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Protein oligomerization on membranes is an important mechanism contributing to
MC-S&G by peripheral proteins[177]. It has been shown that BAR domain proteins form
lattice-like coats on tubular membranes[81]. Protein oligomerization can amplify MCS&G[207]. To ask whether the activation of BIN1 MC-S&G on (+) PI(4,5)P2 membranes
might be caused by effective protein assembly, we characterized the lateral diffusion of
BIN1-FL on (±) PI(4,5)P2 membranes via the fluorescence recovery after photobleaching
(FRAP) method. BIN1-FL showed fluorescence recovery in the bleached region on both
membrane compositions (Figs. 34A-C). However, the averaged recovery half-time t1/2 of
BIN1 on (+) PI(4,5)P2 membranes is 2.5-fold slower than that on (-) PI(4,5)P2
membranes. The averaged mobile fractions on (±) PI(4,5)P2 membranes are not
significantly different (Figs. 34B-D). Recently, Lappalainen et al. reported that the FBAR protein syp1 can induce PI(4,5)P2 clusters, which act as hot spots for protein
oligomeric assembly[99]. Consequently, the lateral diffusion of proteins on membranes is
inhibited. It is likely that the slower BIN1-FL diffusion on membranes with PI(4,5)P2 is
caused by protein oligomerization. This assumption is consistent with the observation
that a BAR domain mutant inefficient in oligomerization diffuses faster on the
membrane[99]. The formation of oligomerized BIN1 networks on (+) PI(4,5)P2
membranes might lead to the enhanced MC-S&G.
In addition to phosphoinositides, association with SH3 domain effectors leads to
similar activation of membrane remodeling (Fig. 28). The synergy of the SH3 domain
binding to other proteins along with the membrane localization through PI(4,5)P2 might
be important for T-tubule biogenesis. Such cooperativity has also been reported for other
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BAR domain proteins with regard to their binding to dynamin and AP-2/clathrin in
endocytosis[208].
Moreover, we provided new insights into how the CNM-related disease mutations
in SH3 domains contribute to the pathogenesis mechanisms (Fig. 33). In vivo cellular
experiments have suggested that the nonsense mutation in the SH3 domain compromised
the recruitment of dynamin2[93]. Our results not only support this claim, but also show
that the disease related truncation of the SH3 domain interferes with autoinhibition
through compromised binding to exon10 (Fig. 30A). Consequently, the curvature sensing
and generation ability of the K436X mutant is no longer regulated by PI(4,5)P2 (Fig. 30B).
It can be hypothesized that active BIN1 adopts an open conformation favorable for
membrane interactions. This assumption is supported by the finding that C-terminal
disease mutants bind to Myotubularin (MTM1) more efficiently due to an increased
accessibility of the MTM1 binding site in the open conformation[191]. Such
conformational change is induced by the loss of the exon10-SH3 interactions. In
summary, membrane remodeling by BIN1 is a synergistic process that involves correct
membrane localization and downstream ligand binding. It requires cooperative spatial
and temporal assembly of proteins to precisely regulate the membrane deformation.
It remains unclear that how the exon10-SH3 interactions interfere with BIN1 NBAR domain functions in the autoinhibited state. The exon10-SH3 complex masks the
exon10 motif from interacting with membranes, which may reduce the electrostatic
interactions with membranes. Our data suggests that the interaction between exon10 and
membranes can enhance the MC-S&G capability (Figs. 26&27A). Releasing exon10
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motif by either PI(4,5)P2 or PRD-SH3 interactions can increase the availability of exon10
motif to modulate membranes. Additionally, our data suggests that BIN1 N-BAR domain
functions are impaired by exon10-SH3 associations. We have shown in Chapter 3 that
BIN1 N-BAR domain alone (aa: 1-254) is able to sense and generate membrane
curvature (Figs. 13, 14&15). This observation suggests that on (-) PI(4,5)P2 membranes,
N-BAR domain in full-length protein may interact with membranes in a different manner
compared to BIN1 N-BAR domain alone. Fig.24D has shown that the autoinhibited
BIN1-FL is able to bind with membranes and the membrane-bound protein densities are
comparable to that of activated BIN1-FL, indicating that in the inhibited state, N-BAR
domain can still interact with membranes. Otherwise, the protein densities (BIN1-FL on
(-) PI(4,5)P2 membranes) are expected to be significantly lower than the active BIN1-FL
(BIN1-FL on (+) PI(4,5)P2 membranes). We hypothesize that the exon10-SH3
interactions can interfere with the processes/interactions responsible for MC-S&G,
including the influence on BIN1 on-membrane assembly, N-terminal H0 insertion and
protein conformation. So far, the crystal structure of BIN1-FL has not been reported yet.
The position of exon10-SH3 complex in full length protein is unknown. If the exon10SH3 complex sits underneath the BAR dimer, which is the membrane interaction
interface, interactions between N-BAR domain and membranes can be altered (Fig. 60A).
Similarly, if the exon10-SH3 complex is positioned near the N-terminal membrane
insertion helix H0, it may prevent the H0 to penetration into the lipid bilayer possibly due
to the steric effects (Fig. 60B). As a result, the MC-S&G mediated through hydrophobic
insertion can be compromised. Furthermore, if the exon10-SH3 domain complex exist
near the distal arm region, it may prevent the BAR domain oligomerization mediated by
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the distal arm. We have shown that mutations at the distal arm region can impair
curvature generation due to the incapacities of BAR domain to membrane curvature
initiation, which requires the lattice-like coat formed by BAR dimers on membranes (Fig.
60C). The preliminary results of studying lateral diffusion of BIN1-FL on (±) PI(4,5)P2
membranes (Fig. 34) supports the hypothesis that the degree of BIN1-FL oligomerization
is related to whether BIN1-FL is activated. It is also possible that the N-BAR domain in
the full length protein could be in a different conformation, which is inactive in MC-S&G
(Fig. 60D). The dissociation of the exon10-SH3 interaction can trigger an conformational
change to activate BIN1-FL. However, it requires future studies to elucidate the
molecular mechanism by which BIN1-FL is autoinhibited.
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Fig. 22 Exon10 peptide is unstructured both in solution and on (+) PI(4,5)P2
membranes.
CD spectra of 10 µM exon10 peptide in 20 mM Hepes, 50 mM NaCl, pH 7.4 buffer (grey
dashed line) and in the presence of 100 nm (diameter) liposomes consisting of 68%
DOPC/20% DOPS/10% DOPE/2% PI(4,5)P2 (black solid line). Lipid concentration is 4
mM. The inset shows the CD spectrum of 100 µM exon10 peptide in buffer. All the
spectra were background corrected. A characteristic random coil peak at 204 nm was
observed in the absence and presence of membranes, indicating that the exon10 motif is
unstructured and that no conformational changes are induced upon membrane binding.
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Fig. 23 The binding affinity of the exon10-SH3 complex is higher than that of SH3PRD and both are dependent on solution ionic strength.
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The association between exon10-SH3 and PRD-SH3 was characterized by ITC in which
500 µM exon10 or 1 mM PRD (derived from dynamin2) was titrated into 50 µM GSTSH3 domains (derived from BIN1) in A) 20 mM Hepes, 50 mM NaCl, pH 7.4 buffer and
B) 20 mM Hepes, 150 mM NaCl, pH 7.4 buffer. Date (black square) was fitted by a
single-site binding model (grey solid line) and the dissociation constant, Kd, is shown for
each titration. Of note, the stoichiometry (number of binding site), n, of each titration is
found to be close to 1, indicating a single SH3 domain binding site for both ligands.
Reducing the salt concentration enhances both exon10-SH3 and PRD-SH3 associations.
Of note, in order to obtain an S-shaped ITC titration profile, the optimal range of cwindow is 1<c<1000 (where c is defined as c = n*[Receptors]/Kd). The c value for
exon10-SH3 titration is 14 (50 mM NaCl) and 5 (150 mM). The c value for PRD-SH3
titration is 3.8 (50 mM NaCl) and 0.8 (150 mM). The differences among c values explain
the observation that the exon10-SH3 titration curve is closer to S-shaped compared to the
PRD-SH3 titration. C) Comparison of averaged dissociation constants at varied solution
conditions. Exon10 binds to SH3 domain stronger than the PRD peptide. Student t-test
was performed to assess the statistical difference. ***: p < 0.005.
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Fig. 24 Curvature sensing ability of BIN1-FL is inhibited on membranes lacking
PI(4,5)P2.
Alexa488 conjugated BIN1-FL (40 nM) was incubated with TexasRed-DHPE labeled
GUVs. A GUV was aspirated by a micropipette and membrane tension was controlled by
the aspiration pressure. A tether was pulled by an aspirated streptavidin-coated
polystyrene bead and the confocal images of the tether cross-sections were recorded.
Fluorescence intensities of protein and lipid in tether cross-sections were plotted against
membrane tension Σ. The protein intensities responded differently to changes in the
membrane tension on A) (+) PI(4,5)P2 membranes and B) (-) PI(4,5)P2 membranes. C)
Data from ten vesicles were binned (vertical error bars represent standard error of the
mean (SEM); horizontal error bars show SEM of the square root of membrane tension)
for two different lipid compositions. The solid lines show linear fits to guide the eye.
Membrane curvature-coupled protein partitioning behavior is only observed on (+)
PI(4,5)P2 membranes. D) demonstrates similar protein adsorption isotherm on (+)
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PI(4,5)P2 or (-) PI(4,5)P2 GUVs. Lipid compositions: (+) PI(4,5)P2: 68% DOPC/20%
DOPS/10% DOPE/2% PI(4,5)P2; (-) PI(4,5)P2: 64% DOPC/26% DOPS/10% DOPE.
Error bars: SEM. Buffer: 50 mM NaCl, Hepes buffer, pH 7.4. F.I.: fluorescence intensity;
a.u.: arbitrary unit.
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Fig. 25 Domain diagrams of human BIN1 isoform8 variants investigated in this
study.
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Fig. 26 Curvature sensing ability of BIN1 variants lacking either exon10 or SH3
domain is less dependent on PI(4,5)P2 than BIN1-FL.
Normalized ratio of fluorescence intensities between protein and lipid channels were
plotted against the square root of membrane tension for A) N-BAR, B) N-BAR* and C)
BIN1-FL-Δexon10 on GUVs (±) PI(4,5)P2. Error bar: SEM.
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Fig. 27 Tubulation capacity of BIN1-FL is autoinhibited on (-) PI(4,5)P2 membranes
in vitro. The autoinhibition in curvature generation requires the co-presence of
exon10 and SH3 domain.
A) Electron micrographs of LUVs (±) PI(4,5)P2 (0.2 mg/mL) incubated with 5 µM BIN1FL, N-BAR* and BIN1-FL-Δexon10 in 20 mM Hepes, 150 mM NaCl, pH 7.4 at room
temperature. Samples were negatively stained and imaged by TEM. In the lipid control
sample, no membrane tubules were observed. Upon the addition of BIN1-FL, tubulation
and vesiculation (generation of vesicles with the diameter less than 30nm, boxed in the
BIN1-FL/(+) PI(4,5)P2 panel) was induced only on the PI(4,5)P2-containing membrane.
Much less curvature generation through BIN1-FL was observed in membranes without
PI(4,5)P2. Neither N-BAR* nor BIN1-FL-Δexon10 showed lipid composition-dependent
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tubulation capacity. Reduced membrane reshaping ability of BIN1-FL-Δexon10 variant is
due to the decreased membrane binding ability. Scale bar: 200 nm. B) Confocal images
of C2C12 myoblasts transfected with BIN1-FL, N-BAR* or N-BAR* D151N mutant
conjugated with red fluorescence protein, mKate, at the C-terminus. In vivo, membrane
tubules are induced both by BIN1-FL and N-BAR*, indicating release of autoinhibition
at the plasma membrane. Scale bar: 20 µm.
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Fig. 28 Addition of PRD increases the curvature sensing & generation capacity of
BIN1 on (-) PI(4,5)P2 membranes.
A) Membrane curvature sensing assay was performed using the (-) PI(4,5)P2 lipid
composition in 20 mM Hepes, 50 mM NaCl, pH 7.4 buffer. 40 nM BIN1-FL was preincubated with 200 µM dynamin2-derived PRD peptide for 15 min prior to the
experiment. Fluorescence intensities of protein and lipid on the tether cross-sections were
measured and plotted against membrane tension Σ. BIN1-FL enriched on the tether when
increasing membrane tension as opposed to Fig. 24B where PRD was absent. B)
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demonstrates that association with PRD peptide activates the curvature sensing ability of
BIN1-FL on (-) PI(4,5)P2 membranes. C) Electron micrographs of 5 µM BIN1-FL or 5
µM BIN1-FL mixed with 200 µM PRD peptide interacting with LUVs (±) PI(4,5)P2 in
20 mM Hepes, 50 mM NaCl buffer. Samples were stained with 2% (w/v) uranyl acetate
solution for contrast enhancement. Scale bar: 200 nm. Morphologies of the liposomes
were categorized into three types: intact vesicles: vesicles with diameters larger than
30nm; vesiculation: vesicles with diameter less than 30nm and tubulation. BIN1-FL
induces vesiculation of (+) PI(4,5)P2 membranes, but not of (-) PI(4,5)P2 liposomes. The
inset shows an enlarged image of the vesicles in the boxed area. The scale bar in the inset
is 50 nm. Addition of the PRD peptide results in both increased tubulation and
vesiculation from (-) PI(4,5)P2 LUVs. The percentage of the three membrane
morphologies was quantified through image analysis.
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Fig. 29 IP3 (water-soluble analog of PI(4,5)P2 headgroup) binds to exon10 motif and
releases membrane curvature sensing ability.
A) In vitro binding affinity between exon10 and IP3 was characterized by the ITC
measurement in which 500 µM exon10 peptide were added to 25 µM IP3 in buffer
containing 0 mM or 50 mM NaCl. Interactions between the exon10 peptide and IP3 were
significantly affected by solution ionic strength. B) Membrane curvature sensing assay
was performed by mixing 20 µM IP3 with 40 nM BIN1-FL and (-) PI(4,5)P2 GUVs in
Hepes, 50 mM NaCl, pH 7.4 buffer.
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Fig. 30 Autoinhibition is absent in the disease mutant K436X. Membrane
recruitment of PRD peptide is enhanced by PI(4,5)P2.
A) ITC measurement of titrating 500 µM exon10 peptide to 50 µM GST-SH3-K436X
mutant indicates no detectable binding. B) Electron micrographs of BIN1-FL-K436X
mutants with LUVs (±) PI(4,5)P2. K436X mutant is able to induce membrane tubules
from liposomes lacking PI(4,5)P2, implying that curvature generation capacity of K436X
mutant is not regulated by PI(4,5)P2. Scale bar: 200 nm. C) Confocal fluorescence images
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of 2 µM Rhodamine labeled PRD peptide only, or 2 µM PRD peptide mixed with 2 µM
Alex488 labeled BIN1-FL, BIN1-FL-K436X, or N-BAR* on vesicles (±) PI(4,5)P2. All
images show the Rhodamine channel under the excitation only by the 543 nm laser.
BIN1-FL, but neither K436X mutant nor N-BAR* domain, is able to recruit the
dynamin2 derived PRD peptide to the membrane. Scale bar: 5 µm. D) Quantifications of
the PRD fluorescence intensities (F.I.) in the absence or presence of BIN1-FL or BIN1FL-K436X on (±) PI(4,5)P2 vesicles. Comparison of the PRD fluorescence intensities in
the presence of 2 µM BIN1-FL or BIN1-FL-K436X on vesicle (±) PI(4,5)P2 was tested
by the Student t-test. (+) PI(4,5)P2 membranes show significantly enhanced membrane
density of the PRD peptide. n.s: p > 0.05; ***: p < 0.005.
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Fig. 31 Titration of the exon10 peptide to pure buffer results in limited amounts of
binding heat generation.
500 µM exon10 peptide were titrated to 20 mM Hepes, 150 mM NaCl, pH 7.4 buffer by
ITC. Little amounts of heat were released and did not vary with ligand-to-receptor ratio.
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Fig. 32 Little bleed-through from Alexa488 into the Rhodamine channel.
GUVs (±) PI(4,5)P2 were incubated with 2 µM BIN1-FL or BIN1-FL-K436X labeled
with Alexa488 dyes. Confocal images were recorded in the Rhodamine channel at an
excitation wavelength of 543 nm to assess the bleed-through effects.
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Fig. 33 Proposed schematic illustration of how membrane composition and proteinligand interaction cooperatively regulate membrane remodeling function of BIN1.
BIN1-FL protein rests in a close conformation through the interaction between SH3 and
exon10 motifs. Exon10 is prevented from interacting with membranes. Upon association
with membranes lacking PI(4,5)P2, BIN1-FL protein is still blocked in the inactive state
unable to sense or induce membrane deformation. Binding with PI(4,5)P2 or the PRD
containing proteins, such as dynamin2, can induce an conformational change in BIN1 and
activate MC-S&G. However, the CNM-related nonsense mutation disturbs the
autoinhibitory interaction leading to an unregulated membrane remodeling.
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Fig. 34 The lateral diffusion of BIN1-FL on (+) PI(4,5)P2 membranes is slower than
on (-) PI(4,5)P2 membranes.
A) An area on an aspirated GUV was bleached and the recovery of fluorescence
intensities was recorded during 220 s period following photobleaching on (±) PI(4,5)P2
membranes. The protein fluorescence intensities of the bleached area were measured
overtime. The recovery fraction was calculated and plotted against time. B) & C) show
the BIN1-FL recovery profile on membranes with or without PI(4,5)P2, respectively. The
half-times t1/2 and mobile fractions obtained from at least 10 individual GUVs were
averaged and plotted with standard error of the mean in D). The Student t-test was used
to determine the statistical significance among the data. ***: p < 0.005; n.s: p > 0.05.
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Chapter 5 Membrane curvature-dependent membrane association of
BIN1 N-BAR domain variants studied by single-liposome assay
BAR domains can sense membrane curvature. In previous chapters, we have
demonstrated that BIN1 preferentially partitions onto membrane tethers pulled from
GUVs as opposed to the lower curvature of GUV membrane. However, in the
micropipette-assisted curvature sorting assay, the radius of the membrane tether ranges
from 10 nm to 50 nm. In order to quantify the curvature sorting ability of BAR domains
across a wider range of membrane curvatures, we will discuss about employing a single
liposome based system to investigate how BAR domains from BIN1 bind to membranes
in a curvature-dependent way.
5.1 CNMs associated mutations do not change membrane affinities of BIN1 N-BAR
domain but membrane binding ability is curvature-dependent
The Single Liposomes of different diameters and therefore Curvature (SLiC assay)
was developed by the Stamou group and has been used to determine the membrane
binding abilities of BAR domains in a membrane curvature-specific manner[38,40,209].
The SLiC assay allows for quantification of membrane association and membrane
curvature sensing at the same time. Protein densities on hundreds of vesicles with known
radii can be measured in a single imaging chamber, which largely improved the
convenience and efficiency of applying the SLiC assay to study protein curvature sensing
behavior. Moreover, information obtained from SLiC assay can help identify the
mechanisms of BAR domain curvature sensing capacity. Controversial arguments exist in
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explaining how BAR domains prefer high membrane curvatures. Previous studies using
the SLiC assay have discovered that the membrane curvature preference of BAR domains
is not due to higher membrane binding affinities (Kd) of BAR domains on curved
membranes. Instead, the protein saturation densities (Bmax) on the smaller liposomes are
much higher than on the flat ones. Increase in Bmax on curved membranes results from
higher number of lipid packing defects, which providing more binding site for the
amphipathic helices mediated membrane insertions. Stamou et al. proposed that the
penetration into the lipid packing defects on curved membranes is a unifying mechanism
for proteins containing amphipathic insertion helices. Through the micropipette-assisted
tether pulling assay, we have demonstrated that the BIN1 N-BAR domain and its diseaserelated mutants are able to partition onto the membrane tethers with diameters ranging
from 20 nm to 100 nm. One advantage of SLiC assay is that it allows the determinations
of Kd and Bmax of BAR domains across a wide range of membrane curvatures (30 nm ~
1000 nm). Therefore, we aim to develop a system to quantify protein-membrane
associations at thermodynamic equilibrium and compare the curvature-dependent
membrane binding differences among BIN1 N-BAR domain variants related to CNMs.
We designed a polydimethylsiloxane (PDMS) imaging chamber as shown in Fig. 35. The
fabrication process of the PDMS imaging chamber is described in detail in Chapter
2.16.1. Inside each well, LUVs were immobilized on BSA-coated surfaces via biotinstreptavidin interactions. Liposomes were labeled with red lipid fluorophores (TexasRedDHPE in our case) while the proteins of interests were labeled with green fluorophores.
Tethered liposomes are visualized through an epi-fluorescence microscope. Localizations
and quantifications of fluorescence intensities in protein & lipid channels are achieved by
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a MATLAB algorithm in order to calculate the membrane-bound protein densities. The
integrated fluorescence intensity of a single vesicle in the lipid channel is proportional to
the surface area of the vesicle (4πr2), thus proportional to the square of the vesicle radius.
The distribution of the integrated lipid fluorescence intensities correlated to the radius
distribution. Via a secondary liposome radius measurement, such as dynamic light
scattering used in this study, one can convert the lipid fluorophore fluorescence intensity
to the actual radius. The integrated fluorescence intensities in the protein channel
(colocalized with lipid fluorescence) relate to the amounts of proteins binding to
membranes. Protein densities were calculated as:
𝐼!   ∝ 𝑁𝑜. 𝑜𝑓  𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝑠  𝑜𝑛  𝑚𝑒𝑏𝑟𝑎𝑛𝑒𝑠

𝐷!   ∝   

𝐼!
𝐼!
   ∝   
𝐴
𝐼!

𝑅! ∝

𝐼!

Therefore, we are able to obtain protein densities on vesicles with known radii.
We measured the membrane binding isotherms of BIN1 N-BAR domains. Fig.
36A shows a representative image obtained by epi-fluorescence microscopy. We
observed that the fluorescence intensities of BIN1 N-BAR domains overlap with the lipid
fluorescence intensities, indicating that BIN1 N-BAR domains bind to the liposomes in
the SLiC assay chamber. The red box in Fig. 36A qualitatively suggests that BIN1 NBAR domains prefer smaller vesicles. Protein fluorescence intensities on the smaller
vesicle (dimmer in lipid channel) are higher than the ones on the larger liposome. The
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line profile in Fig. 36B shows that the protein fluorescence intensities are reversely
correlated to the lipid fluorescence intensities, qualitatively suggesting that BIN1 N-BAR
domains sense membrane curvature during membrane associations.
The SLiC assay has been used to unravel individual protein binding events.
Information about membrane curvature dependence is usually averaged in traditional
ensemble measurements[38]. To gain a quantitative evaluation of the membrane binding
& curvature sensing processes of BIN1 N-BAR, we varied protein concentrations in the
bulk. Fig. 37A shows the BIN1 N-BAR domain (WT) density plotted against liposome
radius at two different bulk concentrations (20 and 100 nM). Each data point represents
the protein density on a single liposome with a given diameter. We found that BIN1 NBAR domains show remarkable curvature sensing ability. Densities of proteins bound to
membranes decrease when radii of liposomes increase, suggesting that BIN1 N-BAR
domains prefer highly curved membranes. At 20 nM bulk concentration, we observed a
400-fold increase in the protein density on 50 nm (radius) liposomes compared to
liposomes with a radius of 1000 nm. This observation is in accordance with the
observation that BIN1 N-BAR domains accumulate on the tubular membranes in the
tether pulling assay. It has been reported that the relationship between the curvature
sensor densities and the liposome radii follows a power-law dependence (the curvature
sensing protein density is proportional to r-α)[38,40]. By converting the curvature sensing
profile (20 nM BIN1 N-BAR in Fig. 37B) to a logarithmic scale, we extracted the
exponent α by fitting the data to a linear relationship. The magnitude of α is a quantitative
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measure of the protein curvature sensing ability, which is 2.4 for BIN1 N-BAR domains
(Fig. 37B).
Thus far, we have demonstrated that SLiC allows for quantification of curvature
sensing capacity of N-BAR domains. We next aim to obtain thermodynamic parameters
describing the BAR-membrane binding process. It has been proposed that membrane
insertion via amphipathic helices is essential for BAR domains to sense membrane
curvature[38,40,77]. Based on the classic Langmuir isotherm model, a higher membranebound density on the smaller liposomes can be caused by either higher membrane
binding affinity (Kd) with curved membranes or higher saturation density (Bmax) on
curved membranes[38]. In order to distinguish which mechanism BIN1 N-BAR domains
utilize to sense membrane curvatures, we performed the SLiC assay at various bulk
protein concentrations ranging from 20 nM to 2 µM. Membrane-bound N-BAR densities
increase with bulk protein concentrations at given liposome radius (Fig. 38A). By fitting
a classic Langmuir isotherm model to our data,

𝐵=

𝐵!"#
𝐾
1 + 𝐶!

thermodynamic parameters Kd and Bmax were obtained and plotted against liposome radii
(Figs. 38B&C). We observed that both dissociation constant Kd and saturation density
Bmax are dependent on membrane curvature (Figs. 38B&C). Dissociation constant Kd
increases from 250 ± 34 nM on 50 nm liposomes to 400 ± 89 nM on 400 nm liposomes
(Fig. 38B). However, the differences in Kd among liposomes with different radii are
within thermodynamic fluctuations. Such observation is found in endophilin N-BAR
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domains as well[38]. Dramatic increase in Bmax is found on 50 nm liposomes. The
dependence of Bmax on liposome radius suggests an increase in the number of protein
binding sites on curved membranes, possibly due to the interactions between amphipathic
helix H0 in BIN1 and the lipid packing defects.
Three point mutations in the BIN1 N-BAR domain relate to the pathogenesis of
centronuclear myopathy. Particularly, mutations in the N-BAR domain compromise the
membrane curvature generation in myocytes. To compare the membrane binding
differences among the CNM-related mutants, we performed the SLiC assay using
recombinant proteins bearing the CNMs-related mutations in the N-BAR domain. We
found that BIN1 N-BAR mutants demonstrate slightly decreased curvature sensing
capacity. As shown in Fig. 39A, within the high membrane curvature regime (vesicle
radiuses ranging from 50 nm to 200 nm), differences in the dissociation constants Kd are
on the order of thermal fluctuations. This observation suggests that on highly curved
membranes, all BIN1 variants bind to membrane strongly and equivalently. However, the
Kd and Bmax of D151N and K35N mutants show stronger membrane curvature
dependency in the low curvature regime (vesicle radius ranging from 200 nm to 1000
nm). For instance, on the 400 nm liposomes, the D151N mutation leads to a 5-fold
decrease in Kd. This observation indicates that the D151N mutant binds to flat
membranes with a weaker affinity, which may explain the observations in Chapter 3 that
the D151N mutant is able to enrich on membrane tethers, however, deficient in initiating
membrane budding from flat membranes (Figs. 14&15). Saturation densities Bmax of
BIN1 mutants are dependent on liposome radiuses as well (Fig. 39B). However, on the
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curved membranes, there is a 6-fold increase in the Bmax of WT and K35N mutants on 50
nm liposomes compared to 400 nm liposomes. This finding is consistent with the
observation that WT and K35N mutants demonstrate slightly higher curvature sensing
ability in the tether pulling assay (Fig. 15). When decreasing membrane curvature,
differences in Bmax among BIN1 variants start to diminish, which was observed on 100%
DOPS GUVs that saturation protein densities among BIN1 N-BAR mutants are similar.
The Kd of the CNM-related mutants at certain liposome radius is always larger than that
of WT BIN1 N-BAR (Fig. 39A). Additionally, the D151N and R154Q mutants show
reduced membrane-bound densities across the entire curvature spectrum that we tested in
the SLiC assay (Fig. 39B). Particularly, the R154Q mutant show lowest amounts of
proteins bound to membranes in the low membrane curvature regime, which agrees with
our hypothesis that the R154Q mutant impairs the membrane deformation capacity
through reduced membrane-bound protein density. Taken together, results from the SLiC
assay demonstrate that all BIN1 N-BAR variants are able to bind with negatively charged
membranes. However, the membrane curvature dependency of Kd and Bmax varies. WT
and K35N show higher membrane-bound density and affinity on smaller liposomes than
D151N and R154Q mutants.
Of note, one limitation that we experienced for the SLiC assay is the inflexibility
in investigating the impacts of lipid compositions on protein-membrane associations. In
this study, we could only use liposomes consisting of 100% DOPS to achieve detectable
protein fluorescence signals on membranes. Lowering the percentage of negative charge
lipids in membranes results in significantly reduced electrostatic interactions between
	
  

137	
  

	
  

membranes and proteins, which decrease the amounts of fluorescent proteins recruited to
the liposomes. Moreover, the liposome area projected to the imaging plane is smaller
compared to the GUV system, because the liposome radius in the SLiC assay ranges only
from 20 nm to 1000 nm. The reduced protein recruitments and small membrane area of
LUVs cause membrane-bound protein fluorescence to be below detection limitations.
The choices of lipid compositions in SLiC assay are limited.
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Fig. 35 Schematic illustration of the PDMS imaging chamber used in SLiC assay.
Consecutive holes (7 mm in diameter) were drilled by a hole puncher. The PDMS and
coverslips were assembled after oxidization by an oxygen plasma. TexasRed-DHPE
labeled LUVs were immobilized on the surface, which was consecutively incubated with
0.1 mg/mL BSA, 1 mg/ml biotinylated-BSA and 0.00125 mg/ml streptavidin in 1x PBS
buffer. Green fluorophore labeled N-BAR domains were added and equilibrated in the
chambers before imaging.
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Fig. 36 Qualitative demonstration of BIN1 N-BAR domains sensing membrane
curvature.
A) Epi-fluorescence images show co-localization of Alexa488-labeled BIN1 N-BAR
domains and 100% DOPS liposomes. Zoomed-in images boxed in red qualitatively
represent membrane curvature sensing ability of BIN1 N-BAR domains. The protein
fluorescence intensities reversely correlate to the lipid fluorescence intensities. Scale bar:
5 µm. B) Intensity line profile of the two vesicles circled in A), in which protein
fluorescence signals are higher on the smaller (dimmer) liposome compared to the
brighter liposome (larger in radius).
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Fig. 37 BIN1 N-BAR domains prefer high membrane curvatures
A) Membrane curvature sensing profile of BIN1 N-BAR. Membrane-bound BIN1 NBAR densities are plotted against liposome radii. Significant increase in protein densities
was observed on smaller liposomes. Protein densities on membranes increase when
increasing bulk protein concentrations. Black (○): 20 nM BIN1 N-BAR WT, red (□):
1000 nM BIN1 N-BAR WT. B) The protein density-liposome radius plot of 20 nM BIN1
N-BAR was converted to a logarithmic scale and reveals a linear relationship. The slope
of the linear fitting represents the strength of BIN1 N-BAR curvature sensing ability.
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Fig. 38 Membrane binding affinity (Kd) and saturation density (Bmax) of BIN1 NBAR are membrane curvature dependent.
BIN1 N-BAR WT densities at given liposome radius are plotted against bulk protein
concentrations. Data was fitted with a Langmuir isotherm model at three different
liposome sizes: (○) 50 nm, (□) 100 nm, (◊) 400 nm. B) From the fits in A), the size
dependency of the apparent equilibrium disassociation constant (Kd) was observed. Kd
varies from 250 nM to 410 nM. However, the differences in Kd are at an order of thermal
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fluctuations. C) The saturation density (Bmax) extracted from A) is a function of liposome
radius. The size-dependency of Bmax was depicted in a log–log plot. The slope of the
linear fitting represents the membrane curvature sensing ability. Membrane curvature
sensing ability of BIN1 N-BAR is not mediated by the higher binding affinity on curved
membranes but relies predominantly on the curvature-dependent Bmax.
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Fig. 39 Comparison of Kd and Bmax on different membrane curvatures among BIN1
N-BAR variants.
A) Apparent equilibrium dissociation constants (Kd) are extracted, which are dependent
on liposome sizes. Higher affinities were observed on curved membranes. BIN1 N-BAR
WT shows slightly smaller Kd than the disease-related mutants. B) Saturation densities
(Bmax) are functions of liposome sizes. Larger saturation densities were observed on
smaller vesicles. Size-dependence of Bmax is greater than equilibrium dissociation
constant Kd.
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Chapter. 6 Comparisons of curvature sensing capacities among BAR
domains by micropipette-assisted tether pulling assay
Another focus of this dissertation is to understand the differences of the MC-S&G
abilities among different types of BAR domains. In the endocytic machinery, multiple
BAR domains are recruited to the clathrin-coated pits (CCPs) at a relatively close time
window[23]. BAR domains involved in clathrin-mediated endocytosis share similar
module architectures, domain structures and functions. One unsolved question is why
cells require multiple types of BAR domains to generate synaptic vesicles. How do BAR
domains functioning differently during CME? Do they function as substitutions if another
BAR domain protein is malfunctioning? Studies have shown that knockout of
amphiphysin1, amphiphysin2, or endophilin impaired but not abolished the synaptic
vesicle recycling, suggesting a functional redundancy of BAR domains during vesicle
cycling. Furthermore, Merrifield et al. have measured the protein recruitment dynamics to
the clathrin-coated pits in NIH-3T3 cells. They found a sequential recruitment of
syndapin2 (F-BAR domain) and a group of N-BAR domain proteins, such as endophilin2,
BIN1, and amphiphysin1[23]. They hypothesized that the sequence of protein recruitment
to the endocytic site is consistent with the pattern of increasing curvatures during the
growth /constriction of the endocytic vesicle. Proteins with less curved membrane
binding interfaces will be recruited first to the CCPs. This finding implies a potential
relationship between the spatial/temporal distributions of endocytic proteins and their
MC-S&G strengths. To test this hypothesis, here I aim to compare the differences in the

	
  

145	
  

	
  

MC-S&G capacities of several BAR domains participating in CME through the
micropipette-assisted tether pulling assay as well as TEM tubulation assay.
6.1 Purifications and characterizations of human amphiphysin N-BAR domains
The N-BAR sequence (amino acids: 1-242) was cloned into the pGEX-6p vector.
Plasmids were transfected into BL21-Codon Plus (DE3)-RIL bacteria. A single colony
was picked and cultured in LB medium overnight at 37 °C. On the next day, the starter
culture was transferred into LB medium (3 L), shaking at 225 rmp, at 37 °C, until
reaching an OD600 of 0.8. 1 mM IPTG was added to induce protein production and cells
were continuously cultured at 18 °C overnight before harvest through centrifugation.
Cells were resuspended in the lysis buffer (20 mM Hepes, 1 M NaCl, pH 7.5). We
chose high salt concentration (1 M NaCl in this case) in order to prevent potential protein
aggregation in solution. Cells were lysed on ice via tip sonication. The supernatant of the
cell lysate was applied to a GST-affinity column equilibrated with the lysis buffer and
eluted with elution buffer (50 mM Tris-HCl, 20 mM reduced glutathione, 1 M NaCl, pH
8.0). The GST-tag was removed through the PreScission protease digestion at 4 °C for 4
hours. The untagged amphiphysin N-BAR were diluted with 20 mM Hepes, 0 mM NaCl,
pH 7.4 buffer to reach 150 mM NaCl concentration. The diluted solution containing
amphiphysin N-BAR was then purified by cation exchange chromatography and gel
filtration chromatography. Fractions of amphiphysin N-BAR from SEC were examined
by the SDS-PAEG electrophoresis (Fig. 40A). The final product was concentrated and
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labeled with Alexa 488 C5-maleimide. Free fluorophores were removed via desalting
columns.
We were able to obtain amphiphysin N-BAR with high purity. As shown in Fig.
40A, fractions eluted from the SEC chromatography were analyzed by SDS-PAGE.
Single bands with anticipated molecular weight are shown on the gel. To exclude
potential protein aggregation, the purified amphiphysin N-BAR was applied to an
analytical gel filtration column. Only one elution peak was observed, consistent with the
retention volume of BIN1 N-BAR domains (Fig. 40B). Meanwhile, the CD spectrum of
human amphiphysin N-BAR showed a characteristic α-helical secondary structure (Fig.
40C). Overall, characterizations in Fig. 40 suggest that the recombinant human
amphiphysin N-BAR domains are pure and correctly fold into α-helices.
Surprisingly, the recombinant N-BAR domains were observed to be nonfunctional in vitro. Both amphiphysin N-BAR and the fluorophore-labeled proteins failed
to tubulate or vesiculate membranes (Figs. 41A&B). Vesicle morphologies after the
addition of amphiphysin N-BAR are similar to a lipid control (Figs. 41A&B).
Furthermore, loss of curvature sensing ability was found when incubating amphiphysin
N-BAR with GUVs composed of 75% DOPC/ 25% DOPG. The curvature-coupling ratio
𝐼! /𝐼!! slowly varies with the square root of membrane tension (Fig. 41C), indicating a
compromised membrane curvature sensing ability of amphiphysin N-BAR.
We observed that during protease digestion to remove GST tags, white cloudiness
appeared upon the addition of PreScission protease. We speculate that the solubility and
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stability of un-tagged amphiphysin N-BAR is poor and that the protein precipitates out of
the solution. Specifically the three dimensional structures of the soluble N-BAR domains
might be altered after the protease digestion, leading to the compromised membrane
deformation capacity of human amphiphysin N-BAR.
6.2 Purifications and characterizations of full-length amphiphysin (amphiphysin-FL)
Since the recombinant amphiphysin N-BAR domains are not able to sense and
generate membrane curvature, I tried to purify full-length human amphiphysin. I found
that high salt concentration is no longer necessary to prevent protein aggregation. Lysis
buffer includes 20 mM Hepes, 300 mM NaCl, pH 7.4 while the GSTrap elution buffer is
50 mM Tris-HCl, 20 mM reduced glutathione, 150 mM NaCl, pH 8.0. During
PreScission protease digestion, much less protein aggregates were observed as opposed to
the situation in amphiphysin N-BAR domains. The untagged amphiphysin-FL was
further purified by cation exchange chromatography. We confirmed that amphiphysin-FL
is functional in vitro. As shown in Figs. 42A&B, both unlabeled and Alexa488-labeled
amphiphysin-FL are able to induce membrane tubulation from Folch fraction vesicles.
Analysis of the membrane tubule diameters induced by the unlabeled and Alexa488labeled proteins found no significant differences. The averaged membrane tubule
diameter generated by amphiphysin-FL is 35 ± 0.6 nm (unlabeled) or 37 ± 1 nm (labeled).
This observation indicates that the introduction of a fluorophore into human
amphiphysin-FL does not interfere with the membrane deformation capacity.
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6.3 Curvature sensing ability of human endophilin N-BAR
We first investigated the curvature sensing ability of human endophilin N-BAR.
The lipid composition we chose here is 25% DOPG/75% DOPC because nonlinearity in
the curvature sorting behavior of endophilin N-BAR has been reported[178] and the
thermodynamics model proposed by Baumgart et al. can assist us in interpreting the
differences, if any, we observed among different BAR domains.
To achieve sufficient protein density allowing for the accurate fluorescence
intensity determination, we chose to use 200 nM of endophilin N-BAR to perform the
curvature sensing assay. Shown in Fig. 43A, a membrane tether was established by the
streptavidin-biotin interactions between the aspirated bead and the GUV. The Alexa488labeled endophilin N-BAR domains were visualized in the green channel while the GUVs
doped with TexasRed-DHPE were imaged in the red channel. Membranes tensions across
the GUV respond to the aspiration pressure in the micropipette. A low membrane tension
(0.0438 mN/m), fluorescence intensities of the membrane tether in both protein and lipid
channel are dimmer compared to the quasiflat vesicular membranes due to the smaller
cross-section area of the membrane tether. However, by increasing the membrane tension
to 0.473 mN/m, endophilin N-BAR starts to accumulate onto the highly curved tubular
membranes, because the fluorescence intensities of the tether in protein channel increase
and become even brighter than that of the GUV (Fig. 43A). Meanwhile, the fluorescence
intensities of the tether in lipid channel decrease suggesting that the membrane tether
becomes narrower at high membrane tension (Fig. 43A). To quantitatively evaluate the
density of endophilin N-BAR on the membrane tether, confocal images of membrane
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tether cross sections were recorded at various membrane tensions. Fig. 43B shows that
the green fluorescence intensities increase when increasing the membrane tension from
0.0438 mN/m to 0.473 mN/m. The fluorescence intensities of the lipid fluorophores drop
as a consequence of the shrinking tubule dimension. Qualitatively, endophilin N-BAR
domains sense membrane curvature by enriching onto curved tubular membranes.
To quantify the enrichment of endophilin N-BAR onto membrane tethers,
fluorescence intensities of endophilin N-BAR and lipid fluorophores were plotted against
the square root of membrane tension (Fig. 43C). The protein fluorescence monotonically
increases with the square root of the membrane tension while the lipid fluorescence
decreases (Fig. 43C). It has been shown that membrane curvature in the pulled tether is
proportional to the square root of the membrane tension[177]. The partitioning ratio 𝐼! /𝐼!!
is defined as the ratio 𝐼! between protein and lipid fluorescence intensities on the tether
!
!
(𝐼! = 𝐼!"##$
/𝐼!"#
) at given membrane tension, and subsequently normalized by the
!
!
corresponding ratio on the vesicle (𝐼!! = 𝐼!"##$
/𝐼!"#
) [199,200]. This partitioning ratio

𝐼! /𝐼!! is an indicator of protein enrichment on the tubular membrane. For a protein
incapable of sensing membrane curvature, the partitioning ratio is expected to be 1.
Previous results have demonstrated a linear relationship between 𝐼! /𝐼!! and the
square root of the membrane tension[80,196], in which the slope of this linear
relationship represents the strength of curvature sorting ability. The analysis in Fig. 43D
allows the assessment of the curvature sorting behavior of endophilin N-BAR. Of note,
the sorting profile in Fig. 43D demonstrates nonlinear curvature coupling, consistent with
published results[178]. At 200 nM bulk protein concentration, we successfully revealed
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three membrane curvature-sensing regimes of endophilin N-BAR (Fig. 43D): 1) Dilute
regime in which the curvature sensing ability of endophilin is weak at low membrane
tension. At low membrane tension, curvature sorting is significantly weaker (smaller
slope) than it is at higher tensions. As membrane tension increases, the curvaturecoupling ratio (𝐼! /𝐼!! ) also slowly increases with Σ1/2 until reaching the second regime; 2)
Linear sorting regime in which the ratiometric parameter 𝐼! /𝐼!! increases linearly with the
square root of membrane tension and the slope of the curvature sorting profile is larger
compared to the first regime; 3) Saturation regime in which the sorting ratio on
membrane tethers becomes nearly constant[178]. The nonlinearity in the curvaturecoupling is a consequence of endophilin oligomerizations on membranes. Protein
assembly on the membrane tether accelerates the protein re-distribution as the protein
density increases. At high membrane tension and protein density, endophilin N-BAR
starts to generate membrane curvature and stabilize the most energetically favorable
curvature[178].
To expand our study to a more physiological relevant lipid compositions, we next
investigated the curvature sensing capacity of endophilin N-BAR using GUVs made of
45% DOPS/30% DOPE/25% DOPC (Fig. 43E). Such lipid composition mimics the
headgroup compositions in the inner-leaflet of the plasma membrane[5]. We excluded
PI(4,5)P2 from the lipid composition to avoid specific effects of PI(4,5)P2 on proteinmembrane interactions, such as promoted amphipathic helix insertion[174]. Membrane
binding of endophilin N-BAR increases due to the higher percentage of negatively
charged lipids. A linear curvature-coupling relationship between 𝐼! /𝐼!! and Σ1/2 was
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observed for inner-leaflet mimicking compositions (Fig. 43E), similar to those found for
the ENTH domain and BIN1 N-BAR domain. The slope of the linear curvature-sorting
was determined to be 7.9 ± 0.2 (Fig. 43E). We hypothesize that the diluted regime is lost
due to the increased membrane-bound protein densities.
6.4 Curvature sensing ability of human amphiphysin and its comparison with
endophilin N-BAR
Next we set out to study the curvature sensing ability of human amphiphysin-FL
under the same lipid compositions. Amphiphysin is an N-BAR protein recruited to the
endocytic pit at similar time window as endophilin[23]. The crystal structures alignment
between the N-BAR domains from human endophilin and amphiphysin demonstrate high
structural similarities (Fig. 44A) except that endophilin N-BAR contains an additional
inserting helix (Hi) at the center of the BAR dimer (red box in Fig. 44A). To compare the
curvature sensing differences between amphiphysin and endophilin, we measured the
curvature sensing ability of human amphiphysin N-BAR on membranes containing 25%
DOPG and 75% DOPC. In order to achieve comparable membrane-bound protein
densities, we chose bulk concentration of 100 nM instead of 200 nM due to the increased
membrane binding affinity of amphiphysin-FL. We found variations in the protein
densities on membranes among different vesicles, possibly due to the variability in
individual vesicle lipid compositions. Therefore, we categorized the curvature sorting
behaviors of amphiphysin-FL into two groups: low or high protein fluorescence
intensities on GUVs. At high membrane bound protein densities (the averaged protein
fluorescence intensities on the vesicular membranes were shown in Fig. 44D), the linear
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dependence of 𝐼! /𝐼!! on Σ1/2 was observed (Fig. 44B). The slope of the curvaturecoupling profile is 9.1 ± 0.4. On membranes covered with less proteins, the 𝐼! /𝐼!! -Σ1/2
relationship deviates from a linear trend (Fig. 44C). The partitioning ratio slowly
increases with Σ1/2 at low membrane tension regime, become proportional to the square
root of membrane tensions with a larger slope, and stays constant at high membrane
tensions (Fig. 44C). This finding suggests that at low membrane-bound protein density,
amphiphysin-FL senses membrane curvature in a nonlinear manner. To compare with
endophilin N-BAR, the curvature sensing data of amphiphysin-FL and endophilin NBAR were plotted together in Fig. 44E. Interestingly, the 𝐼! /𝐼!! -Σ1/2 relationship of these
two proteins are both nonlinear and essentially overlap with each other. This observation
suggests that at low membrane-bound density, amphiphysin and endophilin act as
membrane curvature sensors with comparable curvature sorting abilities.
For the inner-leaflet mimicking lipid compositions, amphiphysin acts as a
curvature sensor as well. To reach the dilute regime in the curvature sensing profile, we
used 30 nM as the protein bulk concentration. By increasing membrane tensions, the
curvature sorting ratio responds nonlinearly to the square root of the membrane tensions
(Fig. 45A). Data from six vesicles demonstrating similar protein fluorescence intensities
were analyzed and binned in Fig. 45B, confirming that the nonlinear curvature sorting of
amphiphysin-FL at low protein concentration is reproducible.
Sorre et al. has reported that protein density influences the strength of curvature
sensing[163]. To make sure we compare the curvature sorting ability of different BAR
domains at similar membrane-bound densities, amphiphysin-FL and endophilin N-BAR
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were titrated into the GUV solution to measure their membrane binding capacity. As
shown in Fig. 45C, the fluorescence intensities on the GUV equators were measured and
plotted against bulk protein concentrations. The protein fluorescence intensities were
proportional to the molecular densities on membranes and increase with the bulk protein
concentration (Fig. 45C). The Langmuir isotherm model was fitted to our data allowing
for the determination of membrane dissociation constant Kd and saturation density Bmax.
Amphiphysin-FL binds to GUVs stronger with a Kd of 556 ± 117 nM, whereas
endophilin N-BAR binds to membranes with a Kd of 930 ± 297 nM. However, the
saturation density Bmax of amphiphysin-FL is smaller than endophilin N-BAR. Bmax for
amphiphysin-FL and endophilin N-BAR are 3546 ± 252 and 9766 ± 1500 (a.u.),
respectively. The difference in the saturation density reflects the different number of
protein binding sites on GUVs, which might be due to the increased cross section area of
amphiphysin-FL compared to BAR domain alone. Based on the isotherm titration, we
estimated that at 100 nM bulk concentration, amphiphysin-FL and endophilin N-BAR are
expected to reach comparable protein densities. Fig. 45D demonstrates the curvature
sensing profile using 100 nM amphiphysin-FL. As the protein concentration increases,
the 𝐼! /𝐼!! -Σ1/2 relationship shifts into the regime II & III, in which the partitioning ratio
first linearly increases with the square root of membrane tensions and then becomes
relatively constant. Compared to the curvature sensing profile of 100 nM endophilin
under the same lipid compositions, the linear sorting regime overlaps with what we
observed for amphiphysin-FL. The slope of the 𝐼! /𝐼!! -Σ1/2 relationship is 7.8 ± 0.5 for
amphiphysin-FL and 7.7 ± 0.3 for endophilin N-BAR. An F-test was performed to ask if
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the two fitting curves are different. The slopes were found to be identical based on the
statistical test.
Overall, nonlinear curvature-coupling behavior is a universal phenomenon for NBAR domain proteins, including amphiphysin (Figs. 44&45), endophilin (Fig. 43) and FBAR proteins (data not shown). Moreover, amphiphysin and endophilin share similar
curvature sensing ability, which may due to the high similarities in the N-BAR domain
structures.
6.5 Tubulation capacity differences between human endophilin N-BAR and fulllength amphiphysin
Thus far, no significant difference in the curvature sensing abilities was found
between endophilin N-BAR and amphiphysin-FL. I next ask the question that whether
endophilin N-BAR and amphiphysin have similar curvature generation capacity. It has
been shown in published results that BAR domains induce membrane tubulation in a
protein concentration dependent manner[196]. At low membrane-bound protein density,
vesicle morphologies remain intact. When certain protein density threshold is reached,
budding structures start to appear on the liposomes, which will ultimately grow into
membrane tubules[196]. At high protein bulk concentration (such as 5 µM), both
endophilin N-BAR[210] and amphiphysin-FL (Fig. 42) are able to induce tubule
formation from vesicles. We wonder if these two proteins may require different critical
protein concentrations to initiate membrane deformation. Proteins of varying
concentrations were incubated with vesicles and the membrane shapes were visualized by
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negative staining TEM. As shown in Fig. 46A, endophilin N-BAR did not change
liposome morphologies at bulk concentrations ranging from 200 nM to 1 µM. No
observable ‘membrane wobbling’[196] or tubulation were found in the samples. Starting
from 2 µM, membrane tubules start to appear, however, the diameters of the membrane
tubules are not homogeneous along the tubules. The occurrence of the membrane tubules
increases until the protein concentration reaches 5 µM. In the meantime, the tubules show
homogeneous diameter. Qualitatively, endophilin N-BAR is able to bend membranes at
protein concentration above 1 µM. In order to quantitatively describe the protein
concentration-dependent membrane shape transitions, we counted and calculated the
percentages of membrane tubules in the TEM images as the representation of the
abundance of deformed membranes at given protein bulk concentration. Fig. 46B shows
that at protein concentrations lower that 2 µM, no membrane tubules were induced by
endophilin N-BAR. The averaged percentage of membrane tubules increases from 5% to
42% when the bulk endophilin N-BAR concentration increases from 2 µM to 5 µM.
Furthermore, the averaged tubule diameter decreases from 65 nm to 32 nm while
increasing protein concentration to 5 µM. The tubule diameters induced by 2 µM
endophilin N-BAR shows a broader distribution (Fig. 48A), which suggests that the
tubule dimensions are heterogeneous. However, at higher protein concentration (5 µM),
the histogram of tubule diameters demonstrates a narrow variation with a peak close to 30
nm.
Contrarily, our data suggests that amphiphysin-FL is able to generate membrane
tubules at a much lower bulk concentration. As shown in Fig. 47A, at 200 nM, no
	
  

156	
  

	
  

membrane tubules were observable. When the concentration increased to 500 nM,
tubules started to form from the liposomes, albeit the density of membrane tubules was
low. Membrane tubules were found in all the samples containing higher protein
concentrations. Fig. 47B demonstrates that the membrane tubule percentages increase
with amphiphysin-FL concentration. The membrane tubule percentage is 16% at 500 nM
and increases to 53% at 5 µM. The variations in the averaged tubule diameters were
smaller among different protein concentrations (Fig. 47C) compared to endophilin NBAR (Fig. 46C). Of note, the tubule diameters slightly increase at higher bulk
concentration. This may be due to the collapse of the membrane tubules during drying
process. The histograms of the tubule diameter distributions at varying concentrations
were centered similarly around 30 nm (Fig. 48B).
To conclude, by varying protein concentrations in the tubulation assay, we found
that amphiphysin-FL is able to deform membrane at a much smaller bulk concentration
than endophilin N-BAR domain. However, the TEM-based tubulation assay only
provides qualitative assessments on the curvature generation capacity because it is
challenging to determine exact protein density on membranes. Zheng Shi et al. have
developed a fluorescence microscopy based assay that allows for quantifying critical
protein density to initiate GUV deformation. In this assay, a single GUV is transferred
into a fluorophore-labeled protein solution, in which changes of membrane area and
membrane-bound protein fluorescence intensities are monitored simultaneously. Future
studies by such assay may provide a precise comparison of the differences in the protein
density needed to tubulate membranes between endophilin N-BAR and amphiphysin-FL.
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Fig. 40 Characterizations of the human amphiphysin N-BAR domains during
protein preparation.
A) SDS-PAGE gel analysis of the elution fractions from size exclusion chromatography.
Single band with correct MW of amphiphysin N-BAR was observed. B) Analytical SEC
elution profile of human amphiphysin N-BAR (black solid) and human BIN1 N-BAR
(grey dashed line), suggesting no aggregation in freshly thawed samples. C) CD spectrum
of unlabeled and Alex488-labeled human amphiphysin N-BAR. A signature α-helical
secondary structure was observed.
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Fig. 41 Recombinant human amphiphysin N-BAR domains are not functional in
vitro.
Electron micrographs of liposomes incubated with 5 µM A) unlabeled human
amphiphysin N-BAR and B) Alex488-labeled human amphiphysin N-BAR. No change in
membrane shapes was induced by amphiphysin N-BAR. Scale bar: 200 nm. C)
Partitioning ratio of protein densities onto cylindrical membrane tubules (𝐼! /𝐼!! ) as a
function of the square root of membrane tensions binned from multiple tethers. Low
curvature sensing ability was observed, as opposed to other BAR domain proteins
reported in published works[80,163,178]. GUV lipid composition: 45 % DOPS/30%
DOPE/25% DOPC. Buffer: 20 mM Hepes, 50 mM NaCl, pH 7.5.
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Fig. 42 Amphiphysin-FL induces membrane deformation in vitro.
Electron micrographs of folch fraction I liposomes incubated with A) 5 µM amphiphysinFL or B) Alexa488-conjugated amphiphysin-FL. Both proteins can induce tubules from
liposomes. Scale bar: 200 nm. C) Quantifications of the tubule diameter induced by
unlabeled (Amp-FL-un) or Alexa488-labeled amphiphysin-FL (Amp-FL-labeled). Both
proteins generated membrane tubules with an averaged diameter around 35 nm. No
significant difference between the two samples was found by the Student t-test. n.s.: p >
0.05.
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Fig. 43 Nonlinear curvature sorting of human endophilin N-BAR domains.
A) A membrane tether was formed from a micropipette-aspirated GUV (to the right) by
the means of a polystyrene bead held with a second micropipette. The green channel
represents the fluorescence of Alexa488-labeled endophilin N-BAR and the red channel
shows the lipid fluorescence from TexasRed-DHPE. Representative images at low
membrane tension (Σ = 0.0438 mN/m) and high membrane tension (Σ = 0.473 mN/m)
were shown. The tether in the protein channel became brighter when membrane tension
was increased, whereas the lipid fluorophore intensities decreased. B) Demonstration of
Kalman-averaged confocal xz line scan images used to monitor endophilin partitioning
under varying membrane tensions. C) Protein and lipid fluorescence intensities quantified
from B) plotted against the square root of membrane tensions. When increasing
membrane tensions, the tether became narrower, however, more endophilin N-BAR
domains accumulated onto the tubular membranes. D) Partitioning ratio (𝐼! /𝐼!! ) from ten
vesicles were binned (vertical error bars represent the standard error of the mean (SEM);
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horizontal error bars show the SEM of the square root of membrane tension). Three
curvature-sensing regimes were observed (shaded in different colors). A)-D) Lipid
composition: 25% DOPG/75% DOPC. E) Curvature sensing assay of endophilin N-BAR
using a different lipid composition (45% DOPS/30% DOPE/25% DOPC). All the
experiments were performed in buffer: 20 mM Hepes, 50 mM NaCl, pH 7.5.
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Fig. 44 Nonlinear sorting of amphiphysin-FL on 75% DOPC/25% DOPG GUVs.
A) Crystal structure alignment of endophilin N-BAR (PDB ID: 1ZZW, green) and human
amphiphysin N-BAR (PDB ID: 3SOG, blue). B) Curvature-coupling ratio the 𝐼! /
𝐼!!   plotted against the square root of membrane tension Σ1/2. On GUVs showing high
protein densities, linear sorting was observed with a slope of 9.1 ± 0.4. C) Curvature
sensing profile of amphiphysin-FL on membranes with low protein densities. The 𝐼! /𝐼!! 	
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Σ1/2 relationship is non-linear; D) Averaged protein fluorescence intensities on the GUVs
selected for the analysis in B) & C). E) Comparison of the curvature sensing ability
between amphiphysin-FL (100 nM) and endophilin N-BAR (200 nM) at low membranebound protein densities. Bulk protein concentration: 100 nM. Error bars: SEM. Buffer: 20
mM Hepes, 50 mM NaCl, pH 7.4. Lipid composition: 25% DOPG/75% DOPC.
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Fig. 45 Amphiphysin-FL senses membrane curvature with similar strength as
endophilin N-BAR.
A) 𝐼! /𝐼!! -Σ1/2 relationship of 30 nM amphiphysin-FL on membranes containing 45%
DOPS/30% DOPE/25% DOPC; B) Data from six GUVs were processed and binned.
Nonlinear curvature sensing of amphiphysin-FL was observed at low protein density
regime. C) GUV binding isotherm of amphiphysin-FL and endophilin N-BAR. D)
Comparison of curvature sorting abilities between amphiphysin-FL (100 nM) and
endophilin N-BAR (100 nM). Slopes of the two linear fittings are not significantly
different based on an F-test. Lipid composition: 45% DOPS/30% DOPE/25% DOPC;
Buffer: 20 mM Hepes, 50 mM NaCl, pH 7.4.
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Fig. 46	
   Endophilin N-BAR domains initiates membrane tubulation at bulk
concentration higher than 1 µM.
A) Electron micrographs of liposomes incubated with endophilin N-BAR domains at
concentrations ranging from 200 nM to 5 µM. Scale bar: 200 nm. B) Membrane tubule
percentages found on EM grids at given protein concentration. The number of liposomes
and the number of membrane tubules were counted in individual images. The membrane
tubule percentage is calculated as: % tubules = (number of membrane tubules) / (number
of membrane tubules + number of vesicles). This parameter is correlated to the
abundance of deformed membranes and can serves as an indicator of membrane
curvature generation strength. C) Quantification of the averaged tubule diameters at each
protein concentration quantified from 10 individual images. Error bar: SEM. Student ttest was performed to determine statistical significance: n.s.: p>0.05, *: p<0.05, **:
p<0.01, ***: p< 0.001.
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Fig. 47 The critical protein concentration to deform liposomes is lowered by human
amphiphysin-FL compared to endophilin N-BAR.
A) Electron micrographs of liposomes incubated with amphiphysin-FL at concentrations
ranging from 200 nM to 5 µM. Scale bar: 200 nm. B) Averaged membrane tubule
percentages found on EM grids at given protein concentration. At least ten individual
TEM images were analyzed. C) Quantification of the averaged tubule diameters at each
protein concentration quantified from 10 individual images. Error bar: SEM. Student ttest was performed to determine statistical significance: n.s.: p>0.05, *: p<0.05, **:
p<0.01, ***: p< 0.001.
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Fig. 48	
   Histograms of tubule diameter distributions induced by endophilin N-BAR
domains and amphiphysin-FL at the indicated bulk concentrations.
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Chapter. 7 Future directions and outlook
7.1 Oligomerization of BIN1 N-BAR domains facilitates membrane curvature
generation
In Chapter 3, we have experimentally shown that protein-protein assembly is
required to drive membrane bud formation in the early stage of membrane tubulation,
which is also suggested from molecular dynamics simulations[185]. However,
simulations did not provide all-atom resolution to reveal the residues involved in the
lateral contacts among neighboring N-BAR domains. To understand the role of the distal
arm region of BAR domain in mediating protein assembly on membranes, a mutagenesis
screening was performed at the BIN1 N-BAR tip allowing us to identify potential
residues regulating membrane deformation capacity. Particularly, I was interested in
mutating the charged residues or the residues capable of forming H-bonds, because Hbonding and electrostatic interactions are two primary driving forces in potential interdimer assemblies. Each mutant (tagged with EGFP at N-terminus) was transfected in the
C2C12 myoblasts and imaged with confocal microscope to evaluate the impacts of
mutations on membrane tubulation. Representative images were shown in Fig. 49 and the
results were summarized in Table 7. Mutating the charged or polar residues at the distal
arm (except His156) compromises BIN1 membrane tubulation ability, highlighting an
essential role of the distal arm region in regulating membrane remodeling. Conservation
of charge at positions 151 and 154 is required for BIN1 N-BAR to tubulate cell
membranes. Mutants D151E and R154K preserve the membrane tubulation ability in vivo.
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As mentioned in Chapter 3, we identified that His155 as a key residue at the distal
arm region of BIN1 N-BAR domain in regulating membrane deformation. Mutation of
this residue to a neutral amino acid (alanine) leads to loss of membrane tubulation in
C2C12 myoblasts (Fig. 50A). Homogeneous green fluorescence was observed in cells
expressing the H155A mutant.
We have already discussed in Chapter 3 that membrane remodeling requires BAR
domains to form a lattice-like coat on the tubular membrane[34,45]. BAR domain
assemblies can be stabilized by amphipathic helices as in the endophilin N-BAR[74,95]
or through edge-edge interactions such as in various F-BAR and endophilin N-BAR
domains[82,83]. The intermolecular contacts in F-BAR domains are stabilized through
the charged residues[83]. Due to the fact that residues D151 and H155 are located in the
arm region with the side chain pointing outward in the crystal structure, this orientation
might allow for interactions between D151 and H155 from a neighboring BAR domain in
an anti-parallel manner.
H155 emerged as a possible candidate interacting with D151. In vivo tubulation
experiments imply that the conservation of charge either at the 151(-) or 155(+) position
is important for maintaining tubulation ability of the BIN1 N-BAR domains (confer
Table 7). Mutating H155 to Arg enhances tubulation ability of BIN1 N-BAR domains
both in vivo and in vitro. The H155R mutant is able to induce membrane tubulation from
plasma membranes (Fig. 50A) and generate tubular membranes from liposomes (Fig.
50C). The H155R mutant forms protein lattice on membranes in the presence of chemical
crosslinkers (Fig. 50B). We speculate that D151 and H155 engage in inter-molecular
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interactions to form protein lattice on membranes. Importantly, we observed that a double
mutation D151N/H155R rescued membrane tubulation in cells. Membrane invaginations
marked by the green fluorescence in C2C12 cells appeared with tubular morphologies
similar to the WT BIN1 N-BAR (Fig. 9A). To test if the double mutant D151N/H155R
enhances the membrane tubulation ability of BIN1 N-BAR in vitro, we purified the
recombinant D151N/H155R mutant. Incubation of the D151N/H155R mutant with
liposomes results in formation of membrane tubules (Fig. 50C). The tubule diameter and
length are comparable to those generated by WT BIN1 N-BAR. The D151N/H155R
mutant forms oligomers on membranes in the presence of crosslinkers as revealed by the
chemical crosslinking assays (Fig. 50B). In the absence of liposomes, the double mutants
were monomeric in solution and were crosslinked into dimers in the presence of
crosslinkers (Fig. 50B). Patterns of oligomeric bands emerged on SDS-PAGE gels upon
addition of BS3 and liposomes (Fig. 50B), different from the dimeric bands of the D151N
alone mutants (Fig. 18D). This observation implies that the H155R mutation successfully
rescued the tubulation and oligomerization ability in the disease mutant D151N.
Our current hypothesis is that D151 and H155 engage in an inter-molecular
interaction of two BAR domain dimers on the membrane and facilitate the formation of a
protein lattice (Fig. 51). This might imply that arginine at the 155 position enhances the
inter-molecular H-bond strength and may thus rescue the tubulation capacity in the
disease mutant. This may be due to the fact that the enthalpic gain upon formation of the
charged-neutral H-bond (D151…H155 in WT or N151…R155 in the double mutant) is
greater compared to a neutral-neutral H-bond (N151…H155 in the disease mutant)[211	
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213] at physiological pH (pH = 7.4). In order to further test this idea, we constructed a
double mutant where these two residues were swapped, and we expressed it in C2C12
myoblasts. Unfortunately, this test proved unsuccessful due to protein aggregations into
vacuole-like structures (Fig. 50A). Future studies such as high-resolution reconstruction
from Cryo-EM images may provide insights in whether these two residues contact each
other upon membrane binding and how single mutation leads to loss of protein assembly.
Table 7 Mutational screening of residues involved in inter-molecular oligomerization at
distal arm of BIN1 N-BAR domain with disease mutants.
Mutants
D151E
R154K
H155A
H156A
H155R
D151N/H155R
D151YY150D
D151RR154D

Tubulation Capacity
in transfected C2C12
cells
+++
+++
/
++
+++
+++
/
/

Mutants

Tubulation Capacity
in transfected
C2C12 cells
Y150A
/
Y157A
/
R154Q/E158D
/
R154Q/Y150D
/
R154Q/Y150E
/
R154Y/Y157R
/
R154E/E158R
/
D149A
/

+++ Tubulation capacity in vivo is comparable to WT BIN1 N-BAR
/ No tubulation in cells
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7.2 BAR domains and actin cytoskeleton
Rearrangements of the cytoskeleton underlying plasma membranes control the
membrane morphology[14,214]. Cellular processes such as formations of filopodia,
pseudopodia, phagocytic cups and axonal growth cones are coupled with cytoskeleton
dynamics[215-218]. Furthermore, bursts of actin polymerization are observed during the
endocytosis[219,220]. Due to the force-generation characteristics of actin polymerization,
it has been proposed that actin drives membrane invagination, aids membrane fission and
pulls vesicles away from the plasma membranes[219,221,222]. Cytoskeleton proteins
may also facilitate membrane tubulations. It has been observed that kinesin motors can
attach to Golgi membranes and induce membrane tubulation[223,224]. BAR domain
proteins involve in membrane curvature generation[225]. BAR domains are also
considered as candidates to integrate cytoskeleton with membrane remodeling. Sven
Bogdan et al. have shown that the CIP4-postive vesicles (a F-BAR protein) in Drosophila
S2R+ cells localize at the tips of actin tails through the adaptor-Wiskott-Aldrich
Syndrome proteins (WASP), which is an actin polymerization nucleator[226]. Similarly,
it has been reported that Toca-1, another F-BAR domain protein, is recruited to the
surface of bacteria to induce actin polymerization to enhance intracellular movement and
cell spreading[227,228]. Knockdown of F-BAR domains results in abnormal bouton
morphology and compromised synaptic transmission[229]. Flies containing the CIP4
mutation demonstrated defects in cell polarization and wing development[230]. I-BAR
proteins, such as IRSp53, MIM, ABBA and IRTKS, also associate with actin nucleating
WASP or WAVE complexes at the membrane deformation sites[217]. Recent studies
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have pointed out that the I-BAR protein IRSp53 is activated through the recruitment of
actin polymerization effectors to induce membrane protrusion[27,28,158]. Overall, BAR
domain proteins demonstrate a dual role in anchoring the cytoskeleton at membrane
deformation sites.
BIN1 transiently interacts with microtubules (MTs) through the microtubulebinding cytoplasmic linker protein 170 (CLIP170)[110]. Although no observable colocalization between BIN1-coated tubules and MTs were found in cells, close proximity
between these two structures was observed[110]. Depolymerization of MTs or
downregulation of CLIP170 leads to a decrease in the number of BIN1-positive
membrane tubules[110]. Additionally, transient association between BIN1 and MTs
facilitate the delivery of L-type calcium channels (Cav1.2) to the T-tubules[111].
BIN1 also interacts with actin. A recent study led by T.T Hong reported that the
cardiac isoform of BIN1 enriches on T-tubules to induce protective inner membrane folds
to restrict ion flux[111]. Cardiac BIN1 promotes actin polymerization at the Z-discs via
the association with actin nucleator N-WASP[111,231]. In order to investigate the
influence of actin cytoskeleton on the biogenesis of T-tubules in skeletal muscle cells, we
co-expressed the fluorescence protein tagged full-length BIN1 (isoform 8) and actin in
C2C12 myoblasts to study the spatial distributions of these two proteins. We observed
that the BIN1-coated membrane tubules (red channel) do not overlap with the actin
filaments (green channel) (Fig. 52, top panel). The co-localization between BIN1 and
actin is not prominent, consistent with the published results. The enlarged image
demonstrates that the growth directions of the actin filaments (marked by the white line
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in the overlay panel) and membrane tubules (marked by the yellow line in the overlay
panel) are different (Fig. 52, middle panel). Interestingly, membrane tubules (yellow box,
Fig. 52, bottom panel) were often found in the area where actin filaments are absent
(white box, Fig. 52, bottom panel). These observations are in good agreement with the
published findings that actin polymerization has an antagonistic effect on BIN1 NBAR[196] or F-BAR domains[190] tubulation capacity. Actin depolymerization
enhances membrane tubule growth[190,196]. In summary, we found an inhibitory effect
of actin polymerization on BIN1-induced membrane tubulation. Contrarily, interactions
with microtubules allow BIN1 to deform membranes[110].
Although we did not observe that BIN1-positive membrane tubules directly
contact actin filaments, it is possible that the interactions between BIN1 and actin are
transient. The correct time course and mechanics of the BAR-cytoskeleton interactions
still remain elusive. It has been suggested that N-WASP complex will be recruited by
BAR domain proteins to initiate actin polymerization. The question arises if N-WASP
will associate with BIN1 in skeletal muscle cells and when this recruitment will happen
during the biogenesis of T-tubules. Thus, we aim to investigate the membrane
recruitment of N-WASP protein to shed lights on the role of actin polymerization during
membrane remodeling.
Neuronal Wiskott-Aldrich Syndrome protein (N-WASP) is recruited by Cdc42 to
initiate the nucleation of actin through activation of the Arp2/3 complex[232-235]. The
domain structure of N-WASP is illustrated schematically in Fig. 53A. N-WASP contains
a WASP homology 1 (WH1) domain at its N-terminus. The WH1 domain interacts with
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the WASP interacting protein (WIP), calmodulin, PI(4,5)P2, and actin filaments.
Following the WH1 domain is a Cdc42 or G-protein binding domain (GBD), which
includes a Cdc42/Rac interactive binding (CRIB) motif. N-WASP also contains a central
PRD domain capable of binding to the proteins containing SH3 domains[234,236-239].
At the C-terminus, there is a VCA domain including a verprolin homology segment (V),
a cofilin homology segment (C) and an acidic region (A). The VCA domains are able to
bind actin monomers (G-actin) and Arp2/3 complex leading to a dramatic enhancement
of actin nucleation[234,238,240]. N-WASP is autoinhibited by the intramolecular
interaction between the GDB domain and the VCA domain[234,241]. Binding to either
PI(4,5)P2 or Cdc42 activates N-WASP to recruit Arp2/3 complex to initiate actin
polymerization[237,242].
Amphiphysin I has been reported to interact with N-WASP through the SH3-PRD
interaction[243]. We are interested in whether BIN1 isoform8 is able to recruit N-WASP
to membranes. We first investigated the distribution of N-WASP in C2C12 myoblasts.
Fig. 53B shows representative confocal images of C2C12 cells expressing GFPconjugated N-WASP or WH1 domain.

We observed homogeneous fluorescence

distributions in cells (Fig. 53B). No specific structures or patterns were induced in vivo
by the overexpression of N-WASP or WH1 domains alone. In contrary, GFP-conjugated
WH1 domains are recruited to the membrane tubules induced by BIN1-FL (isoform8).
This observation is in accordance with the notion that the BIN1-positive membrane
tubules are enriched in PI(4,5)P2 and WH1 domain is able to bind to PI(4,5)P2 (Fig. 53C).
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To quantitatively determine the binding partnership between N-WASP and BIN1,
we purified the recombinant N-WASP proteins and measured its membrane binding
ability on GUV membranes. Shown in Fig. 54A, N-WASP alone weakly binds to GUVs.
Weak fluorescence intensities were observed on the equator of GUVs. Co-incubation of
N-WASP with BIN1 N-BAR* domains does not enhance the membrane recruitment of
N-WASP. In contrary, the presence of BIN1-FL on GUVs significantly increases the
fluorescence intensities of N-WASP on GUVs (Fig. 54A). The N-WASP fluorescence
intensities on membranes under each condition are measured by ImageJ and plotted in
Fig. 54B. The percentage of vesicles bound with N-WASP under each condition is
quantified in Fig. 54B as well. It is clear that incubation of N-WASP with BIN1-FL
increased both the percentage of GUVs showing N-WASP binding and the N-WASP
densities on vesicles. Our result suggests that BIN1 FL recruits N-WASP on membrane
tubules, possibly due to interactions between the SH3 domain in BIN1 and the PRD
domain in N-WASP. A future goal is to investigate how enhanced membrane recruitment
of N-WASP affects actin polymerization and the morphologies of the underlying
membranes.
7.3 PI(4,5)P2 clustering induced membrane shape transitions
In Chapters 3&4, we have demonstrated that the membrane sculpting capacity of
BAR domains depends on the physical properties of membranes such as local lipid
compositions. We have experimentally demonstrated that differences in the membrane
deformation capacities of BIN1 CNMs mutants were amplified on the inner-leaflet
mimicking compositions. Moreover, the MC-S&G function of BIN1-FL is inhibited on
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membranes lacking PI(4,5)P2. We hypothesize that changes in the lipid compositions can
serve as a regulator in the membrane remodeling process. This hypothesis is further
supported by a later observation that the incorporation of phospholipids with
polyunsaturated acyl chains facilitates vesiculation by endocytic proteins, such as
endophilin and dynamin[244]. Acceleration of endocytosis is achieved by the energetic
benefits from the flexibility of the polyunsaturated lipids to adapt their conformation in
curved membranes[244].
Phospholipids with polyunsaturated lipids are abundant only in specific organelles
such as synaptic vesicles[5,244]. In the inner-leaflet of plasma membranes, PI(4,5)P2 is
an

essential

lipid

in

transducing

signals

by

recruiting

specific

peripheral

proteins[245,246]. PI(4,5)P2 is a physiologically important but complicated lipid to work
with because its ionization states are pH & environment dependent[173,247-252].
Furthermore, PI(4,5)P2 has been proposed to associate with cholesterol-dependent lipid
rafts, which is still under debate[247]. A recent study led by Pekka Lappalainen et al. has
reported that BAR domains are able to induce PI(4,5)P2 microdomains which inhibit the
lateral diffusion of both lipids and proteins at the endocytic sites[99]. Incubation with the
membrane sculpting proteins not only generates membrane tubules, but also promotes
PI(4,5)P2 fluorescence quenching due to molecular crowding[99]. We observed a similar
protein clustering phenomenon for BIN1 N-BAR* domains. BIN1 N-BAR* domain
contain a polybasic motif (exon10) to specifically sense the presence of PI(4,5)P2 in
membranes[94]. Confocal images show that at high protein bulk concentrations (> 1 µM),
membrane binding of BIN1 N-BAR* domains leads to heterogeneities in the protein
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fluorescence distributions on GUVs containing 10% PI(4,5)P2 (Fig. 55). Part of the GUV
appears thicker and brighter (Fig. 55). A heterogeneous protein distribution was only
found in N-BAR* domains at high protein concentration and on membranes containing
PI(4,5)P2. We hypothesize that the BIN1 N-BAR* may induce PI(4,5)P2 clusters in
membranes through the exon10 motif. The PI(4,5)P2 clusters further enhance protein
recruitments and assemblies, resulting in the ultimate heterogeneous binding. Overall, a
new hypothetical function of BAR domains emerges in addition to curvature generation.
BAR domains can modulate local membrane composition changes to create hot spots for
signaling protein recruitments.
We are interested in whether the PI(4,5)P2 clusters generated by BAR domains
reversely influence membrane shape transitions. To simplify the system, we incubated
PI(4,5)P2-containing liposomes with Ca2+, instead of BAR domain proteins[247,253].
Experiments have shown that divalent metal ions, such as Ca2+ and Mg2+, can induce
formation of nano-sized domains[253-255]. In sharp contrast with the liposome control in
Fig. 56A, the presence of Ca2+ consumes the liposomes mainly into small vesicles with
diameters around 20 nm (Fig. 56B). Tubules can occasionally be observed. Similar
vesiculation has been reported for BAR domain proteins and proteins containing
amphipathic insertion helices like the ENTH domain. The preliminary result
demonstrates that PI(4,5)P2 clustering induces membrane morphological changes. The
Ca2+ induced PI(4,5)P2 clustering coincides with a surface pressure drop at constant area
in the lipid monolayer system[253], which provides a basis for the membrane
deformation to occur. The PI(4,5)P2 clustering induced membrane deformation might be
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an additional mechanism employed by BAR domains. Future studies such as
quantifications of membrane area changes by transferring PI(4,5)P2-containing GUVs
into the Ca2+ solution or the fluorescent PI(4,5)P2 quenching assay may provide more
insights to understand membrane bending mechanisms of BAR domain proteins.
7.4 BIN1 in T cells
The BIN1 gene is implicated in several human diseases, such as myopathies,
Alzheimer’s disease and cancers. BIN1 expression is found in Jurkat cells, which are
human T lymphocyte cells that have been extensively used to study T cell signaling. The
role of BAR domains in the immune signaling process remains unknown. I am interested
in the question if the membrane deformation capacity of BAR domains is involved in the
signaling receptor recycling process during T cell activation. The EGFP-conjugated BIN1
N-BAR domains were overexpressed in the Jurkat cells. Cells were spread and stimulated
on the glass surface covered by the anti-CD3 antibody OKT3 and visualized by the total
internal reflection microscopy (TIRF). TIRF only excites the fluorescent molecules close
to the surface, allowing detailed examination of the molecule dynamics on plasma
membranes. Cells were spread on the glass surface treated with Poly-L-Lysine (PLL) as
the unstimulated control. Fig. 57 demonstrates the time-course images of BIN1
fluorescence intensities on the plasma membranes in the activated or non-activated cells.
As shown in Fig. 57A, on the plasma membrane of OKT3-stimulated Jurkat cells, BIN1
appeared as dynamic fluorescent speckles at the cell edges. The fluorescence speckles
then transformed into tubular structures and were pulled to the center of the cells. The
cycle of speckle formation-tubulation-movement towards cell center-disappear repeats
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throughout the entire activation time. For the Jurkat cells treated with PLL, BIN1 forms
clusters on the plasma membranes as well, particularly at the cell edges (Fig. 57B).
However, the number of the BIN1 clusters and the BIN1-positive tubules are reduced
compared to the stimulated cells. Future studies are needed to investigate which signaling
proteins co-localizes with those BIN1-coated tubules, who is the force-generator to pull
them to the center of the cells and what are the roles of the dynamic tubulations in the
signaling transduction during immune responses.
In order to examine the spatial distribution of endogenously expressed BIN1
proteins, we added Jurkat cells to glass-bottom dishes coated with OKT3 antibodies or
PLL. After the desired contact time with the stimulatory surface, cells were fixed and
immunostained by the BIN1 antibody and a fluorophore-labeled secondary antibody. The
confocal images in Fig. 58 show that in the stimulated cells, BIN1 is recruited to the
plasma membrane, because accumulations of fluorescence were observed on the edges of
the cells (Figs. 58A&B). On the contrary, in the resting Jurkat cells, the fluorescent BIN1
is homogeneously distributed inside the cells (Fig.58C). Quantifications shown in Fig.
58D clearly demonstrate that the percentage of the cells showing BIN1 accumulations on
the edges is significantly higher in the stimulated cells compared to the resting cells.
However, how and why BIN1 binds to plasma membranes during T cell activation is still
elusive.
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Fig. 49 WT distal arm of a BAR dimer is important for retaining membrane
deformation capacity.
Representative confocal images of C2C12 myoblasts expressing EGFP-conjugated
mutations at the tip region of BIN1 N-BAR domains are shown. Mutations capable of
tubulating membranes are highlighted in the red boxes. Scale bar: 10 µm.
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Fig. 50 H155 is an essential residue in BIN1 N-BAR domain that enhances
membrane deformation capacity.
A) Representative confocal images of C2C12 myoblasts expressing the EGFP-tagged
BIN1 N-BAR mutants. Scale bar: 10 µm. B) SDS-PAGE characterizations of the
recombinant H155R and D151N/H155R double mutant in the chemical crosslinking
assay via BS3. Proteins were incubated in the absence or presence of 100% DOPS LUVs
(0.1 mg/mL, final concentration) at room temperature for 30 min. Indicated amount of
BS3 (Bis[sulfosuccinimidyl] suberate) is added in each sample followed by incubation at
37 °C for 2 min. Samples are analyzed by SDS-PAGE gel and stained by coomassie
staining. In the absence of liposomes, the two mutants are crosslinked into dimers with
MW around 66 kDa. In the presence of liposomes, both the H155R and D151N/H155R
mutants show oligomeric bands at 0.5 mM BS3 concentration. Further increasing
crosslinker concentration yields species that cannot enter the resolving gel. C) Electron
micrographs of incubating BIN1 N-BAR bearing the H155R and D151N/H155R
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mutations with liposomes consisting of 60% DOPC/20% DOPS/10% PI(4,5)P2/10%
DOPE. Both mutants are able to induce tubulations from the membranes. Buffer: 20 mM
Hepes, 150 mM NaCl, pH 7.4. Scale bar: 200 nm.
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Fig. 51 Schematic illustration of the hypothesis that the distal arm of BAR dimers
mediates protein lattice assembly on membranes through potential D151-H155
interactions.
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Fig. 52 BIN1 induced membrane tubules do not co-localize with actin filaments in
vivo.
C2C12 myoblasts expressing EGFP-actin and BIN1-FL-mKate imaged by the confocal
microscope. The third column shows combined images of green & red channels. Middle
panel: the zoomed-in image of a cell showing the details of the spatial correlations
between actin and BIN1. The white stroke highlights the direction of an actin filament,
whereas the yellow stroke highlights the direction of a BIN1-positve tubule. Bottom
panel: a cell expressing both actin and BIN1-FL shows that area enriching in BIN1coated membrane tubules (yellow box) and area enriching in actin filaments (white box)
are mutually exclusive. Scale bar: 10 µm.
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Fig. 53 N-WASP localizes to the BIN1-decorated membrane tubules in C2C12 cells.
A) Schematic illustration of domain structure of N-WASP. The binding partner of each
domain is labeled. B) Representative images of C2C12 myoblasts expressing GFPconjugated N-WASP and WH1 domain. Scale bar: 10 µm. Homogeneously distributed
fluorescence intensities are observed in cells. C) Co-expression of GFP-conjugated WH1
domain and mKate-conjugated BIN1-FL isoform8 in C2C12 cells. BIN1-FL induces
membrane tubulation and WH1 domain is localized on the BIN1-positive tubules.
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Fig. 54 N-WASP is recruited to membranes via BIN1-FL.
A) Confocal images of Alexa594-labeled N-WASP alone, N-WASP with Alexa488labeled BIN1 N-BAR* and N-WASP with Alexa488-labeled BIN1-FL on membranes
containing 60% DOPC/20% DOPS/10% DOPE/10% PI(4,5)P2. Buffer: 20 mM Hepes, 50
mM NaCl, pH 7.4. Only BIN1-FL enhances the recruitment of N-WASP to membranes.
B) Bar plot of the averaged N-WASP fluorescence intensities on GUV equators under the
experimental conditions in A). The percentage of GUVs showing N-WASP binding is
quantified under each incubation condition. Error bar: SEM.

	
  

188	
  

	
  

Fig. 55 BIN1 N-BAR* domains induce heterogeneity on GUVs
Confocal images of GUVs incubated with A) 1 µM; B) 2 µM and C) 4 µM BIN1 NBAR* domains (labeled with Alexa488). Heterogeneous fluorescence intensities in both
protein and lipid channels are observed. Such heterogeneity disappeared at low protein
bulk concentrations. Lipid compositions: 60% DOPC/20% DOPS/10% DOPE/10%
PI(4,5)P2. Buffer: 20 mM Hepes, 50 mM NaCl, pH 7.4.
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Fig. 56 Divalent ion Ca2+ induces vesiculation from liposomes.
Transmission electron micrographs of liposomes consist of 60% DOPC/30% DOPE/10%
PI(4,5)P2 A) alone or with 2 mM Ca2+. Compared to the liposomes control, membranes
containing PI(4,5)P2 were consumed into small vesicles after the addition of Ca2+.
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Fig.57 BIN1 N-BAR induced clusters and tubules on the plasma membranes of
Jurkat cells.
Time-course TIRF images of Jurkat cells expressing EGFP-conjugated BIN1 N-BAR
domains. A) Cells stimulated by OKT3 antibodies coated on the glass. B) Cells were
spread on the glass coated with PLL.
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Fig. 58 Endogenous BIN1 is recruited to the plasma membranes during T cell
activation.
A) & B) Confocal images of endogenous BIN1 in Jurkat cells on the OKT3 or C) PLL
treated surfaces. B) is the zoomed-in image of the area in the white box in A). Cells were
immunostained by a BIN1 antibody. D) Quantification of the cell percentages
demonstrating the edge accumulations of BIN1 fluorescence intensities. The statistical
difference is tested by the Student t-test. ***: p < 0.001.
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Appendix
Plasmids and detailed purification protocol of N-WASP proteins
The 6x his-tagged Rat N-WASP-ΔEVH1 (residues 151–501) is in pSHA plasmid,
which is a derivative of T7 driven pET vector. This plasmid was generously provided by
Dr. Jack Taunton from University of California (San Francisco, San Francisco, CA)[256].
The N-WASP construct encoding amino acids 151-501 is conjugated with a 6x
his-tag. The plasmid was transfected into the BL21-Codon Plus (DE3)-RIL bacteria. A
single colony was picked and cultured in 100 mL LB medium overnight at 37 °C. On the
second day, the starter culture was transferred into 3 L of LB medium, shaking at 225
rpm and 37 °C until reaching OD600 ~ 0.8. 1 mM IPTG was added and cells were
continuously cultured at 18 °C overnight before harvest through centrifugation.
Cells were resuspended in the lysis buffer (20 mM Phosphate, 500 mM NaCl, 20
mM imidazole, pH 7.4) and lysed on ice via tip sonication. The supernatant of cell lysate
was applied to a Ni column equilibrated with the lysis buffer and eluted with elution
buffer (20 mM Phosphate, 500 mM NaCl, 500 mM imidazole, pH 7.4). The Eluents from
the Ni column were further purified by gel filtration (20 mM Hepes, 150 mM NaCl, pH
7.4). The N-WASP ∆EVH1 is not highly overexpressed in E. Coli. The cell lysate ±
IPTG may not look as dramatic on the SDS-PAGE gel. Concentrated protein bands will
be observed from the eluent of Ni Column purification. The expected molecular weight
of His-tagged N-WASP-ΔEVH1 is 41 kDa. However, N-WASP migrates higher on the
gel and the protein band shows at the position corresponding to 50 kDa. The N-WASP
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proteins does not express at 37 °C. 18 or 20 °C for 14 to 16 hours or 25 °C for 6 hours are
more suitable for protein expression induction by IPTG. In order to improve protein yield,
Terrific Broth (TB) instead of Lysogeny Broth (LB) can be chosen for bacteria culture.
The fractions from gel filtration column were analyzed by the SDS-PAEG
electrophoresis. The final product was concentrated and labeled with Alexa594 C5maleimide. Free fluorophores were removed via desalting columns, which are connected
consecutively, in 20 mM Hepes, 150 mM NaCl buffer.
The Rat GFP-N-WASP (full length) and GFP-N-WASP-ΔWH1 (residue 148-501)
were kindly provided by Dr. Michael Way from European Molecular Biology Laboratory
(Meyerhofstrasse, Heidelberg, Germany)[257]. Human GST-Cdc42 (WT) in pGEX-2T
vector (https://www.addgene.org/12175/) and human EGFP-Cdc42 (WT) in pcDNA3
vector (https://www.addgene.org/12599/) were purchased from Addgene (Cambridge,
MA). The WT human Cdc42 gene was inserted between EcoRI and XhoI cloning sites.
The EGFP tag was conjugated at the N-terminus of Cdc42 protein.
Differentiation of C2C12 myoblasts
C2C12 myoblasts are cultured in the Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 20% fetal bovine serum. Cells are maintained in the
incubator at 37°C and 10% CO2. Culture medium is changed every 24-36 hours until
reaching 70% confluence. In order to induce differentiation from myoblasts into
myotubes, cells are transferred into the differentiation medium consisting of DMEM with
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2% horse serum. Cells are placed in the incubator at 37°C and 10% CO2 and the
differentiation medium is changed every 24 hrs.
The formation of myotubes is monitored by visualization under transmit light
microscopy every 12 hours (Fig. 59).
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Fig. 59 Differentiation of C2C12 myoblasts into myotubes.
Cells are visualized under transmit light microscopy. Elongations and fusions of C2C12
myoblasts appear after 24 hours. Myotubes with multiple nuclei are observed in the
differentiation medium. The arrows point to the fused nuclei in the myotubes.
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Fig. 60 Hypothesized molecular mechanisms by which BIN1-FL is autoinhibited on
(-) PI(4,5)P2 membranes
Depending on the position of the exon10-SH3 autoinhibitory complex, the MC-S&G
capacity of BIN1-FL can be compromised by A) impaired membrane binding interface, B)
H0 insertion, C) protein oligomerization and D) protein conformation.
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Table of Abbreviations

	
  

A

Acidic region

a.u.

Arbitory Unit

ARF

ADP Ribosylation Factor

BAR,

Bin/Amphiphysin/Rvs

BAR-PH

BAR-Pleckstrin Homology Domain

BIN1 N-BAR*

BIN1 N-BAR Domain Containing Exon10

BS3

Bissulfosuccinimidyl Suberate

BSA

Bovine Serum Albumin

C

Cofilin Homology segment

CCPs

Clathrin-Coated Pits

CD

Circular Dichroism

CID

Chemically Inducible Dimerization Assay

CLAP

Clathrin And AP2binding Domain

CLIP-170

Cytoplasmic Linker Protein 170

CME

Clathrin-Mediated Endocytosis

CNM

Centronuclear Myopathy

CRIB

Cdc42/Rac Interactive Binding

DM

Myotonic Dystrophies

DMEM medium

Dulbecco's Modified Eagle Medium

DOPC

1,2-Dioleoyl-Sn-Glycero-3-Phosphocholine

DOPE

1,2-Dioleoyl-Sn-Glycero-3-Phosphoethanolamine

DOPS

1,2-Dioleoyl-Sn-Glycero-3-Phospho-L-Serine

dsDNA

Double Strand DNA

DSPE-Bio-

Distearoylphosphatidylethanolamine-N198	
  

	
  

PEG2000

	
  

(Biotinyl(Polyethyleneglycol)2000)

ENTH

Epsin N-Terminal Homology

ERP

Electron Paramagnetic Resonance

exon10

PI(4,5)P2-Interacting Motif

F-BAR

Fes/CIP4 Homology BAR

FBS

Fetal Bovine Serum

FCHo

Fer/Cip4 Homology Domain-Only Protein

F.I.

Fluorescence Intensities

FMOC

9-Fluorenylmethoxycarbonyl

FPLC

Fast Protein Liquid Chromatography

FRAP

Fluorescence Recovery After Photobleaching

FRET

Förster Resonance Energy Transfer

GBD

G-Protein Binding Domain

GFP

Green Fluorescent Protein

GST

Glutathione S-transferase

GUV

Giant Unilamellar Vesicle

GWAS

Genome-Wide Association Studies

H0

N-Terminal Inserting Helices

HPLC

High-Performance Liquid Chromatography

I-BAR

Inverse BAR

IP3

D-Myo-Inositol-1,4,5-triphosphate

IRSp53

Insulin Receptor Substrate p53

ITC

Isothermal Titration Calorimetry

LOAD

Late-Onset Alzheimer’s Disease

LUV

Large Unilamellar Vesicle

MARCKS-ED

Myristoylated Alanine-Rich C-Kinase Substrate
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MBD

Myc-Binding Domain

MC-S&G

Membrane Curvature Sensing and Generation

MT

Microtubule

MTM1

Myotubularin 1

n.s.

Not Significant

N-WASP

Neuronal Wiskott-Aldrich Syndrome Protein

PAGE

Polyacrylamide Gel Electrophoresis

PARP1

Poly (ADP-Ribose) Polymerase

PCR

Polymerase Chain Reaction

PDB

Protein Data Bank

PI(4,5)P2

L-Α-Phosphatidylinositol-4,5-Bisphosphate

PM

Plasma Membranes

PRD

Proline-Rich Domain

PX-BAR

Phox-BAR Domain

SDS

Sodium Dodecyl Sulfate

SEC

Size Exclusion Chromatography

SEM

Standard Error of the Mean;

SH3

Src 3 Homology domain

SLiC

	
  

Single Liposomes Of Different Diameters And
Therefore Curvature

SM

Sphingomyelin

SNX

Sorting Nexins

SR

Sarcoplasmic Reticulum

srGAP2

SLIT-ROBO Rho Gtpase-Activating Protein 2

TEM

Transmission Electron Microscopy

TIRF

Total Internal Reflection Fluorescence Microscope
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TR-DHPE

	
  

	
  

Texasred-1,2-Dihexadecanoyl-sn-Glycero-3-PhosPhoe-Thanolamine Triethylammonium Salt

T-tubules

Transverse tubules

V

Verprolin Homology segment

WASP

Wiskott-Aldrich Syndrome Proteins

WH1

WASP Homology 1

WIP

WASP Interacting Protein

WT

Wild Type

WAVE

WASP family verprolin-homologous protein
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